US20150141984A1 - Methods for treating a lung - Google Patents
Methods for treating a lung Download PDFInfo
- Publication number
- US20150141984A1 US20150141984A1 US14/540,870 US201414540870A US2015141984A1 US 20150141984 A1 US20150141984 A1 US 20150141984A1 US 201414540870 A US201414540870 A US 201414540870A US 2015141984 A1 US2015141984 A1 US 2015141984A1
- Authority
- US
- United States
- Prior art keywords
- airway
- balloon
- electrodes
- treatment apparatus
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F7/123—Devices for heating or cooling internal body cavities using a flexible balloon containing the thermal element
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00434—Neural system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00541—Lung or bronchi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00654—Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00761—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00797—Temperature measured by multiple temperature sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00803—Temperature with temperature prediction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B2018/0212—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument inserted into a body lumen, e.g. catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/361—Image-producing devices, e.g. surgical cameras
- A61B2090/3614—Image-producing devices, e.g. surgical cameras using optical fibre
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0018—Trunk or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M2025/0096—Catheter tip comprising a tool being laterally outward extensions or tools, e.g. hooks or fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1025—Respiratory system
- A61M2210/1039—Lungs
Definitions
- the invention relates to a method for treating lung disease, and more particularly, the invention relates to a method of increasing gas exchanging of a lung by stiffening an airway of the lung.
- the lungs deliver oxygen to the body and remove carbon dioxide.
- Healthy lung tissue includes a multitude of air passageways which lead to respiratory bronchiole within the lung. These airways eventually lead to small sacs called alveoli, where the oxygen and carbon dioxide are exchanged through the ultra-thin walls of the alveoli. This occurs deep within the lungs, in an area which is accessed by a network of airways, consisting of a series of branching tubes which become narrower, shorter, and more numerous as they penetrate deeper into the lungs. As shown in FIG. 1 , tiny air sacks called alveoli 1 surround both alveolar ducts 2 and respiratory bronchiole 3 throughout the lung.
- the alveoli 1 are small, polyhedral recesses composed of a fibrillated connective tissue and surrounded by a few involuntary muscular and elastic fibers. These alveoli 1 inflate and deflate with air when we breath.
- the alveoli are generally grouped together in a tightly packed configuration called an alveolar sac. The thin walls of the alveoli 1 perform gas exchange as we inhale and exhale.
- pulmonary disease such as chronic bronchitis, and emphysema have reduced lung capacity and efficiency, typically due to the breakdown of lung tissue.
- a cross section of a diseased emphysematous lung will look like Swiss cheese due to the deterioration of the alveoli walls which leaves large spaces in the tissue.
- healthy lung tissue when seen in cross section has no noticeable holes because of the small size of the alveoli.
- the lung has larger open spaces 4 and a larger overall volume, but has less wall tissue to achieve gas exchange.
- the patient suffers from the inability to get the air out of their lungs due to the collapse of the airways during exhalation. Heavily diseased areas of the lung become overinflated. Within the confines of the chest cavity, this overinflation restricts the in-flow of fresh air and the proper function of healthier tissue, resulting in significant breathlessness. Thus, the emphysema patient must take in a greater volume of air to achieve the same amount of gas exchange. When severe emphysema patients take in as much air as their chest cavity can accommodate, they still have insufficient gas exchange because their chest is full of non-functional air filling large cavities in the lungs. Emphysema patients will often look barrel-chested and their shoulders will elevate as they strain to make room for their overinflated lungs to work.
- lung volume reduction surgery is performed to improve lung efficiency of the patient and allow the patient to regain mobility.
- lung volume reduction surgery a more diseased portion of an emphysematous lung having a large amount of alveolar wall deterioration is surgically removed.
- LVRS is performed by opening the chest cavity, retracting the ribs, stapling off, and removing the more diseased portion of the lung. This allows the remaining healthier lung tissue to inflate more fully and take greater advantage of the body's ability to inhale and exhale. Because there is more air and more gas exchange in the healthier portion of the lung, lung efficiency is improved.
- Lung volume reduction surgery is an extremely invasive procedure requiring the surgical opening of the chest cavity and removal of lung tissue. This surgery has substantial risks of serious post-operative complications, such as pneumothorax, and requires an extended convalescence.
- the present invention pertains to methods of increasing gas exchange of the lungs of a patient.
- gas exchange is increased by stiffening, strengthening, or destroying airway smooth muscle tone of at least one airway of a lung.
- a method includes: inserting an apparatus into an airway of a lung, and damaging lung cells with the apparatus to cause fibrosis to stiffen the airway so as to increase gas exchange performed by the lung.
- a method includes: inserting an apparatus into an airway of a lung; and damaging tissue in the lung with the apparatus to increase gas exchange performed by the lung.
- a method of increasing gas exchange performed by the lung includes: inserting an apparatus into an airway of a lung; and causing trauma to tissue with the apparatus to cause fibrosis to stiffen the airway.
- Causing trauma to the tissue with the apparatus includes at least one of: heating the tissue; cooling the tissue; delivering a liquid that cause trauma to the tissue; delivering a gas that cause trauma to the tissue; puncturing the tissue; tearing the tissue; cutting the tissue; applying ultrasound to the tissue; and applying ionizing radiation to the tissue.
- Another aspect of the present invention pertains to a method including: inserting an apparatus into an airway of a lung; and destroying airway smooth muscle tone with the apparatus to increase gas exchange performed by the lung.
- a further aspect of the present invention pertains to a method of increasing gas exchange performed by a lung.
- the method includes inserting an apparatus into an airway of a lung, and damaging airway tissue with the apparatus to thicken a wall of the airway.
- the present invention provides advantages of a minimally invasive procedure for surgically treating the effects of pulmonary disease, such as chronic pulmonary disease, without the complications associated with conventional surgery.
- FIG. 1 is a cross-sectional view of an alveolar sack of a healthy lung
- FIG. 2 is a cross-sectional view of an alveolar sack of a diseased lung
- FIG. 3 is an illustration of a lung having a diseased lower portion prior to treatment according to the present invention.
- FIG. 4 is a perspective view of the airway of a lung, wherein the smooth muscle tissue, alveolar sacks, and alveoli are illustrated;
- FIG. 5 is a cross-sectional view of the airway of FIG. 4 taken along the line 5 - 5 of FIG. 4 ;
- FIG. 6 is a schematic side view of lungs being treated with the treatment apparatus in accordance with one embodiment of the present invention.
- FIG. 6A is a schematic cross-sectional view of the airway of FIG. 6 before treatment taken along the line 6 A- 6 A of FIG. 6 ;
- FIG. 6B is a schematic cross-sectional view of the airway of FIG. 6A after being treated in accordance with one method of the present invention
- FIG. 7 is a schematic side view of lungs being treated with a treatment apparatus in accordance with one embodiment of the present invention.
- FIGS. 8 , 9 , 10 A, 10 B, 11 A and 11 B are perspective views of heat treatment apparatus for use with the methods of the present invention.
- FIGS. 12A and 12B are cross-sectional views of heat treatment apparatus for use with the methods of the present invention.
- FIG. 13A is a schematic view of an embodiment of the treatment apparatus for use with the methods of the present invention.
- FIG. 13B is an enlarged view of the circled portion of FIG. 13A ;
- FIG. 13C illustrates another embodiment of a treatment apparatus for use with the methods of the present invention
- FIGS. 14A , 14 B, 15 A, 15 B, 16 A, 16 B, 17 A, and 17 B illustrate additional embodiments of the heat treatment apparatus which employ RF energy for use with the methods of the present invention
- FIG. 18 illustrates an embodiment of the heat treatment apparatus which employs circulating heated fluid for use with the methods of the present invention
- FIG. 19 illustrates an embodiment of the heat treatment apparatus that has both resistive heating and inductive heating for use with the methods of the present invention
- FIGS. 20A and 20B illustrate an embodiment of a heat treatment apparatus that employs electrodes positioned on the outer surface of a balloon for use with the methods of the present invention
- FIGS. 21 , 22 , and 23 show embodiments of the heat treatment apparatus that employ diametrically adjustable electrodes for use with the methods of the present invention
- FIG. 24 illustrates a heat treatment apparatus with multiple electrodes for use with the methods of the present invention
- FIG. 25 illustrates a heat treatment apparatus with multiple balloons for use with the methods of the present invention
- FIG. 26 is a schematic side view of one embodiment of a heat treatment apparatus that employs two collapsible and retractable electrodes for use with the methods of the present invention
- FIG. 27 is an enlarged partial cross-sectional view of a distal end of another embodiment of a heat treatment apparatus having one collapsible electrode for use with the methods of the present invention
- FIG. 28 is a side cross-sectional view of an alternative embodiment of a heat treatment apparatus having two wire shaped electrodes for use with the methods of the present invention
- FIG. 29 is a side cross-sectional view of the device of FIG. 28 in an enlarged state within a bronchial tube;
- FIG. 30 is a side cross-sectional view of an alternative embodiment of a heat treatment apparatus with four electrodes in an enlarged state within a bronchial tube for use with the methods of the present invention
- FIG. 30A is an end view of the device of FIG. 30 ;
- FIG. 31 is a side cross-sectional view of an alternative embodiment of a heat treatment apparatus with a loop shaped electrode in a contracted state for use with the methods of the present invention
- FIG. 32 is a side cross-sectional view of the apparatus of FIG. 31 with the electrode in an expanded state within a bronchial tube for use with the methods of the present invention
- FIG. 33 is a side cross-sectional view of an alternative embodiment of the invention with a plate shape electrode in a contracted state for use with the methods of the present invention
- FIG. 34 is an end view of the apparatus of FIG. 33 in the contracted state
- FIG. 35 is a side cross-sectional view of the apparatus of FIG. 33 with the plate shaped electrodes in an expanded configuration
- FIG. 36 is an end view of the expanded apparatus of FIG. 35 for use with the methods of the present invention.
- FIG. 37 is a side cross-sectional view of a body conduit and an apparatus for treating the body conduit according to the present invention.
- FIG. 38 is a schematic side view of lungs being treated with a treatment apparatus in accordance with one aspect of the present invention.
- FIG. 39 is a side cross-sectional view of a distal end of an embodiment of a treatment apparatus for use with the methods of the present invention.
- FIG. 40 is a side cross-sectional view of a distal end of another embodiment of a treatment apparatus for use with the methods of the present invention.
- FIG. 41 is a side cross-sectional view of a distal end of a further embodiment of a treatment apparatus for use with the methods of the present invention.
- FIG. 42 is a side cross-sectional view of another embodiment of a treatment apparatus for use with the methods of the present invention.
- FIGS. 43A and 43B are side views of two variations of an embodiment of a treatment apparatus having a plurality of wire shaped electrodes for use with the methods of the present invention
- FIG. 43C is a cross-sectional side view of another variation of a treatment apparatus having a plurality of wire shaped electrodes for use with the methods of the present invention.
- FIG. 44 is a side view of another embodiment of a treatment apparatus with electrodes positioned on expandable balloons for use with the methods of the present invention.
- FIG. 45 is a perspective view of an embodiment of a treatment apparatus with electrodes positioned in grooves for use with the methods of the present invention.
- FIG. 46 is a perspective view of an embodiment of a treatment apparatus with electrodes in a biasing element for use with the methods of the present invention
- FIG. 47 is a perspective view of an embodiment of a treatment apparatus with electrodes and a biasing element for use with the methods of the present invention
- FIG. 48 is a side view of an embodiment of a treatment apparatus in an unexpanded position for use with the methods of the present invention.
- FIG. 49 is a side view of the treatment apparatus of FIG. 48 in an expanded position
- FIG. 50 is a side view of an embodiment of a treatment apparatus in an expanded position for use with the methods of the present invention.
- FIG. 51 is a side view of an embodiment of a treatment apparatus having a plurality of lumens containing electrodes for use with the methods of the present invention
- FIG. 52 is a side view of an embodiment of a treatment apparatus having electrodes exposed by cut away sections of a tube for use with the methods of the present invention
- FIG. 53 is a side cross-sectional view of an embodiment of a treatment apparatus with electrodes positioned on an expandable balloon for use with the methods of the present invention
- FIG. 54 is a schematic side view of an embodiment of a treatment apparatus with a balloon for heating of tissue for use with the methods of the present invention
- FIG. 55 is a side cross-sectional view of another embodiment of a treatment apparatus for treatment with heated fluid
- FIG. 56 is a side view of a treatment apparatus having a cryoprobe for use with the methods of the present invention.
- FIG. 57 is a cross-sectional view of an embodiment of a treatment apparatus that includes a brush for with the methods of the present invention
- FIG. 58 is a side cross-sectional view of the device illustrated in FIG. 57 after it has treated the airway of a lung;
- FIG. 58A is a cross-sectional view of the device illustrated in FIG. 58 taken along the line 58 A- 58 A of FIG. 58 ;
- FIG. 59 is a side cross-sectional view of a treatment apparatus that includes a device for cutting or slicing the tissue of an air way of a lung in accordance with methods of the present invention
- FIG. 60 illustrates a partial side cross-sectional view of the embodiment illustrated in FIG. 9 , where the treatment apparatus has treated the tissue of the lung;
- FIG. 60A is a cross-sectional view of the device illustrated in FIG. 60 taken along the line 60 A- 60 A of FIG. 60 ;
- FIG. 61 is a side cross-sectional view of another embodiment of a treatment apparatus, where the treatment apparatus includes a plurality of members for slicing or cutting the air way of a lung in accordance with the methods of the present invention
- FIG. 62 illustrates the treatment apparatus of FIG. 61 in a deployed position
- FIG. 62A is a cross-sectional view of the device illustrated in FIG. 62 taken along the line 62 A- 62 A of FIG. 62 .
- FIG. 63 illustrates a further embodiment of a treatment apparatus where the treatment apparatus includes a plurality of pins that puncture or penetrate the air way of a lung in accordance with the methods of the present invention
- FIG. 64 illustrates the treatment apparatus of FIG. 63 in a deployed position
- FIG. 64A is a cross-sectional view of the device illustrated in FIG. 64 taken along the line 64 A- 64 A of FIG. 64 ;
- FIG. 65 illustrates an alternative embodiment of the treatment apparatus illustrated in FIGS. 63 and 64 for use with the methods of the present invention
- FIGS. 66-70 illustrate embodiments of treatment apparatus that deliver a fluid to the airway to treat the lungs in accordance with the methods of the present invention
- FIG. 71 is a side view of a bronchoscope that may be used to deploy the above-illustrated treatment apparatus when practicing the present invention.
- FIG. 72 is a cross-sectional view of the device illustrated in FIG. 71 taken along the line 72 - 72 of FIG. 71 .
- FIG. 3 illustrates human lungs 20 having a left lung 30 and a right lung 32 .
- a diseased portion 31 is located at the lower portion or base of the left lung 30 (indicated by the volume of the lung below the dashed line on the left lung).
- the diseased portions of an unhealthy lung are not generally located in discrete areas. That is, the diseased portions may not be distributed heterogeneously, and are more homogeneous.
- the trachea 22 extends down from the larynx and conveys air to and from the lungs.
- the trachea 22 divides into right and left main bronchi 24 , which in turn form lobar, segmental, and sub-segmental bronchi or bronchial passageways.
- the bronchial tree extends to the terminal bronchiole.
- alveolar sacs 26 contain alveoli 28 that perform gas exchange as humans inhale and exhale.
- FIG. 4 illustrates an airway 25 of the lung 30 in greater detail.
- the airway 25 is a bronchial tube, air passage, lumen, bronchial airway, or respiratory bronchiole of the lung 30 .
- the airway 25 includes smooth muscle tissue that helically winds around the bronchiole to define a duct of the airway 25 through which air may be inhaled and exhaled during operation of the lung.
- the smooth muscle tissue is arranged around the airways in a generally helical pattern with pitch angles ranging from about ⁇ 30 to about +30 degrees. As the airway 25 branches deeper into the lung, more and more alveolar sacs 26 and alveoli 28 appear, as shown in FIGS. 3 and 4 .
- FIG. 5 illustrates a light microscopic cross-section of the tissue of the airway 25 , which is a collection of cells and intercellular substances that surround the cells, together defining the airway 25 .
- the airway 25 defines an airway duct 40 through which gases are inhaled and exhaled.
- the airway 25 of FIG. 5 is a medium sized bronchus having an duct diameter DI of about 3 mm.
- the airway 25 includes a folded inner surface or epithelium 38 surrounded by stroma 32 and the smooth muscle tissue 27 .
- the airway 25 also has mucous glands 34 and cartilage 30 surrounding the smooth muscle tissue. Nerve fibers and blood vessels 36 also surround the airway.
- the smooth muscle tissue 27 is part of the overall tissue of the airway 25 .
- the diseased portion 31 of the lung 30 is located at the lower portion or base of the lung.
- this diseased portion 31 has been stricken by emphysema.
- the emphysematous portion 31 of the lung 30 generally includes sections in which the walls between the adjacent alveoli 28 have deteriorated to a degree that the lung tissue looks like Swiss cheese in cross section. When this occurs, pulmonary function is impaired to a great degree.
- the pulmonary system utilizes two simple mechanisms, air exchange into and out of the lungs 30 and gas exchange into and out of the blood.
- both of these mechanisms are impaired, leading to dyspnea (shortness of breath), limitations in physical activities, and increased incidence of related diseases.
- dyspnea shortness of breath
- limitations in physical activities and increased incidence of related diseases.
- To improve their condition either or both of these impairments need to be improved.
- One way to address this is by restoring some of the lost air exchanging ability.
- Air exchange is created by movement of muscles that increase and decrease the pressures around the lungs. Inspiration occurs when a decrease in pressure around the lungs to below atmospheric pressure expands the lungs, which in turn causes the pressure in the terminal end points of the airways (the alveoli 28 ) to drop below atmospheric. This pulls the air into the alveoli 28 through the ‘ conducting airways 25 .
- Exhalation is a passive process. Normal exhalation occurs when the muscles relax, allowing the natural elasticity of the lung structure to expel the air from within. In addition to making up the driving force to expel air from the lungs, the elasticity also mechanically helps keep conducting airways from collapsing. It is the-loss of elasticity of lung tissue that leads to the condition known as “dynamic airway collapse”.
- airway obstruction in the emphysematous patient has two components, “small airways disease” and dynamic airway collapse of the mid-sized airways. Both contribute to the patient's inability to get adequate amounts of air to and from the alveoli 28 , which are the gas exchanging membranes in the lungs. Small airways disease is primarily caused by mucous plugging and inflammation of the small (less than 2 mm in diameter) airways, whereas dynamic airway collapse of the mid-sized airways (3 mm-6 mm) is mechanical in nature.
- Embodiments of the present invention aim to increase the strength of the airway walls to keep the airway open, which will increase gas exchange.
- the present invention is based in part on the discovery that the airway 25 is strengthened because of the natural formation of fibrotic tissue, such as scar tissue, in response to trauma or injury. Fibrosis is the formation of fibrous or fibrotic tissue as a reparative or reactive process, i.e., regrowth of tissue after injury. The formation of fibrotic tissue essentially deposits additional tissue to the airway, which strengthens the wall of the airway. This stimulation of additional material will increase the thickness of the airway wall, thus strengthening the airway to help prevent the airway from collapsing during exhalation.
- the airway 25 is stiffened because the fibrotic tissue is thicker than the previous diseased tissue supporting the airway. As described below, the trauma can be caused by damaging the airway tissue, such as by delivering heat to the airway and/or by mechanical insult to the airway tissue.
- the balance of forces during exhalation is shifted back toward keeping the airways open.
- Stiffening airway wall by stimulating the deposition of fibrotic tissue helps prevent airway collapse during exhalation, and will thus result in an increase in airflow.
- the greater the scarring or injury the greater the build-up of fibrotic tissue.
- the airway tissue is injured to such an extent that the airway wall thickens, it is preferable not to create so much fibrotic tissue that the airway closes. That is, it is preferable that the formation of fibrotic tissue does not cause stenosis. Stenosis may be prevented by controlling the extent of injury or damage to the airways of the lung. It is also preferable not to ablate or vaporize large amounts of airway tissue such that the airway loses its structure. Hence, it is preferable to damage enough airway tissue to cause fibrotic tissue to develop and stiffen the existing airway wall, rather than completely destroying the existing airway wall to define a new cavity, and rather than destroying so much tissue that a mass of scar tissue blocks the airway.
- the gas exchange of the lung 30 can also be increased in accordance with the embodiments of the present invention by destroying the airway smooth muscle tone.
- Smooth muscle tone refers to ability of the smooth muscle of the airway to respond to signals that trigger the airway smooth muscle to continually and partially contract. By destroying the smooth muscle or disrupting the smooth muscle's ability to respond to such signals, the contraction force is removed and the airway will become larger.
- the pressure in the airway is higher than the alviolar pressure that acts on the outside of the airway.
- a “floppy” or diseased airway will remain open on inspiration.
- the alviolar pressure builds and at some point exceeds the air pressure in the airway.
- a floppy airway will be more prone to collapse and inhibit the flow of air out of the alveoli.
- the smooth muscle tone may further restrict the airway diameter. Hence, the removal or destruction of at least some of the smooth muscle tone will beneficially increase gas exchange during the expiration cycle.
- the present invention strives to relieve the effects of emphysema and other forms of pulmonary disease by increasing the efficiency of gas exchange in the lung 30 .
- this may be achieved by inserting an apparatus into an airway of the lung through the trachea 22 , and then damaging tissue of the airway 25 to cause fibrosis to strengthen the airway and/or to destroy smooth muscle tone of the airway.
- bronchial tubes can be employed to treat a bronchial tube regardless of whether the tube lumen has collapsed or not.
- the devices can be used to treat bronchial tubes that have not collapsed, are partially collapsed, or are fully collapsed.
- bronchial tubes may exhibit different degrees of closure depending on the state of respiration.
- a bronchial tube may have a fully expanded lumen during inhalation but partially or completely closed during exhalation.
- FIG. 6 is a schematic view of the lung 32 being treated with a treatment apparatus 40 in accordance with a method of the present invention.
- the preferred apparatus 40 is an elongated member that may be electronically or manually controlled by a surgeon or controller 42 to damage lung cells to cause fibrosis to stiffen the airway and/or to destroy smooth muscle tone of the airway so as to increase gas exchange performed by the lung.
- the damaging of cells of airway tissue and/or destruction of smooth muscle tone of the airway with the apparatus 40 may be accomplished by any one of, or combinations of, the following:
- FIG. 6A is a representational cross-sectional view of the airway 25 of the lung 32 during expiration before it has been treated with the apparatus 40
- FIG. 6B is a representational cross-sectional view of the airway 25 during expiration after it has been treated with the apparatus 40 in accordance with a preferred method of the present invention FIG. 6B .
- the airway 25 is partially collapsed due to pulmonary disease, such as described earlier. In this state, air exchange is adversely affected.
- the treatment apparatus 40 has damaged the tissue of the airway 25 so as increase the thickness of the airway wall. More particularly, the airway 25 has been strengthened because of the natural formation of fibrotic tissue in response to trauma or injury. The formation of the fibrotic tissue has deposited additional tissue to the airway, which strengthens the wall of the airway.
- the airway wall shown in FIG. 6B is thicker than the airway wall shown in FIG. 6A . This increased thickness of the airway wall strengthens the airway to help prevent the airway from collapsing during exhalation.
- the airway illustrated in FIG. 6B is not collapsed to the same extent as the untreated airway illustrated in FIG. 6B .
- the lung 32 is stricken with emphysema, the previously described balance of forces during exhalation is shifted back toward keeping the airway 25 open, which helps prevent airway collapse during exhalation, and will thus result in an increased airflow and gas exchange.
- FIGS. 7-70 illustrate embodiments of treatment apparatus or devices 40 A- 40 AX that can be used to destroy airway smooth muscle tone and/or damage airway tissue to induce fibrosis according to the present invention.
- the treatment apparatus may be actuated continuously for a predetermined period while stationary, may be pulsed, may be actuated multiple times as they are moved along an airway, may be operated continuously while moving the treatment apparatus in an airway to achieve a “painting” of the airway, or may be actuated in a combination of any of these techniques.
- the particular energy application pattern desired can be achieved by configuring the treatment apparatus itself or by moving the treatment apparatus to different desired treatment locations in the airway.
- FIG. 7 is a schematic side view of lungs being treated with a treatment apparatus 40 A in accordance with one embodiment of the present invention.
- the treatment apparatus 40 A is an elongated member for delivery of energy from an energy source 50 to a treatment site 52 at an airway of the lungs.
- the energy may be delivered by the treatment apparatus 40 A in a variety of treatment patterns to achieve a desired response. Examples of patterns are discussed in further detail below.
- the energy which is delivered by the treatment apparatus 40 A may be any of a variety of types of energy including, but not limited to, radiant, laser, radio frequency, microwave, heat energy, or mechanical energy (such as in the form of cutting or mechanical dilation).
- the delivery of laser or light energy may be in conjunction with the delivery of a photodynamic agent, where the laser or light energy stimulates the photodynamic agent and initiates a cytotoxic, or cell damaging chemical reaction.
- the airway smooth muscle tone can be destroyed and the cells of the airway tissue of the airway 25 can be damaged by exposing the tissue 27 to energy.
- the damaging of the airway tissue by energy will induce fibrosis so as to strengthen the airway.
- a pattern for treatment can be chosen from a variety of patterns including longitudinal stripes, circumferential bands, helical stripes, and the like as well as spot patterns having rectangular, elliptical, circular or other shapes.
- the size, number, and spacing of the treatment bands, stripes, or spots are chosen to provide a desired clinical effect of strengthening the airway wall or destroying the smooth muscle tone of the airway without completely destroying the airway or obstructing the airway.
- FIG. 8 illustrates another treatment apparatus 408 for use with one embodiment of the present invention.
- the treatment apparatus 408 includes an elongated, cylindrical member 90 having a heating element that has a plurality of electrodes designated 92 and 94 located on the outer surface of the member.
- the electrodes are electrically connected to a source of RF energy via connector 98 .
- each electrode is configured as a band as shown that has a width of about 0.2 mm to about 3 mm, and preferably each electrode band is separate from the next by a distance of about 0.5 mm to 10 mm.
- the heating element may include one or more electrode bands.
- the treatment apparatus 408 has a distal end 100 that is rounded to reduce the amount of resistance encountered when the apparatus is advanced into the airway 25 .
- the apparatus 408 has an outer diameter that is approximately equal to (or can be expandable to equal) the desired final inner diameter of the lumen of an air passage to be treated. Typically, the outer diameter ranges from about 1.3 mm to about 7 mm.
- the heating element comprises a plurality of electrode bands
- the distance between each band is preferably less than about three times the outer diameter of the apparatus. The effect will be that the patency bands formed on the wall of the lumen by the electrodes 92 , 94 will be separated from each other by no more than a distance equal to about three times the length of the outer diameter of the lumen.
- the patency bands so configured will provide good support for the airway 25 to prevent the lumen from collapsing.
- the treatment apparatus 408 applies a sufficient amount of energy to the walls of collapsible air passages 25 to destroy airway smooth muscle tone and damage cells of the airway tissue to induce fibrosis and create a more rigid wall that can support a non-collapsed lumen.
- energy emanates from the electrode bands 92 , 94 , so that following treatment with this particular apparatus, the walls of the air passage 25 will develop patency bands corresponding to locations along the walls.
- the contours of the patency bands should substantially match those of the electrode bands. As is apparent, the number and width of each electrode band are not critical.
- the apparatus In the case where there is only one electrode band, it may be necessary to move the apparatus and heat more than one area of the lumen wall in order to damage sufficient amounts of the airway wall to induce enough fibrosis to increase the strength of the airway wall such that it is no longer collapsed, i.e., the lumen remains substantially open during normal breathing.
- an RF generator is activated to provide suitable RF energy, preferably at a selected frequency in the range of 10 MHZ to 1000 MHZ.
- the emitted energy is converted within the tissue into heat in the range of about 40° C. to about 95° C.
- RF energy is no longer applied after there has been damage to the tissue to induce a healing response.
- the RF energy is applied for a length of time in the range of about 1 seconds to about 120 seconds.
- Suitable RF power sources are commercially available and well known to those skilled in the art.
- the RF generator employed has a single channel, delivering approximately 1 to 25 watts of RF energy and possessing continuous flow capability. The rate of transformation can be controlled by varying the energy delivered to the heating element.
- RF energy for energizing the heating element
- other forms of energy such as alternating current, microwaves, ultrasound, and light (either coherent (e.g., laser) or incoherent (e.g., light emitting diode or tungsten filament) can be used), and that the thermal energy generated from a resistive coil, a hot fluid element (e.g., circulating liquids, gases, combinations of liquids and gases, etc.), a curie point element, or similar elements can be used as well.
- the hot fluid element may comprise, for example, an elongated member similar to the one illustrated in FIG.
- the heating element operates as a unipolar, internal electrode in the patient's body.
- An outer electrode (not shown) having a much larger surface area than that of the electrode bands is placed on the outer surface of the patient's body.
- an external metal mesh or solid plate is placed on the skin with conductive gel.
- Both electrodes are connected to an RF generator which produces an electric field at a high frequency within the patient's body. Because the collective surface area of the electrode bands is much smaller than that of the outer electrode, the density of the high frequency electric field is much higher around the electrode bands. The electric field reaches its highest density between the two electrodes in the region near the heating element. The increased density of the field around the electrode bands produces localized heating of the tissue of the lumen wall.
- a heating element comprising a bipolar electrode can also be used.
- electrode band 92 would be a first conductive element and electrode band 94 would be a second conductive element.
- FIG. 9 illustrates another treatment apparatus 40 C for use with another embodiment of the present invention.
- the treatment apparatus 40 C includes a heating element having multiple, i.e., double, bipolar electrode bands. Bands 91 are connected to the positive electrode of the RF generator and bands 93 are connected to the negative electrode. The material between the conductive elements are electrically insulated.
- heating elements have been shown as electrode bands, other configurations can be used such as, for example, spiral, ring and grid patterns. These elements will create corresponding patterns on the lumen wall.
- FIG. 10A illustrates another embodiment of the treatment apparatus 40 D for use with another embodiment of the present invention.
- the treatment apparatus 40 D includes an elongated, cylindrical member having a heating element that comprises electrodes 106 and 104 located on the other surface of the member.
- the heating element comprises a bipolar electrode wherein one of the electrodes is the active electrode and the other electrode is the return electrode, or vice-versa.
- One electrode is connected to the RF positive electrode of the generator and the other is connected to the negative electrode.
- Segment 108 of the member situated between the electrodes is made of electrically insulating material.
- the segment of elongated member in and around electrode 104 is fabricated of material that is expandable and substantially impervious to air or other suitable gases for causing the elongated member to balloon.
- this section of the elongated member is radially expandable and deformable in response to compressed gas or any other suitable force or material that is applied into the interior region of the elongated member.
- the elongated member will substantially return to its original, non-expanded form when the internal force is deactivated or the material is withdrawn.
- FIG. 10B illustrates the elongated member in the expanded position. The degree of expansion or distance that the member expands will depend on, among other things, the pressure applied and the elasticity of the member wall.
- material between position 102 on the elongated member to the base of electrode 106 is fabricated from expandable material such as latex or polyethylene.
- the material selected preferably does not melt at the temperature ranges used in the treatment.
- Radial expansion causes electrode 104 to come into thermal or electrical contact with tissue of the air passage 25 to be treated.
- Electrode 104 is preferably a spring coil.
- the treatment apparatus 400 may comprise more than one such coil electrode, which may be positioned along the length of the elongated member so that a plurality of locations along a bronchial tube can be treated simultaneously.
- FIGS. 11A , 11 B, 12 A and 12 B illustrate a further embodiment of the treatment apparatus 40 E for use with an embodiment of the present invention.
- the treatment apparatus 40 E includes an elongated, cylindrical member 110 having one or more electrodes 112 situated on the outer surface of the elongated member. Preferably, a plurality of these electrodes form a number of rows of electrodes that are positioned along the length of the elongated member.
- the segment of surface of the elongated member at and around the electrodes is arranged in pleats 114 . By being folded in this manner, the surface can expand radially when an outward force is applied from the interior of the cylindrical member as shown in FIGS. 12A and 12B .
- the electrodes comprise non-ferrous (e.g., aluminum) strips and an electromagnet 114 which is positioned in the interior of the elongated member.
- an electromagnet 114 which is positioned in the interior of the elongated member.
- the treatment apparatus may comprise a plurality of rows of the electrodes.
- FIG. 13A illustrates another embodiment of a treatment apparatus 40 F for use with another embodiment of the present invention.
- the treatment apparatus 40 F includes a balloon 128 placed at the distal end of a catheter shaft 122 .
- the catheter shaft is connected to syringe 124 located at the proximal end and is connected to an RF generator 126 in between the syringe and balloon.
- FIG. 13B which is an enlarged, cut away view of the device, the balloon 128 , which is illustrated in the non-inflated state, is constructed of an elastomeric material 144 .
- a preferred elastomeric material is silicone.
- Electrodes 140 and 142 Extending from lumen 146 of the shaft and into the interior of the balloon are electrodes 140 and 142 which are spaced apart and supported by rod 145 .
- each electrode is configured as a loop or ring around the rod.
- Catheter shafts suitable for use in the present invention are substantially any of the catheter shafts in current clinical use for surgical procedures.
- Balloons suitable for the present invention may be of similar material and design as those currently being used in percutaneous transluminal angioplasty.
- U.S. Pat. Nos. 4,807,620; 5,057,106; 5,190,517; 5,281,218; 5,314,466; 5,370,677; 5,370,678; 5,405,346; 5,431,649; 5,437,664; 5,447,529; and 5,454,809 the disclosures of which are all incorporated herein by reference.
- the inventive heat treatment apparatus will be described using balloons that are fabricated from an elastomeric material such as, for instance, silicone, natural latex, and polyethylene.
- the material selected preferably does not melt at the temperature ranges used in the treatment and is preferably impervious to the fluid used to inflate the balloon.
- the degree of expansion is proportional to the amount of force introduced into the interior of the balloon.
- the balloon preferably will substantially return to its original, non-expanded form when the internal force is deactivated.
- its diameter will preferably be about 1 mm to 30 mm depending on the site to be treated.
- the balloon is typically attached to the catheter tip and the balloon material is folded or collapsed so that when it is fully inflated the balloon diameter has a fixed dimension.
- balloons made of non-elastic materials such as, for example, polyester (e.g., MYLAR) and polyethylene, can also be used.
- the balloon serves as a vessel or reservoir for medium that is heated.
- the electrodes are bipolar electrodes
- the fluid e.g., saline
- the balloon upon being inflated serves as structural support for the bronchial tubes.
- electrodes 140 and 142 are connected via cables 136 and 138 , through the wall of the balloon 128 , and through the catheter shaft 122 to a radio frequency (RF) generator 126 with controls 130 .
- the catheter shaft 122 is also connected to the syringe 124 or other similar device for forcing a noncompressible fluid, such as saline, from source 134 through valve 132 to inflate the balloon with the fluid as the operating surgeon deems appropriate.
- the frequency range of RF radiation useful in the present invention is typically about 10 KHZ to about 100 MHZ and preferably in the range of about 10 KHZ to about 800 KHZ. However, frequencies outside this range may be used at the discretion of the operating surgeon.
- microwave radiation typically in the frequency range of about 1,000 MHZ to about 2,000 MHZ, preferably in the range of about 1,100 MHZ to about 1,500 MHZ, may be used in place of RF radiation.
- frequencies outside this range may be used at the discretion of the operating surgeon.
- the RF generator 126 may be replaced with a microwave generator, and the cables 136 and 138 replaced with a waveguide. Other modifications familiar to those skilled in the art may also be required.
- alternating current can be employed.
- the balloon is inflated through the catheter shaft 122 with fluid from the syringe 124 located conveniently for the surgeon.
- the balloon is preferably inflated until the lumen has expanded to its normal diameter with the balloon in substantial contact with the inner surface of the lumen.
- the balloon is preferably inflated until it is in substantial contact with the inner surface of the lumen.
- inflation of the balloon is not necessary in treating a non-collapsed bronchial lumen which has a diameter that is about equal to, or less than that of the outer surface of the uninflated balloon.
- the balloon interior has fluid, e.g., electrically conductive saline, present which becomes heated by the application of RF energy.
- the exact amount of inflation is determined by the operating surgeon who monitors the balloon expansion by means of endoscopy, or other suitable imaging methods of the art.
- the heat required is induced in the tissue of the bronchial tube wall by the RF or microwave radiation emitting from the balloon tip.
- FIGS. 14A , 14 B, 15 A, 15 B, 16 A, 16 B, 17 A, and 17 B illustrate other embodiments of the electrode configurations which can be employed with the treatment apparatus 40 F shown in FIG. 13A .
- the balloons are shown in the inflated state containing fluid 151 .
- the arrows depict the path of the electric field between the two electrodes or probes that serve as RF poles in the manners described above.
- FIG. 14A which is a cross-sectional view of balloon 150
- electrodes 152 and 154 are configured as elongated wires that are attached at opposite sides of nonconductive rod 156 .
- FIG. 14B is a side view of the balloon with the electrodes inside the interior of the balloon which is sealed except for conduit 158 through which fluid 151 (e.g., saline) is introduced and removed.
- fluid 151 e.g., saline
- FIG. 15A which is a cross-sectional view of the balloon 160
- electrodes 162 and 164 are wires each configured as a semi-circle and positioned at opposite sides of each other to form a circle.
- the electrodes have opposite polarities and are electrically insulated from each other.
- FIG. 15B is a side view of the balloon with the electrodes inside the interior of the balloon which is sealed except for conduit 168 through which fluid 151 is introduced and removed.
- FIG. 16A which is cross-sectional view of the balloon 170
- electrodes 172 and 174 are wires with tips that protrude into the interior region of the balloon which has a hollow disk or horse shoe configuration with partition 176 separating the two halves of the disk.
- Fluid 151 is introduced and removed from the balloon through conduit 178 in support member 175 .
- the electrodes remain stationary in the solid regions of support member 175 as shown in side view FIG. 16B .
- FIGS. 17A and 17B illustrate another embodiment in which the balloon 180 is fabricated of an electrically conductive material and therefore also serves as an electrode. In this fashion, one of the electrodes is an integral part of the balloon itself.
- the second electrode 182 is attached to non-conducting rod 186 .
- FIG. 17B is a perspective view of the balloon with electrode 182 in the interior of the balloon which is sealed except for conduit 188 through which fluid 151 is introduced and removed.
- Suitable electrically conductive materials for fabricating the balloon in this case include, for example, a polyester film (e.g. MYLAR) that is coated with gold, silver, or platinum.
- FIG. 18 illustrates another embodiment of the treatment apparatus 40 G for use with one embodiment of the present invention.
- the heat generated to heat the fluid in the balloon is supplied by a circulating, hot fluid.
- a balloon 190 substantially the same as balloon 128 of the embodiment shown in FIG. 13A
- a catheter 192 containing a smaller, coaxial catheter 194 (coaxial catheter 194 is substantially the same as catheter 192 , differing only in size.)
- a heated fluid 198 which may be a liquid, such as water or physiologically compatibly saline solution, is pumped by a metering, circulating pump 202 , through a heating unit 200 , then through the outer catheter 192 to the balloon.
- the fluid heats the surface of the balloon and exits through the inner coaxial catheter 194 to return to the pump.
- a positive pressure is maintained within the system to keep the balloon at the proper inflation.
- This embodiment is employed in substantially the same manner as the other embodiments described above regarding its use to heat the airway tissue to induce fibrosis and strengthen the airway and destroy smooth muscle tone.
- the choice of the temperature of the circulating liquid is at the discretion of the operating surgeon, but will usually be in the range of about 60° C. to about 95° C.
- the treatment apparatus 40 H shown in FIG. 19 represents another embodiment of the treatment apparatus for performing another embodiment of the present invention, wherein the heat generated to heat the fluid in the balloon is supplied by a hot fluid that is injected into the balloon.
- the catheter 208 includes electrodes 210 and 216 positioned in lumen 206 of the catheter. The electrodes are connected to AC generator 218 although an RF generator can also be used.
- the channel or lumen 206 also serves as a reservoir for liquid which is introduced from source 222 through syringe 204 .
- the fluid serves both to inflate the balloon as well as to supply the heat treatment of the bronchial tube. A positive pressure is maintained within the system to keep the balloon at the proper inflation. Instead of using resistive heating, the fluid can be heated with heat exchanger 208 .
- the RF energy is applied for a length of time in the range of about 1 second to about 600 seconds and preferably about 5 to about 120 seconds.
- Suitable RF power sources are commercially available and well known to those skilled in the art.
- the RF generator employed has a single channel that is capable of delivering approximately 1 to 100 watts and preferably 1 to 25 watts of RF energy and possesses continuous flow capability.
- the lumen or the bronchial tube is maintained at a temperature of at least about 60° C. and typically between 70° C. to 95° C. and preferably between 70° C. to 85° C.
- the treatment apparatus of the present invention may include more than one balloon and attendant bipolar electrodes which are positioned along the length of the elongated member so that a plurality of locations along a bronchial tube can be treated simultaneously.
- FIG. 13C illustrates an alternative embodiment of the treatment apparatus of FIG. 13A described above, which includes two balloons 148 A, 148 B that are spaced apart. Each balloon 148 A, 148 B includes a suitable set of bipolar electrodes as described previously.
- the balloons can be connected to separate sources of fluid or they can share a common source.
- FIGS. 20A and 20B show a further embodiment of the treatment apparatus 401 for use with another embodiment of the present invention.
- the treatment apparatus 401 includes a balloon 300 , similar to the balloons described earlier, that is positioned at or near the distal end of elongated rod 310 which is positioned within the lumen or aperture 351 of catheter sheath 350 .
- the term “rod” also encompasses tubes which have hollow channels.
- the balloon with inner surface 301 is in the inflated state having been inflated with an appropriate fluid such as air or saline that is injected from conduit 330 and into the interior of the balloon through aperture 331 in the rod.
- the apparatus includes electrodes 302 and 304 , similar to those described earlier, which are spaced apart along the outer perimeter of the inflated balloon. It is understood that the number of electrodes and their configurations on the outer surface of the balloon can be varied. These electrodes come into contact with the wall of the airway 25 when the balloon is inflated.
- the electrodes employed in the present invention can have different configurations.
- the electrodes can be conventional coil wires with round cross sections, or they can have a non-round configuration, such as, for example, a thin, foil or band with a rectangular cross section.
- electrodes 302 and 304 are preferably flat bands each extending around the circumference of the balloon.
- each band is positioned around the outer surface of the balloon with the two ends overlapping each other.
- electrode 302 is a band having ends 303 and 313 with a portion of the band adjacent to end 303 overlapping a portion of the band adjacent to end 313 .
- electrode 304 is a band having overlapping ends 305 and 315 .
- the balloon of the treatment apparatus 401 is preferably constructed of nonelastic material that is initially folded and/or collapsed. In this non-inflated state, the diameter of the balloon is small enough that the balloon can be positioned inside an aperture or working channel of a bronchoscope.
- the bronchoscope first is positioned at the treatment site before the balloon is exposed and then inflated. Heat treatment is then commenced to damage airway tissue to induce fibrosis and/or destroy smooth muscle tone.
- FIGS. 20A and 20B show that electrodes 302 and 304 are connected via cables 322 and 342 , respectively, to a radio frequency (RF) generator 329 with controls 338 , such as described earlier.
- Rod 310 is also connected to syringe 350 which is employed to inject a fluid from source 346 through valve 348 into the balloon.
- RF radio frequency
- FIG. 21 illustrates another embodiment of the treatment apparatus 40 J for use with another method of the present invention which includes a pair of electrode coils 410 and 420 that are positioned in tandem.
- the number of electrode coils is not critical.
- the apparatus also includes an elongated rod 430 which has a distal end 431 that is connected to a tip or knob 440 and has a proximal end which is at least partially slidably positioned inside aperture 451 of catheter sheath 450 that includes end coupler 435 .
- Coil 410 has two ends, the first end 411 being attached to knob 440 and the second end 412 is attached to rotatable or floating coupler 470 .
- coil 420 has two ends, the first end 421 is attached to rotatable coupler 470 and the second end 422 is attached to end coupler 435 .
- each coil has a “barrel” configuration so that the diameter of the outer contour formed by each coil is largest at its center and smallest at its two ends.
- a number of preferred methods can be employed to change the diameters of the contour.
- One method is to compress or expand the coils along the axis. For example, by pushing rod 430 outward so that knob 440 extends away from catheter sheath 450 , the coil diameters will decrease.
- Another method of changing the diameter is to apply torque to the coils.
- Torque can be applied by rotating the rod in a clockwise or counterclockwise direction while keeping end coupler 435 stationary, e.g., attached to the inner surface of catheter sheath. Torque can also be applied by keeping rod 430 stationary while rotating end coupler 435 . Alternatively, torque can be applied by rotating the rod in one direction while rotation end coupler 435 in the opposite direction. During the rotation process, rotatable coupler 470 will also rotate to thereby transfer torque from one coil to the other.
- the treatment apparatus is constructed so that end coupler 435 remains stationary. Torque is preferably applied by manually rotating rod 430 . When more than one coil is employed, a rotatable coupler is required to connect adjacent coils. Multiple coil configurations are preferred over one with a single coil that has the same length (in the relaxed state) as the sum of the lengths of the smaller coils since the diameters of the smaller coils will tend to be more uniform and in contact with the wall of the bronchial tube being treated. Each coil in the embodiment shown in FIG. 21 is connected to an appropriate source of energy.
- coils 410 and 420 can be connected by lines 415 and 425 to a radio frequency generator 430 as described above.
- the heat treatment apparatus 40 J is positioned at the treatment site before the diameters of the coils are adjusted by applying torque. Energy is then applied to the coils.
- FIGS. 22 and 23 show embodiments of the heat treatment apparatus 40 K, 40 L for use with further methods of the present invention, which are similar to that of FIG. 21 .
- the apparatus of FIG. 22 includes a pair of electrode coils 510 and 520 that are positioned in tandem.
- the apparatus also includes an elongated rod 530 which has a distal end 531 that is connected to a tip or knob 540 and has a proximal end which is at least partially slidably positioned inside aperture 551 of catheter sheath 550 that includes end coupler 535 .
- Coil 510 has two ends, the first end 511 being attached to knob 540 and the second end 512 is attached to rotatable coupler 570 .
- each electrode has a cone-shaped contour and comprises a coil that is wound about and along the axis of the rod 530 and which in the relaxed state has a large diameter at one end and a small diameter at the other end.
- the treatment apparatus 40 L of FIG. 23 includes a pair of electrode coils 610 and 620 that are positioned in tandem.
- the apparatus also includes an elongated rod 630 which has a distal end 631 that is connected to a tip or knob 640 and has a proximal end which is at least partially slidably positioned inside aperture 651 of catheter sheath 650 that includes end coupler 635 .
- Coil 610 has two ends, the first end 611 being attached to knob 640 and the second end 612 is attached to rotatable coupler 670 .
- coil 620 has two ends, the first end 621 is attached to rotatable coupler 670 and the second end 622 is attached to end coupler 635 .
- each electrode has a single loop configuration that comprises a coil that is wound once about the rod 630 . In this configuration, the two electrodes when in the relaxed state preferably form loops having the same diameter.
- the devices 40 K, 40 L of FIGS. 22 and 23 operate in essentially the same manner as the device 40 J of FIG. 21 . Specifically, the same methods can be employed to adjust the radial diameter of the coils by compressing or pulling the coils or by applying torque to the coils.
- each coil is connected to an appropriate source of energy.
- coils 610 and 620 can be connected by lines 615 and 625 to a radio frequency generator 330 as shown in FIG. 20A .
- the electrodes may be constructed of a suitable current conducting metal or alloys such as, for example, copper, steel, and platinum.
- the electrodes can also be constructed of a shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature.
- a shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature.
- a shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature.
- the shape memory metal used should have the characteristic of assuming a deflection away (i.e., expands) from the elongated rod when activated, i.e., heated in excess of the normal body temperature and preferably between 60° C.
- a preferred shape memory alloy is available as NITINOL from Raychem Corp., Menlo Park, Calif.
- the electrodes are constructed of NITINOL in a predetermined shape and in the alloy's super elastic phase which can withstand very large deflections without plastic deformation.
- the heat treatment apparatuses employing a unipolar electrode can also be employed.
- the heating device can have one or more inner electrodes 302 and/or 304 on the balloon surface and an outer or external electrode 388 that has a much larger surface area than that of the internal electrode(s) and that is placed on the outer surface of the patient's body.
- the external electrode can be an external metal mesh or solid plate that is placed on the skin with conductive gel. Both the internal and external electrodes are connected to an RF generator which produces an electric field at a high frequency within the balloon.
- the density of the high frequency electric field is much higher around the internal electrode(s).
- the electric field reaches its highest density in the region near the internal electrode(s).
- the increased density of the field around the internal electrode(s) produces localized heating of the tissue to destroy smooth muscle tone and damage tissue to cause fibrosis, which stiffens the airway 25 so as to increase gas exchange performed by the lung.
- the heat treatment apparatus can have more than one electrode that is positioned at or near the distal end of the elongated rod.
- FIG. 24 depicts schematically the distal end 700 of a treatment apparatus 40 M which comprises electrodes 701 , 702 , and 703 .
- two of the three electrodes e.g., 701 and 702
- the other electrode 702
- Heat will be generated in the tissue adjacent the region between electrodes 701 and 702 and the region between electrodes 702 and 703 .
- These electrodes 701 , 702 , and 703 can be attached to the exterior surface of a balloon, alternatively they represent adjustable coils in embodiments that do not require a balloon.
- electrodes 701 and 702 can be first activated to heat a section of the bronchial tube wall.
- electrode 703 can also be activated so that a second section of the bronchial tube wall is heat treated simultaneously.
- electrode 701 is disconnected to the RF generator before electrode 703 is activated so that the second section is treated subsequent to treatment of the first section.
- the device can operate in the monopolar, bipolar mode, or both modes at the same time.
- electrodes 701 and 702 can be designed to operate in the bipolar mode while electrode 703 is designed to operate in the monopolar mode.
- the electrodes can be constructed of different materials and/or constructed to have different configurations.
- electrode 701 can be made of a shape memory alloy and/or it can be a coil while each of the other electrodes 702 and 703 can be made of a non-shape memory material and/or it can be a band with a rectangular cross section.
- the treatment apparatus can comprise more than one balloon that is attached to the elongated rod.
- FIG. 25 depicts schematically the distal end of a treatment apparatus 40 N for use with embodiments of the present invention, which comprises balloons 810 and 820 . Electrodes 811 and 812 are attached to the exterior surface of balloon 810 and electrodes 821 and 822 are attached to the exterior surface balloon 820 .
- the treatment apparatus 40 N includes an elongated rod 860 which is positioned with the lumen of catheter sheath 850 .
- the treatment apparatus 40 N is preferably constructed in the same manner as the device shown in FIG. 208 except for the additional balloon. Operation of the device 40 N is also similar although the surgeon has the choice of activating both sets of electrode simultaneously or one set at a time.
- FIG. 26 illustrates another embodiment of a treatment apparatus 40 P for use with the methods of the present invention.
- the treatment apparatus 40 P is introduced through a catheter, bronchoscope, or other tubular introducer member 1012 .
- the heat treatment apparatus includes a shaft 1014 and one or more electrodes 1016 . Electrically connected to the electrodes 1016 is an RF generator 1018 or other energy source.
- the RF generator is controlled by a controller 1020 .
- the invention will be described as employing an RF generator, other energy sources, such as alternating current and microwave may also be used.
- the electrodes include a first conical electrode 1016 A connected to an inner shaft 1022 and a second conical electrode 1016 B connected to an outer shaft 1024 .
- the conical electrodes 1016 A, 1016 B are positioned with their axes aligned and may be fixed or movable with respect to each other.
- Each of the conical electrodes 1016 A, 1016 B includes at least two overlapping sections 1026 .
- the sections 1026 are flexible and overlap one another to allow the electrodes 1016 A, 1016 B to be compressed within the lumen of the catheter 1012 for insertion into the bronchial tube of a patient.
- the shaft 1014 is used to push the electrodes 1016 A, 1016 B out of the distal end of the catheter.
- the electrodes 1016 A, 1016 B expand radially outwardly until the distal ends of the electrodes contact the walls of the bronchial tube.
- the electrodes 1016 A, 10168 are electrically connected to the RF generator 1018 by electrical cables 1028 , 1030 .
- the two electrodes are preferably oppositely charged with one of the electrodes connected to a negative output of the RF generator and the other electrode connected to a positive output of the RF generator.
- both the electrodes 1016 A, 1016 B or a single electrode 1016 may be connected to the same output of the RF generator and an external electrode 1034 may be used.
- the external electrode 1034 is connected to an output of the RF generator 1018 having an opposite polarity of the output connected to the internal electrode 1016 .
- FIG. 27 illustrates an alternative embodiment of a heat treatment apparatus 1040 having a single electrode 1016 positioned on a shaft 1014 .
- the electrode 1016 is shown as it is deployed from the distal end of a catheter 1012 for heat treatment of the lumen of bronchial tubes.
- the electrodes 1016 of the embodiment of FIGS. 26 and 27 are formed of a suitable conductive material such as metal, plastic with a metal coating, or the like.
- the two or more sections 1026 of each of the cone shaped electrodes is fixed to the shaft 1014 and biased outwardly so that the sections expand or unfold to an enlarged diameter upon release from the distal end of the catheter 1012 .
- the electrodes 1016 preferably have an enlarged diameter which is equal to or slightly greater than an interior diameter of the bronchial tube to be treated. As shown most clearly in FIG. 27 , the sides of the sections 1026 overlap one another even in the expanded state.
- the distal end of the catheter 1012 is first positioned at the treatment site by known catheter tracking methods.
- the catheter 1012 is then retracted over the heat treatment apparatus to expose and expand the electrodes 1016 .
- Each electrode 1016 of the energy emitting apparatus 40 P expands radially outward upon retraction of the catheter 1012 until the electrodes come into contact with the wall of the bronchial tube.
- the distance between the two energy emitting electrodes 1016 A, 1016 B may be fixed or may be changeable by sliding the inner shaft 1022 within the outer shaft 1024 .
- the heat treatment apparatus 40 P is retracted back inside the catheter 1012 by sliding the catheter over the electrodes.
- the sides of the sections 1026 of the electrode 1016 slide over each other upon coming into contact with a distal edge of the catheter 1012 .
- FIGS. 28 and 29 illustrate an alternative embodiment of a treatment apparatus 400 for use with the methods of the present invention.
- the treatment apparatus 400 may be delivered to a treatment site in a collapsed configuration illustrated in FIG. 28 .
- the treatment apparatus 400 includes two leaf spring or wire shaped electrodes 1054 A and 1054 B.
- the electrodes 1054 A, 1054 B are connected to an insulating end cap 1056 of a hollow shaft 1058 .
- the electrodes 1054 A, 1054 B are electrically connected to the RF generator or other energy source by electric cables 1060 , 1062 .
- the heat treatment apparatus 1050 is provided with a central shaft 1064 which is slid able within the hollow shaft 1058 .
- the central shaft 1064 has a shaft tip 1048 which is connected to a distal end of each of the electrodes 1054 A, 1054 B.
- Each of the electrodes 1054 A, 1054 B is preferably insulated with an insulating sleeve 1066 except for an exposed contact section 1068 .
- the treatment apparatus 400 is delivered to the lumen of a bronchial tube to be treated either alone or through a catheter, bronchoscope, or other channel.
- the electrodes 1054 A, 1054 B are expanded radially outwardly by moving the central shaft 1064 proximally with respect to the hollow shaft 1058 of the treatment apparatus 400 .
- the exposed contact sections 1068 of the electrodes 1054 A, 1054 B come into contact with the walls of the airway or bronchial tube 8 , shown in FIG. 29 .
- the electrodes 1054 A, 1054 B may be configured to bend at a predetermined location forming a sharp bend as shown in FIG. 29 . Alternatively, the electrodes 1054 A, 1054 B may form a more gradual curve in the expanded configuration.
- the electrodes 1054 A, 1054 B are preferably connected to opposite poles of the energy source. Alternatively, both of the electrodes 1054 A, 1054 B may be connected to the same lead of the energy source and the external electrode 1034 may be used. Upon completion of the treatment process the electrodes 1054 are retracted back into the catheter for removal or moving to a subsequent treatment site.
- FIGS. 30 and 30A illustrate another embodiment of the treatment apparatus 40 R for use with embodiments of the present invention.
- the treatment apparatus 40 R includes four electrodes 1054 A, 1054 B, 1054 C, 1054 D.
- the four electrode embodiment of FIGS. 30 and 30A operates in the same manner as the embodiments of FIGS. 28 and 29 with a slidable central shaft 1064 employed to move the electrodes from a compressed configuration to the expanded configuration illustrated in FIGS. 30 and 30A .
- Each electrode 1054 A- 1054 D is connected at a proximal end to the insulating end cap 1056 of the hollow shaft 1058 and at a distal end to the central shaft 1064 . Relative motion of the hollow shaft 1058 with respect to the central shaft 1064 moves the electrodes 1054 from the collapsed to the expanded position.
- FIGS. 31 and 32 illustrate a further embodiment of a heat treatment apparatus 40 S employing one or more wire or leaf spring shaped loop electrodes 1094 .
- the loop electrode 1094 expands from a contracted positioned within a catheter 1092 as illustrated in FIG. 31 to an expanded position illustrated in FIG. 32 . In the expanded position, the loop shaped electrode 1094 comes into contact with the walls of the airway or bronchial tube B.
- FIGS. 31 and 32 has been illustrated with a single loop shaped electrode 1094 , it should be understood that multiple loop shaped electrodes may also be use.
- the loop shaped electrode 1092 is connected to the shaft 1096 of the heat treatment apparatus 40 S by an end cap 1098 and is electrically connected to the energy source by the electric cables 1100 .
- FIGS. 33-36 illustrate an alternative embodiment of a treatment apparatus 40 T for use with the embodiments of the present invention.
- the treatment apparatus 40 T includes a flexible plate shaped electrode 1114 .
- the flexible plate shaped electrode 1114 is substantially flower shaped in plan having a plurality of petals 1116 with curved distal ends extending from a central section 1120 .
- the petals 1116 flex along a hinge line 1118 to the compressed insertion configuration illustrated in FIG. 33 in which the petals 1116 extend substantially perpendicularly from the central section 1120 of the flexible plate shaped electrode 1114 .
- the flexible plate shaped electrode 1114 is preferably formed of a conductive material and fixed to the end of a shaft 1122 . Electric cables 1124 connect the plate shaped electrode 1114 to the energy source.
- the electrodes in each of the forgoing embodiments may be fabricated of any material which when compressed will return to an expanded configuration upon release of the compression forces.
- one method of controlling the expansion of the electrodes is the use of shape memory alloy electrodes. With a shape memory alloy, the constraint of the electrodes within a catheter may not be necessary.
- the shape memory alloy electrodes may be formed to expand to an expanded energy delivery configuration upon heating to body temperature within the body. The expansion of the electrodes is limited by the size of the bronchial tube in which the electrode is positioned.
- the heat treatment apparatus may be employed in a bipolar mode in which two different expandable electrodes are connected to two different outputs of the RF generator 1018 having opposite polarities.
- the electrodes 1016 A, 1016 B may be connected by the electrical cables 1028 , 1030 to different terminals of the RF generator 1018 .
- multiple electrodes may be connected to one terminal of the RF generator.
- the oppositely charged electrodes are separated by an insulating material.
- the inner shaft 1022 and outer shaft 1024 are formed of an insulating material.
- the end cap 1056 and central shaft distal tip are formed of insulating materials.
- the electrode will be connected to the positive or negative terminal of the RF generator 1018 and the opposite terminal of the RF generator will be connected to the external electrode 1032 .
- the frequency range of RF radiation useful in the present invention is typically about 10 KHz to about 100 MHZ, preferably in the range of about 200 KHz to about 800 KHz. However, frequencies outside this range may be used at the discretion of the operating surgeon.
- the amount of power employed will be from about 0.01 to 100 watts and preferably in the range of about 1 to 25 watts for about 1 to 60 seconds.
- alternating current or microwave radiation typically in the frequency range of about 1,000 MHZ to about 2,000 MHZ and preferably from about 1,100 MHZ to about 1,500 MHZ may be used in place of RF radiation.
- the RF generator 1018 is replaced with a microwave generator, and the electric cables 1028 , 1030 are replaced with waveguides.
- the heat treatment apparatus with the bipolar electrodes When the heat treatment apparatus with the bipolar electrodes is positioned inside the lumen of a bronchial tube, activation of the RF generator 1018 causes tissue in the lumen wall to increase in temperature.
- the heating may be caused by resistance heating of the electrodes themselves and/or power losses through the tissue of the bronchial wall.
- the particular heat pattern in the tissue will depend on the path of the electric field created by the positioning and configuration of the electrodes.
- the external electrode 1034 shown in FIG. 26 , having a much larger surface area than the inner electrodes is placed on the outer surface of the patient's body.
- the external electrode 1034 can be an external metal mesh or a solid plate that is placed on the skin with conductive gel.
- Both the internal and external electrodes are connected to the RF generator 1018 which produces an electric field at a high frequency. Because the collective surface area of the internal electrodes is much smaller than that of the outer electrode 1034 , the density of the high frequency electric field is much higher around the internal electrodes. The electric field reaches its highest density in the region near the internal electrodes. The increased density of the field around the internal electrodes produces localized heating of the tissue around the bronchial tube without causing significant heating of the body tissue between the bronchial tube and the external electrode.
- the catheter is retracted to expose the electrodes.
- the size of the energy emitting device is designed so that expansion of the electrodes causes the lumen to expand to its normal or noncollapsed diameter due to contact of the electrodes with the inner surface of the lumen.
- the device is designed so that upon expansion the electrodes are in substantial contact with the inner surface of the lumen. Indeed, only minimum expansion may be necessary in treating a noncollapsed bronchial lumen.
- the degree of expansion of the electrodes of the heat treatment apparatus can be monitored by means of endoscopy, fluoroscopy, or by other suitable imaging methods of the art.
- the heat required is induced in the tissue of the bronchial tube wall by the RF or microwave radiation emitting from the electrodes.
- the RF or microwave energy is applied while observing the tissue for changes via simultaneous endoscopy, or other suitable imaging methods of the art.
- the electrodes employed in the heat treatment apparatus are constructed of a suitable current conducting metal or alloys such as, for example, copper, steel, platinum, and the like or of a plastic material with a conductive metal insert.
- the electrodes can also be constructed of a shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature.
- a predetermined i.e., programmed
- shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature.
- Such metals are well known in the art as described, for example, in U.S. Pat. Nos. 4,621,882 and 4,772,112 which are incorporated herein by reference.
- the shape memory metal used should have the characteristic of assuming a deflection away (i.e., expands) from the elongated rod when activated, i.e., heated in excess of the normal body temperature and preferably between 60° C. and 95° C.
- a preferred shape memory alloy is available as NITINOL from Raychem Corp., Menlo Park, Calif.
- the electrodes are constructed of NITINOL in a predetermined shape and in the alloy's super elastic phase which can withstand very large deflections without plastic deformation.
- Substantial tissue transformation may be achieved very rapidly, depending upon the specific treatment conditions. Because the transformation can proceed at a rather rapid rate, the RF energy should be applied at low power levels. Preferably, the RF energy is applied for a length of time in the range of about 0.1 second to about 600 seconds, and preferably about 1 to about 60 seconds. Suitable RF power sources are commercially available and well known to those skilled in the art. In one embodiment the RF generator 18 employed has a single channel, delivering approximately 1 to 100 watts, preferably 1 to 25 watts and possessing continuous flow capability. The rate of tissue damage to induce fibrosis can be controlled by varying the energy delivered to the heat treatment apparatus. Regardless of the source of energy used during treatment, the lumen or the bronchial tube is maintained at a temperature of at least about 45° C., preferably between 60° C. and 95° C.
- the heat treatment apparatus includes multiple energy emitting devices, not all the electrodes need to be activated at the same time. That is, different combinations of electrodes can be employed sequentially. For example, in the case of the embodiment shown in FIG. 26 , with two electrodes 1016 A, 1016 B, the electrodes can be activated simultaneously or sequentially.
- the apparatus can operate in the monopolar, bipolar mode, or both modes at the same time.
- one of the electrodes can be designed to operate in the bipolar mode while another electrode operates in the monopolar mode.
- a preliminary diagnosis is made to identify the air passages or bronchial tube that can be treated.
- excessive fluid is first removed from the obstructed air passage by conventional means such as with a suction catheter.
- the heat treatment apparatus is maneuvered to the treatment site.
- the device can be positioned directly at the treatment site or it can be positioned into place with a bronchoscope.
- the elongated shafts 1022 , 1024 and outer catheter 1012 are preferably made of a flexible material so that the catheter can be maneuvered through a bronchoscope.
- a bronchoscope is a modified catheter which includes an illuminating and visualization instrument for monitoring the treatment site and a channel for passing instruments (e.g., the treatment apparatus) into the bronchial tubes.
- the bronchoscope In operation, the bronchoscope is advanced from the person's nasal or oral cavity, through the trachea, main stem bronchus, and into an obstructed air passage.
- the heat treatment apparatus is advanced forward through the bronchoscope to expose the tip of the heat treatment apparatus before the heat treatment apparatus is energized.
- the treatment apparatus can be moved to another position for further heat treatment of the air passage. This process can be repeated as many times as necessary to form a series of patency bands supporting an air passage.
- This procedure is applied to a sufficient number of air passages until the physician determines that he is finished. As is apparent, the procedure can be completed in one treatment or multiple treatments. After completion of the treatment, energy is discontinued and the heat treatment apparatus is removed from the patient.
- Temperature monitoring and impedance monitoring can be utilized in a system which provides feedback to the user in the form of sounds, lights, other displays or a mechanism which shuts down the application of energy from the heating element to the treatment site when sufficient tissue transformation is detected and to avoid burning of the treatment site.
- the amount of energy applied can be decreased or eliminated manually or automatically under certain conditions. For example, the temperature of the wall of the air passage, or of the heating element can be monitored and the energy being applied adjusted accordingly.
- the surgeon can, if desired, override the feedback control system.
- a microprocessor can be included and incorporated into the feedback control system to switch the power on and off, as well as to modulate the power.
- the microprocessor can serve as a controller to monitor the temperature and modulate the power.
- the invention is also directed to the demonstration or instruction of the inventive surgical techniques including, but not limited to, written instructions, actual instructions involving patients, audio-visual presentations, animal demonstrations, and the like.
- FIG. 37 illustrates another treatment apparatus 40 U that delivers light to the walls of the airway 25 .
- the light delivery device 40 U includes an outer catheter or sheath 2016 surrounding a light transmitting fiber 2018 .
- a light directing member 2020 is positioned at a distal end of the light delivery device 2010 for directing the light to the conduit walls.
- the light delivery device 40 U is used to irradiate the smooth muscle surrounding the airways to induce fibrosis and/or destroy smooth muscle tone of the airway.
- the light delivery device 40 U is an elongated device such as a catheter containing a fiber optic.
- the light delivery device 40 U is connected by a conventional optical connection to a light source 2022 .
- the treatment of an airway with the light delivery device 40 U involves placing a visualization system such as an endoscope or bronchoscope into the airways.
- the light delivery device 40 U is then inserted through or next to the bronchoscope or endoscope while visualizing the airways.
- the light delivery device 40 U which has been positioned with a distal end within an airway to be treated is energized so that radiant energy is emitted in a generally radially direction from a distal end of the light delivery device.
- the distal end of the light delivery device 40 U is moved through the airway in a uniform painting like motion to expose the entire length of an airway to be treated to the light.
- the light delivery device 40 U may be passed along the airway one or more times to achieve adequate treatment.
- the painting like motion used to exposed the entire length of an airway to the light may be performed by moving the entire light delivery device from the proximal end either manually or by motor.
- the light used may be coherent or incoherent light in the range of infrared, visible, or ultraviolet.
- the light source 2022 may be any known source, such as a UV laser source.
- the light is ultraviolet light having a wavelength of about 240-350 nm or visible light in the red visible range.
- the intensity of the light may vary depending on the application.
- the light intensity should be bright enough to damage the cells of the tissue to induce fibrosis and/or to destroy the smooth muscle tone or the airway.
- the light intensity may vary depending on the wavelength used, the application, the thickness of the smooth muscle, and other factors.
- FIGS. 39-42 illustrate different exemplary embodiments of the distal tip of the light delivery device for irradiating the airway walls.
- a light delivery device 40 V includes a sheath 2016 having a plurality of windows 2024 which allow the light which has been redirected by the light directing member 2020 to pass substantially radially out of the sheath.
- the light directing member 2020 is fitted into the distal end of the sheath 2016 .
- the light directing member 2020 is a parabolic diffusing mirror having a reflective surface 2026 which is substantially parabolic in cross section. The light passes from the light source along the light transmitting fiber 2018 and is reflected by the reflective surface 2026 of the light directing member 2020 through the windows 2024 .
- the windows 2024 are preferably a plurality of light transmitting sections spaced around the distal end of the sheath.
- the windows 2024 may be open bores extending through the sheath 2016 .
- the windows 2024 may be formed of a transparent material which allows the light to pass out of the sheath 2016 .
- FIG. 40 illustrates an alternative embodiment of a light delivery device 40 W in which the light directing member 2020 has a conical shaped reflective surface 2032 .
- This conical shaped reflective surface may be formed at any desired angle which directs the light transmitted by the light transmitting fiber 2018 radially out of the sheath 2016 .
- the use of a conical reflective surface 2032 creates a light delivery pattern in which the light rays are directed in a generally coherent radial pattern which is at a generally fixed angle with respect to a longitudinal axis of the light delivery device.
- the light delivery device of FIG. 39 with the parabolic reflective surface 2026 directs light in a diverging radial pattern which will illuminate a larger area of the airway walls.
- FIG. 41 illustrates a further alternative embodiment of a light delivery device 40 X in which the light directing member 2020 is a substantially conical member including concave reflective surfaces 2036 . These concave reflective surfaces 2036 direct the light which passes in a generally parallel arrangement through the light transmitting fiber 2018 out of the sheath 2016 in a converging or crossing pattern.
- the windows have been replaced by a transparent tip 2038 of the sheath 2016 .
- the light directing members 2020 having a reflective surface as illustrated in FIGS. 39-41 may be formed in any of the known manners, such as by coating a molded member with a reflective coating, such as aluminum.
- treatment apparatus 40 Y includes a diffusing lens 2042 , such as a Teflon lens, that may be positioned at the end of the light transmitting fiber 2018 as illustrated schematically in FIG. 42 .
- the diffusing lens 2042 may direct the light from the light transmitting fiber 2018 in a generally conical pattern as shown in FIG. 42 .
- the diffusing lens 2042 may direct the light in a more radially oriented pattern with the light rays being prevented from exiting the lens in a direction substantially parallel with the longitudinal axis of the light transmitting fiber 2018 by a reflective or blocking member.
- the sheath 2016 surrounding the light transmitting fiber 2018 and the diffusing lens 2042 may be eliminated entirely and the lens may be affixed directly to the end of the fiber.
- the light delivery devices 40 U, 40 V, 40 W, 40 X, 40 Y can be used in conjunction with photo activatable substances such as those known as psoralens. These light activatable compounds, when activated, enhance the ability of visible light to destroy tissue.
- the psoralens may by injected intravenously.
- the light delivered by the light delivery devices is matched to the absorption spectrum of the chosen psoralens such that the light exposure activates the compound.
- a lower light intensity may be used to cause trauma to the tissue than the light intensity required to achieve destruction without the light activatable compounds.
- FIGS. 43-56 illustrate further embodiments of treatment apparatus that may be used with the methods of the present invention.
- the treatment apparatus of FIGS. 43-53 include tissue contacting electrodes configured to be placed within the airway. These apparatus can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated electrodes, similar to the previously described treatment apparatus.
- monopolar energy delivery one or more electrodes of the treatment apparatus are connected to a single pole of the energy source 3032 and an optional external electrode 3044 is connected to an opposite pole of the energy source.
- bipolar energy delivery multiple electrodes are connected to opposite poles of the energy source 3032 and the external electrode 3044 is omitted.
- the number and arrangement of the electrodes may vary depending on the pattern of energy delivery desired.
- the treatment apparatus of FIGS. 54 and 55 are used to deliver radiant or heat energy to the airway.
- the treatment apparatus of FIG. 54 can also deliver indirect radio frequency or microwave energy to the tissue.
- the treatment apparatus of FIG. 56 is used to remove heat energy from the tissue.
- the treatment apparatus 40 Z of FIG. 43A includes a catheter 3036 for delivering a shaft 3040 having a plurality of electrodes 3038 to a treatment site.
- the electrodes 3038 are formed from a plurality of wires which are soldered or otherwise connected together at two connection areas 3042 .
- the electrodes 3038 between the connection areas 3042 are formed into a basket shape so that arch shaped portions of the wires will contact the walls of an airway.
- the wires may be coated with an insulating material except at the tissue contact points. Alternatively, the wires of the basket may be exposed while the connection areas 3042 and shaft 3040 are insulated.
- the electrodes 3038 are formed of a resilient material which will allow the distal end of the treatment apparatus to be retracted into the catheter 3036 for delivery of the catheter to the treatment site and will allow the electrodes to return to their original basket shape upon deployment.
- the treatment apparatus 40 Z is preferably configured such that the electrodes 3038 have sufficient resilience to come into contact with the airway walls for treatment.
- FIG. 43B illustrates a treatment apparatus 40 AA in which the distal end of the device is provided with a ball shaped member 3050 for easily inserting the device to a treatment site without causing trauma to surrounding tissue.
- FIG. 43C illustrates a treatment apparatus 40 AB having electrodes 3038 connected to the distal end of the catheter 3036 and forming a basket shape. The basket shape may be expanded radially during use to insure contact between the electrodes 3038 and the airway walls by pulling on a center pull wire 3052 which is connected to a distal end 3050 of the device and extends through a lumen of the catheter 3036 .
- the treatment apparatus 40 A may be delivered to a treatment site through a delivery catheter or sheath 3054 and may be drawn along the airway to treat the airway in a pattern of longitudinal or helical stripes.
- FIG. 44 illustrates a treatment apparatus 40 AC in which a catheter shaft 3046 is provided with a plurality of electrodes 3048 positioned on inflatable balloons 3050 .
- the balloons 3050 are inflated through the catheter shaft 3046 to cause the electrodes 3048 come into contact with the airway walls 3100 .
- the electrodes 3048 are preferably connected to the energy source 3032 by conductive wires (not shown) which extend from the electrodes through or along the balloons 3050 and through the catheter shaft 3046 to the energy source.
- the electrodes may be used in a bipolar mode without an external electrode.
- the treatment apparatus 40 C may be operated in a monopolar mode with an external electrode 3044 .
- the electrodes 3048 may be continuous circular electrodes or may be spaced around the balloons 3050 .
- An alternative apparatus device 40 AD of FIG. 45 includes a catheter 3056 having one or more grooves 3060 in an exterior surface. Positioned within the grooves 3060 are electrodes 3058 for delivery of energy to the airway walls. Although the grooves 3060 have been illustrated in a longitudinal pattern, the grooves may be easily configured in any desired pattern.
- the treatment apparatus 400 of FIG. 45 includes a biasing member (not shown) for biasing the catheter 3056 against the airway wall such that the electrodes 3058 contact the tissue.
- the biasing member may be a spring element, an off axis pull wire, an inflatable balloon element, or other biasing member.
- the biasing function may be performed by providing a preformed curve in the catheter 3056 which causes the catheter to curve into contact with the airway wall when extended from a delivery catheter.
- FIG. 46 illustrates a treatment apparatus 40 AE having one or more electrodes 3068 connected to a distal end of a catheter 3066 .
- the electrodes 3068 are supported between the distal end of the catheter 3066 and a device tip 3070 .
- a connecting shaft 3072 supports the tip 3070 .
- Also connected between the distal end of the catheter 3066 and the tip 3070 is a spring element 307 4 for biasing the electrodes 3068 against a wall of the airway.
- the spring element 307 4 may have one end which slides in a track or groove in the catheter 3066 such that the spring can flex to a variety of different positions depending on an internal diameter of the airway to be treated.
- FIG. 47 illustrates an alternative treatment apparatus 40 AF in which the one or more electrodes 3078 are positioned on a body 80 secured to an end of a catheter 3076 .
- the body 3080 is illustrated as egg shaped, however, other body shapes may also be used.
- the electrodes 3078 extend through holes 3082 in the body 3080 and along the body surface.
- a biasing member such as the spring element 3084 is preferably provided on the body 3080 for biasing the body with the electrodes against the airway walls.
- Leads 3085 are connected to the electrodes and extend through the catheter 3076 to the energy source 3032 .
- FIGS. 48 and 49 illustrate a further treatment apparatus 40 AG having one or more loop shaped electrodes 3088 connected to a catheter shaft 3086 .
- the loop of the electrode 3088 lies along the sides of a central core 3090 .
- a distal end of the loop electrode 3088 is secured to the core 3090 and to an optional tip member 3092 .
- the core 3090 is slidable in a lumen of the catheter 3086 .
- the electrode 3088 or the core 3090 may be spring biased to return to the configuration of FIG. 49 when a constraining force is removed.
- This constraining force may be applied by a delivery catheter or bronchoscope through which the treatment apparatus 40 AG is inserted or by a releasable catch.
- the treatment apparatus 40 AH of FIG. 50 includes a plurality electrodes 3098 positioned on leaf springs 3096 which are outwardly biased.
- the leaf springs 3096 are connected to a shaft 3102 which is positioned within a delivery catheter 3094 .
- the leaf springs 3096 and electrodes 3098 are delivered through the delivery catheter 3094 to a treatment site within the airways.
- the leaf springs 3096 exit the distal end of the delivery catheter 3094 the leaf springs bend outward until the electrodes 3098 come into contact with the airway walls for application of energy to the airway walls.
- FIGS. 51 and 52 illustrate embodiments of treatment apparatus 40 AI, 40 AJ in which electrodes 3106 in the form of wires are positioned in one or more lumens 3108 of a catheter 3104 . Openings 3110 are formed in the side walls of the catheters 3104 to expose the electrodes 3106 . As shown in FIG. 51 , the treatment apparatus 40 AI has multiple lumens 3108 with electrodes provided in each of the lumens. The side wall of the treatment apparatus 40 AI is cut away to expose one or more of the electrodes 3106 through a side wall opening 3110 . In FIG. 51 , the opening 3110 exposes two electrodes positioned in adjacent lumens.
- the treatment apparatus 40 AI may be provided with a biasing member as discussed above to bring the electrodes 3106 of the treatment apparatus into contact with the airway wall.
- the treatment apparatus 40 AJ of FIG. 52 includes a catheter 3104 which has been formed into a loop shape to allow the electrode 3106 to be exposed on opposite sides of the device which contact opposite sides of the airway.
- the resilience of the loop shape causes the electrodes to come into contact with the airway walls.
- the treatment apparatus 40 AK of FIG. 53 is in the form of a balloon catheter.
- the treatment apparatus 40 AK includes electrodes 3118 positioned on an exterior surface of an inflatable balloon 3116 .
- the electrodes 3118 are electrically connected to the energy source 3032 by the leads 3120 extending through the balloon and through the lumen-of the balloon catheter 3114 .
- the balloon 3116 is filled with a fluid such as saline or air to bring the electrodes into contact with the airway wall 3100 .
- FIG. 54 illustrates an alternative embodiment of a balloon catheter treatment apparatus 40 AM in which a fluid within the balloon 3126 is heated by internal electrodes 3128 .
- the electrodes 3128 are illustrated in the shape of coils surrounding the shaft of the catheter 3124 , however other electrode shapes may also be used.
- the electrodes 3128 may be used as resistance heaters by application of an electric current to the electrodes.
- radio frequency or microwave energy may be applied to the electrodes 3128 to heat a fluid within the balloon 3126 . The heat then passes from an exterior of the balloon 3126 to the airway wall.
- the radio frequency or microwave energy may also be applied indirectly to the airway wall through the fluid and the balloon.
- hot fluid may be transmitted to the balloon 3126 from an external heating device for conductive heating of the airway tissue.
- FIG. 55 illustrates a treatment apparatus 40 AN for delivering heated fluid to the airway walls to heat the airway tissue.
- the treatment apparatus 40 A includes a heating element 3132 provided within a fluid delivery catheter 3134 .
- the fluid passes over the heating element 3132 and out of openings 3136 in the end of the catheter 3134 .
- the openings 3136 are arranged to direct the fluid at the airway walls 3100 .
- the heating element 3132 may be a coiled resistance heating element or any other heating element.
- the heating element 3132 may be positioned anywhere along the body of the catheter 3134 or may be an external heating device separate from the catheter.
- the heating element 3132 may also be replaced with a friction producing heating element which heats fluid passing through the fluid delivery catheter 3134 .
- a friction producing heating element a friction element rotates and contacts a stationary element for purpose of heating the fluid.
- FIG. 56 illustrates an alternative embodiment of a treatment apparatus 40 AP including a cryoprobe tip 3150 for transferring or removing energy in the form of heat from an airway wall 3100 .
- the cryoprobe tip 3150 is delivered to the treatment site by a cryoprobe shaft 3152 . Transfer of energy from the tissue structures of the airway wall can be used in the same manner as the delivery of energy with any of the devices discussed above.
- the particular configuration of the cryoprobe treatment apparatus 40 AP may vary as is known in the art.
- FIGS. 57 and 58 illustrate another embodiment of a treatment apparatus 40 AQ that may be used to treat a lung according to the present invention.
- the treatment apparatus 40 AQ like the previously described treatment apparatus, damages tissue of the airway 25 so as to induce fibrosis and add thickness to the airway wall.
- the treatment apparatus 40 AQ also destroys the airway smooth muscle tone to increase gas exchange.
- a bristled brush 4000 having a plurality of bristles 4002 is introduced into the airway 25 so as to puncture the airway wall with the bristles 4002 .
- the bristles 4002 may be needles, pins, or other similarly shaped members.
- the bristles 4002 are located at the distal end of an elongated member 4004 .
- the bristles 4002 extend radially outward from the outer surface of the distal end of the elongated member 4004 , and are preferably flexible.
- the brush 4000 has at least one bristle 4002 that may be manipulated to damage the tissue of the airway 25 .
- the brush 4000 is inserted through a tube-like member or cannula 4006 which has been inserted into the airway 25 . Because the outer diameter of the brush 4000 (as measured about the most distal ends or tips of the bristles 4002 ) is greater than the interior diameter of the cannula 4006 , the bristles 4002 bend against the interior surface of the cannula 4006 when the brush 4000 is located within the interior of the cannula 4006 .
- FIG. 58 illustrates the brush 4000 after it has been pushed through the most distal opening 4005 of the cannula 4006 .
- the brush 4000 is located at least partially outside of the cannula 4006 .
- the bristles 4002 will return radially outward to their original straight configuration, rather than the bent configuration shown in FIG. 57 where the bristles interfere with the interior surface of the cannula 4006 .
- the bristles 4002 extend radially outward toward the wall of the airway 25 when the distal end of the brush is forced through the opening of the cannula.
- the bristles 4002 have penetrated the wall of the airway 25 to thus cause trauma to the tissue.
- the brush 4000 of the treatment apparatus 40 A extends from the outlet 4005 of the cannula 4006 , the brush 4000 may be moved along the length of the duct as illustrated by the arrow 4007 in FIG. 58 so as to cause further trauma and damage to the airway 25 .
- the brush 4000 may be rotated while in the airway 25 so as to cause damage to the airway 25 .
- the brush 4000 may be moved along the select lengths of the airway 25 to damage predetermined portions of the airway, as desired.
- the brush 4000 may be retracted back through the opening 4005 of the cannula 4000 such that undesired damage is not caused to other portions of the airway 25 when the brush 4000 is removed from the airway and eventually the lung.
- the bristles 4002 are preferably the flexible pins illustrated in FIG. 58 , and are preferably made of a metallic material such as stainless steel.
- the bristles preferably have a caliber that permits them to be easily bent and resiliently return to their original position after being bent.
- the bristles 4002 may take other forms.
- the bristles 4002 may be rigid and substantially not elastic such that they are not easily bendable. That is, the bristles may be needle-like members. In this case, the length of each needle-like member must be sufficiently small so that the brush 4000 may travel through the cannula 4006 , because the needle-like members will not bend in the cannula 4006 when contacting the interior surface of the cannula 4006 .
- the brush 4000 has needle-like members which may be manipulated in the airway 25 so as to cause trauma to the airway wall.
- the bristles 4002 preferably each have a sharp point or tip that will puncture the airway wall to cause damage and thus induce fibrosis and/or destroy smooth muscle tone.
- the tips of the bristles may be blunt such that the bristles will tear or rip the airway, rather than simply puncturing the airway wall. In this case, the tearing action will damage cells of tissue to induce a fibrotic response.
- the bristles 4002 may be razor-like members having a sharp longitudinal edge that slices the airway 25 to cause damage.
- FIGS. 59 and 60 illustrate another embodiment of a treatment apparatus 40 AR for use with the method of the present invention.
- the treatment apparatus 40 AR causes damage to the airway 25 by preferably cutting through the airway wall.
- the treatment apparatus 40 AR includes a cutting device 4100 having a plurality of elongated blades 4102 , 4103 . As shown by the end view in FIG. 60A , the elongated blades 4102 , 4103 are circumferentially spaced at four locations along the exterior surface of an inner rod 4104 . However, additional blades may be included. For example, the blades may be circumferentially spaced at eight locations along the exterior surface of the inner rod 4104 .
- the inner rod or tube 4104 is located at least partially inside the interior of an outer tube or cannula 4106 . As shown by the arrow 4107 in FIG. 60 , the inner tube 4104 is movable within the interior of the outer tube 4106 along the lengthwise direction of the outer tube 4106 . As shown in FIGS. 59 and 60 , each of the elongated blades 4102 is pivotally connected to the inner tube 4104 by a pivot connection 4112 located at the most distal end of the inner tube 4104 so as to be rotatable about the pivot connection 4112 . Each of the elongated blades 4102 located toward the distal end of the inner rod 4104 is also pivotally connected by another pivot connection 4110 to another elongated blade 4103 .
- the pivot connection 4110 defines a point about which each of the blades 4102 , 4103 rotates.
- the elongated blade 4103 is pivotally connected to the outer tube 4106 by a further pivot blade connection 4108 so as to be rotatable about the pivot connection 4108 .
- the blades 4102 and 4103 are movable in the direction shown by the arrow 4109 in FIG. 60 when relative motion occurs between the inner tube 4104 and the outer tube 4106 , preferably when the inner tube 4104 and/or the outer tube 4106 are moved in the direction of the arrow 4107 .
- the inner tube 4104 and the outer tube 4106 are moved from the positions illustrated in FIG. 59 to the positions illustrated in FIG.
- each of the elongated blades 4102 and 4103 will pivot about the pivot connections 4108 , 4110 , 4112 such that the elongated blades 4102 , 4103 move toward the wall of the airway 25 and cut through tissue of the airway to induce fibrosis.
- the elongated blades 4102 , 4103 will damage tissue 27 such that scar tissue develops to thicken the wall of the airway and thus strengthen the airway. As shown in FIG. 60 , the elongated blades 4102 , 4103 have cut or sliced through the tissue of the airway.
- the elongated blades 4102 , 4103 may be repeatedly collapsed and expanded as shown in FIGS. 59 and 60 so as to cause multiple cuts to the airway tissue, as desired. Additionally, the elongated blades 4102 , 4103 may be moved in the longitudinal direction of the airway wall while the blades are in the expanded position shown in FIG. 60 so as to further slice the airway tissue. Likewise, the cutting apparatus 4100 may be rotated in the airway 25 as shown by the arrow 4105 in FIG. 60 so as to cut and/or tear the tissue of the airway 25 .
- the elongated blades 4102 , 4103 are preferably thin razor-like elongated members of stainless steel that easily slice through the airway tissue.
- the elongated blades 4102 , 4103 may take other configurations.
- the elongated blades 4102 , 4103 may be rods having a serrated surface or surfaces that cut or tear through the airway tissue.
- the elongated blades 4102 , 4103 may each include a plurality of pins that function to penetrate or puncture the airway tissue to destroy smooth muscle tone and/or induce fibrosis to strengthen the airway wall and thus improve gas exchange efficiency.
- FIGS. 61-62 illustrate a further embodiment of a treatment apparatus 40 AS for use with the method of the present invention.
- the treatment apparatus 40 AS includes a slicing device 4200 that slices through the airway tissue to destroy smooth muscle tone and/or damage lung tissue and induce fibrosis to strengthen the airway wall.
- the slicing device 4200 includes a plurality of elongated slicing members 4202 that each include a razor edge 4208 located at the most distal end of the slicing members.
- the slicing members 4202 are preferably elongated metallic members that protrude from the an outlet 4201 of an inner tube 4204 .
- the slicing members 4202 are movable in the inner tube 4202 along the lengthwise direction of the inner tube 4204 as shown by the arrows 4207 illustrated in FIG. 62 .
- the inner tube 4204 similar to the previously described embodiments, is located within an outer tube or cannula 4206 .
- the slicing members 4202 may be forced out of an opening 4203 of the outer tube 4206 at the most distal end of the outer tube such that they project outwardly from the end of the outer tube 4206 .
- FIG. 61 illustrates the slicing members 4202 located completely inside of the outer tube 4206
- FIG. 62 illustrates the slicing members 4202 after they have been moved out of the opening 4203 of the outer tube 4206 .
- the slicing members 4202 may be manually forced through the opening 4203 or automatically caused to move through the opening 4203 by a controller (not illustrated).
- each of the slicing members acts like a spring and moves toward the airway wall after exiting the outlet 4203 .
- the slicing members 4202 may be attached to the inner tube 4204 such that the slicing members 4202 move with the inner tube 4204 when the inner tube is moved relative to the outer tube 4206 . Additionally, the slicing members 402 may not be attached to the inner tube 4204 such that they are movable relative to the inner tube 4204 , as well as the outer tube 4206 . As shown by the arrow 4209 in FIG. 61 , the slicing members 4202 can be rotated relative to the airway 25 during the treatment process so as to slice, cut, or tear through the airway wall to cause further trauma.
- FIGS. 61-62 includes only four slicing members 4202 , other numbers of slicing members are contemplated.
- the treatment apparatus 4 AS can slice the airway tissue with 8, 16, 32, 56, or other numbers of slicing members 4202 that are movable relative the airway 25 so as to cause damage to the airway tissue of the lung.
- the slicing members 4202 can be moved to repetitively slice through the tissue of the airway 25 so as to define a plurality of sliced areas 4210 .
- the greater the number of sliced areas 4210 made with the treatment apparatus 40 AS the greater the damage of smooth muscle tone and the greater the fibrotic response, which will thicken the airway wall and strengthen the airway wall to thus increase gas exchange.
- the slicing members 4202 are preferably thin and elongated members having a razor edge 4208 .
- the slicing members 4202 can be other configurations.
- each of the slicing members 4202 may include a pin point rather than a razor edge.
- each of the slicing members 4202 may include serrations or a razor edge along the elongated edges or sides of the slicing members 4202 , which may extend the entire length of the slicing member or only along predetermined portions of the length.
- FIGS. 63-65 illustrate further embodiments of treatment apparatus 40 AT for use with the present invention.
- the treatment apparatus 40 AT includes a balloon 4312 having a plurality of pins 4308 attached to the outer surface of the balloon.
- the balloon 4312 is similar to the previously described balloons and may be fabricated from like materials.
- the balloon 4312 is partially located within an inner tube 4304 , as well as a containment sheath 4309 .
- the balloon 4312 extends from the outlet end of the inner tube 4304 .
- the inner tube 4304 is connected to a fluid supply 4314 , which can supply a pressurized gas or fluid to the interior of the tube 4304 and hence the interior of the balloon 4312 to cause the balloon to expand as shown in FIG. 64 .
- the sheath 4309 that surrounds or encases the balloon 4312 includes a plurality of openings 4302 that extend through the cylindrical wall of the sheath 4309 .
- the openings 4302 communicate the exterior of the sheath 4309 with the interior of the sheath.
- the balloon 4312 is attached to the sheath 4309 at the most distal end 4310 of the sheath.
- the openings 4302 in the sheath 4309 are located at locations on the exterior surface of the sheath 4309 such that when the balloon 4312 is expanded the pins 4308 will travel through the openings 4302 and protrude from the exterior surface of the sheath 4309 .
- the openings 4302 are spaced along the length and the circumference of the sheath 4309 the same distance that the pins 4308 are spaced along the length and circumference of the balloon 4312 .
- the pins will move radially toward the airway and extend through the openings 4302 .
- the pins 4308 will protrude through the openings 4302 and will puncture the tissue of the airway 25 so as to destroy smooth muscle tone and/or induce fibrosis and strengthen the airway.
- the sheath 4309 is preferably formed of a rigid material, such as hard plastic, so that the location of the openings 4302 relative to the location of the pins 4308 on the balloon 4312 remains relatively constant during the treatment process.
- the sheath 4309 is preferably attached to the outer tube 4306 such that the sheath 4309 will move when the outer tube 4306 is moved: Hence, after the balloon has been expanded to cause pins 4308 to extend through the openings 4302 and puncture the airway tissue, the sheath 4309 , the outer tube 4306 , the balloon, and the pins 4308 may be moved in the longitudinal direction of the airway 25 so as to further tear or slice through the airway tissue. Likewise, as shown by the arrow 4307 shown in FIG. 64 , the sheath 4309 may be rotated so as to rotate the pins 4308 to cause further damage to the tissue of the airway.
- the pins 4308 are located on diametrically opposite sides of the balloon 4312 , as are the openings 4302 of the sheath 4309 .
- the balloon 4312 may include further rows and columns of pins 4308 and the sheath may include further rows and columns of openings 4302 , as illustrated by the embodiment of the treatment apparatus 40 AT illustrated in FIG. 65 .
- the balloon 4312 includes eight rows of pins 4308 equally spaced along the length and circumference of the balloon 4312 .
- the sheath 4309 also includes correspondingly located openings 4302 that the pins 4308 may protrude through when the balloon 4312 is expanded.
- Other numbers of pins 4308 and openings 4302 are also contemplated.
- the balloons of the embodiments illustrated in FIGS. 63-65 can be repeatedly expanded and contracted so as to cause multiple punctures to the airway tissue to destroy the airway smooth muscle tone and induce fibrosis and hence stiffen the wall of the airway.
- the pins 4308 can be other configurations.
- a plurality of razors, knives, or blunt members can be attached to the balloon such that the airway tissue is sliced, cut, or torn when the balloon is expanded.
- FIG. 66 illustrates another embodiment of a treatment apparatus 40 AU that may be used according to the present invention.
- the treatment apparatus 40 AU includes a balloon 4412 , which is illustrated in its expanded state in FIG. 66 .
- the balloon 4412 includes a plurality of openings 4402 that communicate the exterior of the balloon with the interior of the balloon.
- the openings 4402 are a plurality of small holes that extend through the wall of the balloon 4412 .
- the balloon 4412 is attached to the end of a tube or cannula 4406 .
- the interior of the balloon 4412 may be filled with a liquid or gas from the fluid supply 4408 .
- the fluid supply 4408 is in communication with the interior of the balloon 4412 through the tube 4406 .
- the balloon may be expanded as shown in FIG.
- the fluid that exits the balloon 4412 may be a heated liquid or gas, similar to the above-described embodiments that destroy cells of the airway tissue by the application of heat.
- the fluid is preferably a biocompatible liquid, such as liquid saline or air.
- the fluid delivered by the supply 4408 may be cold liquid or gas that destroys the airway tissue by removing heat from the airway tissue when it passes through the openings 4402 of the balloon 4412 .
- the liquid or gas supplied by the supply 4408 is cooled to a temperature that destroys airway smooth muscle tone and/or damage airway tissue to induce a fibrotic response to strengthen the airway 25 .
- the liquid or gas delivered by the treatment apparatus 40 AU can also destroy tissue cells by chemically reacting with the tissue.
- the treatment apparatus 40 AU can deliver an acid to the airway tissue to cause trauma to the tissue.
- the balloon 4412 illustrated in FIG. 66 contacts the wall of the airway 25
- the balloon 4412 can be smaller than the airway 25 such that it does not contact the airway wall when expanded.
- FIGS. 67 and 68 illustrate another embodiment of a treatment apparatus 40 A that can be used to perform the present method of the invention.
- the treatment apparatus 40 AV like the apparatus 40 AU illustrated in FIG. 66 , includes a balloon 4512 .
- the balloon 4512 is illustrated in its collapsed condition in FIG. 67 , and is illustrated in its expanded condition in FIG. 68 .
- the balloon 4512 includes a plurality of tubes 4504 attached to the exterior surface of the balloon 4512 .
- the interior of the balloon 4512 is not in communication with the interior of the tubes 4504 .
- the plurality of tubes 4504 are preferably circumferentially spaced about the exterior cylindrical surface of the balloon 4512 .
- Each of the tubes 4504 extends along the longitudinal length of the balloon 4512 and through the interior of a tube or cannula 4508 .
- the balloon 4512 may be inflated by a fluid supply 4514 which supplies a gas or liquid to the interior of the balloon 4512 to cause it to expand to the position illustrated in FIG. 68 .
- the expansion of the balloon 4512 does not cause a liquid or gas to be delivered to the wall of the airway 25 . Rather, a separate fluid supply 4510 delivers a liquid or gas to the interior of each of the tubes 4504 .
- the liquid or gas delivered by the fluid supply 4510 travels through the interior of the elongated tubes 4504 and out of a plurality of openings 4502 spaced along the length of each of the tubes 4504 .
- the openings 4502 are equidistantly spaced along the length of the tube 4504 .
- the supply 4510 may supply a liquid or gas to the interior of the tubes 4504 and out of the openings 4502 such that the liquid or gas from the supply 4510 contacts the airway tissue.
- the liquid or gas supplied from the supply 4510 will damage the airway tissue.
- the fluid or gas delivered through the holes 4502 damages tissue 27 to induce fibrosis and thicken the wall of the airway 25 so as to strengthen the airway wall and increase the gas exchange efficiency of the lung.
- the fluid or gas can also destroy the smooth muscle tone to increase gas exchange.
- FIG. 69 illustrates an additional embodiment of a treatment apparatus 40 AW for use with the methods of the present invention.
- the treatment apparatus 40 AW includes a tube or cannula 4604 having a plurality of holes 4602 located at a most distal end of the tube 4604 .
- the plurality of holes 4602 form a plurality of columns and rows about the circumference of the tube 4604 , as illustrated in FIG. 69 .
- the holes 4602 deliver a fluid, such as that described above in reference to FIGS. 66-68 to the tissue of the airway 25 to damage cells and induce fibrosis. As shown in FIG.
- a gas supply 4610 and/or a liquid supply 4612 may deliver a fluid to the interior of the tube 4604 , through the holes 4602 , and to the tissue of the airway 25 .
- a gas and/or a fluid will destroy smooth muscle tone and/or damage tissue to induce fibrosis and increase the gas exchange efficiency of the lung.
- FIG. 70 illustrates a further embodiment of a treatment apparatus 40 AX for use with the methods according to the present invention.
- the treatment apparatus 40 AX like the embodiments illustrated in FIGS. 66-69 , delivers a liquid or a gas to the airway 25 so as to damage of the airway tissue.
- an inner tube 4702 is located within an outer tube 4704 .
- the inner tube 4702 may be connected to a gas supply or a liquid supply 4710 .
- the outer tube 4704 may be connected to a gas supply or liquid supply 4712 .
- the fluid delivered to the interior of the inner tube 4702 from the supply 4710 exits the outlet 4708 at the distal end of the inner tube 4702 .
- the fluid delivered from the supply 4712 exits the outlet 4706 at the most distal end of the outer tube 4704 .
- two separate liquids, two separate gases, or a combination of liquids and gases may be delivered to the airway tissue to cause trauma to destroy smooth muscle tone and/or cause fibrosis and strengthen the airway 25 .
- two liquids or gases may be combined at the outlets 4706 , 4708 to cause a chemical reaction that damages the cells of the airway tissue to induce fibrosis.
- FIGS. 71 and 72 illustrate a bronchoscope, such as described earlier, that may be used with each of the above-described treatment apparatus 40 .
- the bronchoscope 5000 has a treatment apparatus 40 slidably positioned within a lumen of the bronchoscope.
- the bronchoscope also includes an image-transmitting fiber 5008 and illuminating fiber 5020 . Any conventional bronchoscope with an appropriately sized and directed working lumen may be employed.
- the image transmitting fiber collects light from the distal end of the treating apparatus and directs the light to a viewing apparatus (not shown) for displaying an image of the air passage.
- the bronchoscope may have a panning system which enables the tip to be moved in different directions.
- the bronchoscope as illustrated in FIGS. 71 and 72 is advanced from the person's nasal or oral cavity, and through the trachea, main stem bronchus, and into an air passage.
- the treatment apparatus 40 is advanced forward from the bronchoscope such that the treatment apparatus may be used to destroy airway smooth muscle tone and/or cause damage to airway tissue to induce fibrosis and strengthen an airway of the lung.
- This procedure is applied to a sufficient number of obstructed air passages until the physician determines that the treatment is finished. As is apparent, the procedure can be completed in one treatment or multiple treatments.
- the bronchoscope and the treatment apparatus 40 are then removed from the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Radiology & Medical Imaging (AREA)
- Plasma & Fusion (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Electromagnetism (AREA)
- Thermal Sciences (AREA)
- Surgical Instruments (AREA)
Abstract
A method for treating a lung may include moving a balloon through an airway of the lung while the balloon is in a deflated configuration, and inflating the balloon to cause one or more radio frequency electrodes disposed adjacent an outer surface of the balloon to contact tissue defining the airway. The method also may include delivering radio frequency energy from the one or more radio frequency electrodes to damage nerve tissue.
Description
- The present application is a continuation of U.S. application Ser. No. 13/590,129, filed Aug. 20, 2012, which is a continuation of U.S. application Ser. No. 12/328,582, filed on Dec. 4, 2008, now U.S. Pat. No. 8,267,094, which is a continuation of U.S. application Ser. No. 11/117,905, filed Apr. 29, 2005, now U.S. Pat. No. 7,740,017, which is:
- a) a continuation application of U.S. application Ser. No. 09/999,851, filed Oct. 25, 2001, now U.S. Pat. No. 7,027,869, which is a continuation-in-part application of U.S. application Ser. No. 09/296,040, filed Apr. 21, 1999, now U.S. Pat. No. 6,411,852, each of which are herein incorporated by reference in their entirety,
- (b) a continuation-in-part application of U.S. application Ser. No. 09/436,455 filed Nov. 8, 1999, now U.S. Pat. No. 7,425,212, which is incorporated by reference herein in its entirety, and
- (c) a continuation-in-part application of U.S. application Ser. No. 10/232,909 filed on Aug. 30, 2002, now U.S. Pat. No. 7,556,624, which is a continuation of U.S. application Ser. No. 09/349,715 filed Jul. 8, 1999, now U.S. Pat. No. 6,488,673, each of which are herein incorporated by reference in their entirety.
- U.S. application Ser. No. 09/999,851, now U.S. Pat. No. 7,027,869, is also a continuation-in-part application of U.S. application Ser. No. 09/535,856 filed on Mar. 27, 2000, now U.S. Pat. No. 6,634,363, which is also incorporated by reference in its entirety.
- The present application is related to U.S. application Ser. No. 09/095,323 filed Jun. 10, 1998, now abandoned, U.S. application Ser. No. 09/260,401 filed on Mar. 1, 1999, now U.S. Pat. No. 6,283,988, U.S. application Ser. No. 09/003,750 filed Jan. 7, 1998, now U.S. Pat. No. 5,972,026, and U.S. application Ser. No. 08/833,550 filed Apr. 7, 1997, now U.S. Pat. No. 6,273,907, each of which are herein incorporated by reference in their entirety.
- 1. Field of the Invention
- The invention relates to a method for treating lung disease, and more particularly, the invention relates to a method of increasing gas exchanging of a lung by stiffening an airway of the lung.
- 2. Brief Description of the Related Art
- The lungs deliver oxygen to the body and remove carbon dioxide. Healthy lung tissue includes a multitude of air passageways which lead to respiratory bronchiole within the lung. These airways eventually lead to small sacs called alveoli, where the oxygen and carbon dioxide are exchanged through the ultra-thin walls of the alveoli. This occurs deep within the lungs, in an area which is accessed by a network of airways, consisting of a series of branching tubes which become narrower, shorter, and more numerous as they penetrate deeper into the lungs. As shown in
FIG. 1 , tiny air sacks called alveoli 1 surround bothalveolar ducts 2 and respiratory bronchiole 3 throughout the lung. The alveoli 1 are small, polyhedral recesses composed of a fibrillated connective tissue and surrounded by a few involuntary muscular and elastic fibers. These alveoli 1 inflate and deflate with air when we breath. The alveoli are generally grouped together in a tightly packed configuration called an alveolar sac. The thin walls of the alveoli 1 perform gas exchange as we inhale and exhale. - During inhalation, as the diaphragm contracts and the ribs are raised, a vacuum is created in the chest, and air is drawn into the lungs. As the diaphragm relaxes, normal lungs act like a stretched balloon and rebound to the normal relaxed state, forcing air out of the lungs. The elasticity of the lungs is maintained by the supportive structure of the alveoli. This network of connective tissue provides strength to the airway walls, as well as elasticity to the lungs, both of which contribute to the lung's ability to function effectively.
- Patients with pulmonary disease, such as chronic bronchitis, and emphysema have reduced lung capacity and efficiency, typically due to the breakdown of lung tissue.
- In cases of severe chronic pulmonary disease, such as emphysema, lung tissue is destroyed, reducing the strength of the airways. This reduction in strength of the airway walls allows the walls to become “floppy” thereby losing their-ability to remain open during exhalation. In the lungs of an emphysema patient, illustrated in
FIG. 2 , the walls between adjacent alveoli within the alveolar sac deteriorate. This wall deterioration is accelerated by the chemicals in smoke which affect the production of mucus in the lungs. Although the break down of the walls of the alveoli in the lungs occurs over time even in a healthy patient, this deterioration is greatly accelerated in a smoker causing the smoker's lungs to have multiple large spaces 4 with few connecting walls in the place of the much smaller and more dense alveoli spaces 1 in healthy lung tissue. - A cross section of a diseased emphysematous lung will look like Swiss cheese due to the deterioration of the alveoli walls which leaves large spaces in the tissue. In contrast, healthy lung tissue when seen in cross section has no noticeable holes because of the small size of the alveoli. When many of the walls of the alveoli 1 have deteriorated as shown in
FIG. 2 , the lung has larger open spaces 4 and a larger overall volume, but has less wall tissue to achieve gas exchange. - In this diseased state, the patient suffers from the inability to get the air out of their lungs due to the collapse of the airways during exhalation. Heavily diseased areas of the lung become overinflated. Within the confines of the chest cavity, this overinflation restricts the in-flow of fresh air and the proper function of healthier tissue, resulting in significant breathlessness. Thus, the emphysema patient must take in a greater volume of air to achieve the same amount of gas exchange. When severe emphysema patients take in as much air as their chest cavity can accommodate, they still have insufficient gas exchange because their chest is full of non-functional air filling large cavities in the lungs. Emphysema patients will often look barrel-chested and their shoulders will elevate as they strain to make room for their overinflated lungs to work.
- A wide variety of drugs are available for treating the symptoms of pulmonary disease, but none are curative. Chronic bronchitis and emphysema are typically treated with antibiotics and bronchodilators. Unfortunately, a large number of patients are not responsive to these medications or become non-responsive after prolonged periods of treatment.
- In severe emphysema cases, lung volume reduction surgery (LVRS) is performed to improve lung efficiency of the patient and allow the patient to regain mobility. In lung volume reduction surgery, a more diseased portion of an emphysematous lung having a large amount of alveolar wall deterioration is surgically removed. LVRS is performed by opening the chest cavity, retracting the ribs, stapling off, and removing the more diseased portion of the lung. This allows the remaining healthier lung tissue to inflate more fully and take greater advantage of the body's ability to inhale and exhale. Because there is more air and more gas exchange in the healthier portion of the lung, lung efficiency is improved.
- Lung volume reduction surgery is an extremely invasive procedure requiring the surgical opening of the chest cavity and removal of lung tissue. This surgery has substantial risks of serious post-operative complications, such as pneumothorax, and requires an extended convalescence.
- Accordingly, it is desirable to improve air exchange for patients having chronic obstructive pulmonary diseases, such as chronic bronchitis and emphysema. It is especially desirable to achieve improved air exchange of emphysema patients without invasive open chest surgery and the associated complications.
- The present invention pertains to methods of increasing gas exchange of the lungs of a patient. According to the present invention, gas exchange is increased by stiffening, strengthening, or destroying airway smooth muscle tone of at least one airway of a lung.
- In accordance with one aspect of the present invention, a method includes: inserting an apparatus into an airway of a lung, and damaging lung cells with the apparatus to cause fibrosis to stiffen the airway so as to increase gas exchange performed by the lung.
- In accordance with another aspect of the present invention, a method includes: inserting an apparatus into an airway of a lung; and damaging tissue in the lung with the apparatus to increase gas exchange performed by the lung.
- In accordance with a further aspect of the present invention, a method of increasing gas exchange performed by the lung, includes: inserting an apparatus into an airway of a lung; and causing trauma to tissue with the apparatus to cause fibrosis to stiffen the airway. Causing trauma to the tissue with the apparatus includes at least one of: heating the tissue; cooling the tissue; delivering a liquid that cause trauma to the tissue; delivering a gas that cause trauma to the tissue; puncturing the tissue; tearing the tissue; cutting the tissue; applying ultrasound to the tissue; and applying ionizing radiation to the tissue.
- Another aspect of the present invention pertains to a method including: inserting an apparatus into an airway of a lung; and destroying airway smooth muscle tone with the apparatus to increase gas exchange performed by the lung.
- A further aspect of the present invention pertains to a method of increasing gas exchange performed by a lung. The method includes inserting an apparatus into an airway of a lung, and damaging airway tissue with the apparatus to thicken a wall of the airway.
- The present invention provides advantages of a minimally invasive procedure for surgically treating the effects of pulmonary disease, such as chronic pulmonary disease, without the complications associated with conventional surgery.
- The invention will now be described in greater detail with reference to the preferred embodiments illustrated in the accompanying drawings, in which like elements bear like reference numerals, and wherein:
-
FIG. 1 is a cross-sectional view of an alveolar sack of a healthy lung; -
FIG. 2 is a cross-sectional view of an alveolar sack of a diseased lung; -
FIG. 3 is an illustration of a lung having a diseased lower portion prior to treatment according to the present invention; -
FIG. 4 is a perspective view of the airway of a lung, wherein the smooth muscle tissue, alveolar sacks, and alveoli are illustrated; -
FIG. 5 is a cross-sectional view of the airway ofFIG. 4 taken along the line 5-5 ofFIG. 4 ; -
FIG. 6 is a schematic side view of lungs being treated with the treatment apparatus in accordance with one embodiment of the present invention; -
FIG. 6A is a schematic cross-sectional view of the airway ofFIG. 6 before treatment taken along theline 6A-6A ofFIG. 6 ; -
FIG. 6B is a schematic cross-sectional view of the airway ofFIG. 6A after being treated in accordance with one method of the present invention; -
FIG. 7 is a schematic side view of lungs being treated with a treatment apparatus in accordance with one embodiment of the present invention; -
FIGS. 8 , 9, 10A, 10B, 11A and 11B are perspective views of heat treatment apparatus for use with the methods of the present invention; -
FIGS. 12A and 12B are cross-sectional views of heat treatment apparatus for use with the methods of the present invention; -
FIG. 13A is a schematic view of an embodiment of the treatment apparatus for use with the methods of the present invention; -
FIG. 13B is an enlarged view of the circled portion ofFIG. 13A ; -
FIG. 13C illustrates another embodiment of a treatment apparatus for use with the methods of the present invention; -
FIGS. 14A , 14B, 15A, 15B, 16A, 16B, 17A, and 17B illustrate additional embodiments of the heat treatment apparatus which employ RF energy for use with the methods of the present invention; -
FIG. 18 illustrates an embodiment of the heat treatment apparatus which employs circulating heated fluid for use with the methods of the present invention; -
FIG. 19 illustrates an embodiment of the heat treatment apparatus that has both resistive heating and inductive heating for use with the methods of the present invention; -
FIGS. 20A and 20B illustrate an embodiment of a heat treatment apparatus that employs electrodes positioned on the outer surface of a balloon for use with the methods of the present invention; -
FIGS. 21 , 22, and 23 show embodiments of the heat treatment apparatus that employ diametrically adjustable electrodes for use with the methods of the present invention; -
FIG. 24 illustrates a heat treatment apparatus with multiple electrodes for use with the methods of the present invention; -
FIG. 25 illustrates a heat treatment apparatus with multiple balloons for use with the methods of the present invention; -
FIG. 26 is a schematic side view of one embodiment of a heat treatment apparatus that employs two collapsible and retractable electrodes for use with the methods of the present invention; -
FIG. 27 is an enlarged partial cross-sectional view of a distal end of another embodiment of a heat treatment apparatus having one collapsible electrode for use with the methods of the present invention; -
FIG. 28 is a side cross-sectional view of an alternative embodiment of a heat treatment apparatus having two wire shaped electrodes for use with the methods of the present invention; -
FIG. 29 is a side cross-sectional view of the device ofFIG. 28 in an enlarged state within a bronchial tube; -
FIG. 30 is a side cross-sectional view of an alternative embodiment of a heat treatment apparatus with four electrodes in an enlarged state within a bronchial tube for use with the methods of the present invention; -
FIG. 30A is an end view of the device ofFIG. 30 ; -
FIG. 31 is a side cross-sectional view of an alternative embodiment of a heat treatment apparatus with a loop shaped electrode in a contracted state for use with the methods of the present invention; -
FIG. 32 is a side cross-sectional view of the apparatus ofFIG. 31 with the electrode in an expanded state within a bronchial tube for use with the methods of the present invention; -
FIG. 33 is a side cross-sectional view of an alternative embodiment of the invention with a plate shape electrode in a contracted state for use with the methods of the present invention; -
FIG. 34 is an end view of the apparatus ofFIG. 33 in the contracted state; -
FIG. 35 is a side cross-sectional view of the apparatus ofFIG. 33 with the plate shaped electrodes in an expanded configuration; and -
FIG. 36 is an end view of the expanded apparatus ofFIG. 35 for use with the methods of the present invention; -
FIG. 37 is a side cross-sectional view of a body conduit and an apparatus for treating the body conduit according to the present invention; -
FIG. 38 is a schematic side view of lungs being treated with a treatment apparatus in accordance with one aspect of the present invention; -
FIG. 39 is a side cross-sectional view of a distal end of an embodiment of a treatment apparatus for use with the methods of the present invention; -
FIG. 40 is a side cross-sectional view of a distal end of another embodiment of a treatment apparatus for use with the methods of the present invention; -
FIG. 41 is a side cross-sectional view of a distal end of a further embodiment of a treatment apparatus for use with the methods of the present invention; -
FIG. 42 is a side cross-sectional view of another embodiment of a treatment apparatus for use with the methods of the present invention; -
FIGS. 43A and 43B are side views of two variations of an embodiment of a treatment apparatus having a plurality of wire shaped electrodes for use with the methods of the present invention; -
FIG. 43C is a cross-sectional side view of another variation of a treatment apparatus having a plurality of wire shaped electrodes for use with the methods of the present invention; -
FIG. 44 is a side view of another embodiment of a treatment apparatus with electrodes positioned on expandable balloons for use with the methods of the present invention; -
FIG. 45 is a perspective view of an embodiment of a treatment apparatus with electrodes positioned in grooves for use with the methods of the present invention; -
FIG. 46 is a perspective view of an embodiment of a treatment apparatus with electrodes in a biasing element for use with the methods of the present invention; -
FIG. 47 is a perspective view of an embodiment of a treatment apparatus with electrodes and a biasing element for use with the methods of the present invention; -
FIG. 48 is a side view of an embodiment of a treatment apparatus in an unexpanded position for use with the methods of the present invention; -
FIG. 49 is a side view of the treatment apparatus ofFIG. 48 in an expanded position; -
FIG. 50 is a side view of an embodiment of a treatment apparatus in an expanded position for use with the methods of the present invention; -
FIG. 51 is a side view of an embodiment of a treatment apparatus having a plurality of lumens containing electrodes for use with the methods of the present invention; -
FIG. 52 is a side view of an embodiment of a treatment apparatus having electrodes exposed by cut away sections of a tube for use with the methods of the present invention; -
FIG. 53 is a side cross-sectional view of an embodiment of a treatment apparatus with electrodes positioned on an expandable balloon for use with the methods of the present invention; -
FIG. 54 is a schematic side view of an embodiment of a treatment apparatus with a balloon for heating of tissue for use with the methods of the present invention; -
FIG. 55 is a side cross-sectional view of another embodiment of a treatment apparatus for treatment with heated fluid; -
FIG. 56 is a side view of a treatment apparatus having a cryoprobe for use with the methods of the present invention; -
FIG. 57 is a cross-sectional view of an embodiment of a treatment apparatus that includes a brush for with the methods of the present invention; -
FIG. 58 is a side cross-sectional view of the device illustrated inFIG. 57 after it has treated the airway of a lung; -
FIG. 58A is a cross-sectional view of the device illustrated inFIG. 58 taken along theline 58A-58A ofFIG. 58 ; -
FIG. 59 is a side cross-sectional view of a treatment apparatus that includes a device for cutting or slicing the tissue of an air way of a lung in accordance with methods of the present invention; -
FIG. 60 illustrates a partial side cross-sectional view of the embodiment illustrated inFIG. 9 , where the treatment apparatus has treated the tissue of the lung; -
FIG. 60A is a cross-sectional view of the device illustrated inFIG. 60 taken along theline 60A-60A ofFIG. 60 ; -
FIG. 61 is a side cross-sectional view of another embodiment of a treatment apparatus, where the treatment apparatus includes a plurality of members for slicing or cutting the air way of a lung in accordance with the methods of the present invention; -
FIG. 62 illustrates the treatment apparatus ofFIG. 61 in a deployed position; -
FIG. 62A is a cross-sectional view of the device illustrated inFIG. 62 taken along theline 62A-62A ofFIG. 62 . -
FIG. 63 illustrates a further embodiment of a treatment apparatus where the treatment apparatus includes a plurality of pins that puncture or penetrate the air way of a lung in accordance with the methods of the present invention; -
FIG. 64 illustrates the treatment apparatus ofFIG. 63 in a deployed position; -
FIG. 64A is a cross-sectional view of the device illustrated inFIG. 64 taken along theline 64A-64A ofFIG. 64 ; -
FIG. 65 illustrates an alternative embodiment of the treatment apparatus illustrated inFIGS. 63 and 64 for use with the methods of the present invention; -
FIGS. 66-70 illustrate embodiments of treatment apparatus that deliver a fluid to the airway to treat the lungs in accordance with the methods of the present invention; -
FIG. 71 is a side view of a bronchoscope that may be used to deploy the above-illustrated treatment apparatus when practicing the present invention; and -
FIG. 72 is a cross-sectional view of the device illustrated inFIG. 71 taken along the line 72-72 ofFIG. 71 . - In the following description, like reference numerals refer to like parts.
-
FIG. 3 illustrateshuman lungs 20 having aleft lung 30 and aright lung 32. Adiseased portion 31 is located at the lower portion or base of the left lung 30 (indicated by the volume of the lung below the dashed line on the left lung). In some cases, the diseased portions of an unhealthy lung are not generally located in discrete areas. That is, the diseased portions may not be distributed heterogeneously, and are more homogeneous. - As illustrated in
FIG. 3 , thetrachea 22 extends down from the larynx and conveys air to and from the lungs. Thetrachea 22 divides into right and leftmain bronchi 24, which in turn form lobar, segmental, and sub-segmental bronchi or bronchial passageways. Eventually, the bronchial tree extends to the terminal bronchiole. At the terminal bronchiole,alveolar sacs 26 containalveoli 28 that perform gas exchange as humans inhale and exhale. -
FIG. 4 illustrates anairway 25 of thelung 30 in greater detail. Theairway 25 is a bronchial tube, air passage, lumen, bronchial airway, or respiratory bronchiole of thelung 30. Theairway 25 includes smooth muscle tissue that helically winds around the bronchiole to define a duct of theairway 25 through which air may be inhaled and exhaled during operation of the lung. The smooth muscle tissue is arranged around the airways in a generally helical pattern with pitch angles ranging from about −30 to about +30 degrees. As theairway 25 branches deeper into the lung, more and morealveolar sacs 26 andalveoli 28 appear, as shown inFIGS. 3 and 4 . -
FIG. 5 illustrates a light microscopic cross-section of the tissue of theairway 25, which is a collection of cells and intercellular substances that surround the cells, together defining theairway 25. Theairway 25 defines anairway duct 40 through which gases are inhaled and exhaled. Theairway 25 ofFIG. 5 is a medium sized bronchus having an duct diameter DI of about 3 mm. Theairway 25 includes a folded inner surface orepithelium 38 surrounded bystroma 32 and thesmooth muscle tissue 27. Theairway 25 also hasmucous glands 34 andcartilage 30 surrounding the smooth muscle tissue. Nerve fibers andblood vessels 36 also surround the airway. Hence, as shown inFIG. 5 , thesmooth muscle tissue 27 is part of the overall tissue of theairway 25. - Referring again to
FIG. 3 , thediseased portion 31 of thelung 30 is located at the lower portion or base of the lung. By way of example, it can be considered that thisdiseased portion 31 has been stricken by emphysema. Theemphysematous portion 31 of thelung 30 generally includes sections in which the walls between theadjacent alveoli 28 have deteriorated to a degree that the lung tissue looks like Swiss cheese in cross section. When this occurs, pulmonary function is impaired to a great degree. - The pulmonary system utilizes two simple mechanisms, air exchange into and out of the
lungs 30 and gas exchange into and out of the blood. In patients with emphysema, both of these mechanisms are impaired, leading to dyspnea (shortness of breath), limitations in physical activities, and increased incidence of related diseases. To improve their condition, either or both of these impairments need to be improved. One way to address this is by restoring some of the lost air exchanging ability. - Air exchange is created by movement of muscles that increase and decrease the pressures around the lungs. Inspiration occurs when a decrease in pressure around the lungs to below atmospheric pressure expands the lungs, which in turn causes the pressure in the terminal end points of the airways (the alveoli 28) to drop below atmospheric. This pulls the air into the alveoli 28 through the ‘ conducting
airways 25. - Exhalation is a passive process. Normal exhalation occurs when the muscles relax, allowing the natural elasticity of the lung structure to expel the air from within. In addition to making up the driving force to expel air from the lungs, the elasticity also mechanically helps keep conducting airways from collapsing. It is the-loss of elasticity of lung tissue that leads to the condition known as “dynamic airway collapse”.
- In more detail, airway obstruction in the emphysematous patient has two components, “small airways disease” and dynamic airway collapse of the mid-sized airways. Both contribute to the patient's inability to get adequate amounts of air to and from the alveoli 28, which are the gas exchanging membranes in the lungs. Small airways disease is primarily caused by mucous plugging and inflammation of the small (less than 2 mm in diameter) airways, whereas dynamic airway collapse of the mid-sized airways (3 mm-6 mm) is mechanical in nature.
- The mechanics of mid-size airway “patency” are dictated by four forces being in balance with one another. If the balance of those forces shifts, airway collapse will occur. Specifically, these forces are: (1) air pressure inside the airway in question, (2) air pressure in the alveoli directly surrounding that airway, (3)“tethering” of the airway by the surrounding tissue (parenchyma) and (4) stiffness of the airway wall itself. It is inherent in the movement of gases within the lungs that the pressure in the alveoli 28 directly surrounding the
airway 25 must be higher than that within the airway itself during exhalation. Otherwise, no air would move from the alveoli 28 to, and through, theairway 25 on its way out of the lung. Since this inherent pressure differential would collapse anairway 25 if that airway were made of a very flexible material, there must be some mechanical strength built into the airway system to oppose this collapse in healthy people. This strength comes from both the stiffness of the airway wall and the tethering action of the surrounding parenchyma. - In patients with emphysema, the number of parenchymal tethers touching each airway is reduced. This in turn reduces the tethering forces that maintain the airway open. With these tethering forces reduced, the only thing keeping the airway open is the stiffness of the airway wall. In an emphysematous lung, this is often not enough, and the airways collapse during exhalation. Embodiments of the present invention aim to increase the strength of the airway walls to keep the airway open, which will increase gas exchange.
- By strengthening the airway walls of an emphysematous lung, the balance of forces during exhalation is shifted back toward keeping the airways open. In short, stiffening the airway wall helps prevent airway collapse during exhalation, which will thus result in an increase in airflow and gas exchange.
- One way to achieve this stiffening is to thicken the walls themselves. The present invention is based in part on the discovery that the
airway 25 is strengthened because of the natural formation of fibrotic tissue, such as scar tissue, in response to trauma or injury. Fibrosis is the formation of fibrous or fibrotic tissue as a reparative or reactive process, i.e., regrowth of tissue after injury. The formation of fibrotic tissue essentially deposits additional tissue to the airway, which strengthens the wall of the airway. This stimulation of additional material will increase the thickness of the airway wall, thus strengthening the airway to help prevent the airway from collapsing during exhalation. Theairway 25 is stiffened because the fibrotic tissue is thicker than the previous diseased tissue supporting the airway. As described below, the trauma can be caused by damaging the airway tissue, such as by delivering heat to the airway and/or by mechanical insult to the airway tissue. - By strengthening the airway walls of an emphysematous lung in accordance with the embodiments of the present invention, the balance of forces during exhalation is shifted back toward keeping the airways open. Stiffening airway wall by stimulating the deposition of fibrotic tissue helps prevent airway collapse during exhalation, and will thus result in an increase in airflow. In general, the greater the scarring or injury, the greater the build-up of fibrotic tissue. The thicker the airway wall due to build-up of fibrotic tissue, the less likely that it will collapse as it may have prior to treatment according to the present invention.
- If the airway tissue is injured to such an extent that the airway wall thickens, it is preferable not to create so much fibrotic tissue that the airway closes. That is, it is preferable that the formation of fibrotic tissue does not cause stenosis. Stenosis may be prevented by controlling the extent of injury or damage to the airways of the lung. It is also preferable not to ablate or vaporize large amounts of airway tissue such that the airway loses its structure. Hence, it is preferable to damage enough airway tissue to cause fibrotic tissue to develop and stiffen the existing airway wall, rather than completely destroying the existing airway wall to define a new cavity, and rather than destroying so much tissue that a mass of scar tissue blocks the airway.
- The gas exchange of the
lung 30 can also be increased in accordance with the embodiments of the present invention by destroying the airway smooth muscle tone. Smooth muscle tone refers to ability of the smooth muscle of the airway to respond to signals that trigger the airway smooth muscle to continually and partially contract. By destroying the smooth muscle or disrupting the smooth muscle's ability to respond to such signals, the contraction force is removed and the airway will become larger. - When one inhales, the pressure in the airway is higher than the alviolar pressure that acts on the outside of the airway. This being the case, a “floppy” or diseased airway will remain open on inspiration. However, as described above, upon expiration, the alviolar pressure builds and at some point exceeds the air pressure in the airway. In this state, a floppy airway will be more prone to collapse and inhibit the flow of air out of the alveoli. The smooth muscle tone may further restrict the airway diameter. Hence, the removal or destruction of at least some of the smooth muscle tone will beneficially increase gas exchange during the expiration cycle.
- Thus, the present invention strives to relieve the effects of emphysema and other forms of pulmonary disease by increasing the efficiency of gas exchange in the
lung 30. Generally speaking, this may be achieved by inserting an apparatus into an airway of the lung through thetrachea 22, and then damaging tissue of theairway 25 to cause fibrosis to strengthen the airway and/or to destroy smooth muscle tone of the airway. - The following description of the treatment apparatus for use with the embodiments of the present invention can be employed to treat a bronchial tube regardless of whether the tube lumen has collapsed or not. Specifically, the devices can be used to treat bronchial tubes that have not collapsed, are partially collapsed, or are fully collapsed. Moreover, bronchial tubes may exhibit different degrees of closure depending on the state of respiration. For example, a bronchial tube may have a fully expanded lumen during inhalation but partially or completely closed during exhalation.
-
FIG. 6 is a schematic view of thelung 32 being treated with atreatment apparatus 40 in accordance with a method of the present invention. Thepreferred apparatus 40 is an elongated member that may be electronically or manually controlled by a surgeon orcontroller 42 to damage lung cells to cause fibrosis to stiffen the airway and/or to destroy smooth muscle tone of the airway so as to increase gas exchange performed by the lung. As described further below, the damaging of cells of airway tissue and/or destruction of smooth muscle tone of the airway with theapparatus 40 may be accomplished by any one of, or combinations of, the following: - (1) heating the tissue;
- (2) cooling the tissue;
- (3) delivering a liquid that damages the tissue;
- (4) delivering a gas that damages the tissue;
- (5) puncturing the tissue;
- (6) tearing the tissue;
- (7) cutting the tissue;
- (8) applying ultrasound to the tissue;
- (9) applying ionizing radiation to the tissue;
- (10) other methods that cause trauma to lung cells to cause fibrosis to stiffen the airway so as to increase gas exchange performed by the lung; and
- (11) other methods that destroy smooth muscle tone of the airway so as to increase gas exchange performed by the lung. A more detailed description of the methods of stiffening the
airway 25 and destroying the airway smooth muscle tone to increase gas exchange follows. -
FIG. 6A is a representational cross-sectional view of theairway 25 of thelung 32 during expiration before it has been treated with theapparatus 40, whileFIG. 6B is a representational cross-sectional view of theairway 25 during expiration after it has been treated with theapparatus 40 in accordance with a preferred method of the present inventionFIG. 6B . - As illustrated in
FIG. 6A , theairway 25 is partially collapsed due to pulmonary disease, such as described earlier. In this state, air exchange is adversely affected. InFIG. 6B , thetreatment apparatus 40 has damaged the tissue of theairway 25 so as increase the thickness of the airway wall. More particularly, theairway 25 has been strengthened because of the natural formation of fibrotic tissue in response to trauma or injury. The formation of the fibrotic tissue has deposited additional tissue to the airway, which strengthens the wall of the airway. Thus, the airway wall shown inFIG. 6B is thicker than the airway wall shown inFIG. 6A . This increased thickness of the airway wall strengthens the airway to help prevent the airway from collapsing during exhalation. Accordingly, the airway illustrated inFIG. 6B is not collapsed to the same extent as the untreated airway illustrated inFIG. 6B . Hence, if thelung 32 is stricken with emphysema, the previously described balance of forces during exhalation is shifted back toward keeping theairway 25 open, which helps prevent airway collapse during exhalation, and will thus result in an increased airflow and gas exchange. -
FIGS. 7-70 illustrate embodiments of treatment apparatus or devices 40A-40AX that can be used to destroy airway smooth muscle tone and/or damage airway tissue to induce fibrosis according to the present invention. These are just some of the examples of the type of treatment apparatus which may be used to perform the methods according to the present invention. It should be recognized that each of the treatment apparatus described below can be modified to deliver or remove energy in different patterns, depending on the treatment to be performed. The treatment apparatus may be actuated continuously for a predetermined period while stationary, may be pulsed, may be actuated multiple times as they are moved along an airway, may be operated continuously while moving the treatment apparatus in an airway to achieve a “painting” of the airway, or may be actuated in a combination of any of these techniques. The particular energy application pattern desired can be achieved by configuring the treatment apparatus itself or by moving the treatment apparatus to different desired treatment locations in the airway. -
FIG. 7 is a schematic side view of lungs being treated with a treatment apparatus 40A in accordance with one embodiment of the present invention. The treatment apparatus 40A is an elongated member for delivery of energy from anenergy source 50 to atreatment site 52 at an airway of the lungs. The energy may be delivered by the treatment apparatus 40A in a variety of treatment patterns to achieve a desired response. Examples of patterns are discussed in further detail below. The energy which is delivered by the treatment apparatus 40A may be any of a variety of types of energy including, but not limited to, radiant, laser, radio frequency, microwave, heat energy, or mechanical energy (such as in the form of cutting or mechanical dilation). In addition, the delivery of laser or light energy may be in conjunction with the delivery of a photodynamic agent, where the laser or light energy stimulates the photodynamic agent and initiates a cytotoxic, or cell damaging chemical reaction. - The airway smooth muscle tone can be destroyed and the cells of the airway tissue of the
airway 25 can be damaged by exposing thetissue 27 to energy. The damaging of the airway tissue by energy will induce fibrosis so as to strengthen the airway. A pattern for treatment can be chosen from a variety of patterns including longitudinal stripes, circumferential bands, helical stripes, and the like as well as spot patterns having rectangular, elliptical, circular or other shapes. The size, number, and spacing of the treatment bands, stripes, or spots are chosen to provide a desired clinical effect of strengthening the airway wall or destroying the smooth muscle tone of the airway without completely destroying the airway or obstructing the airway. -
FIG. 8 illustrates another treatment apparatus 408 for use with one embodiment of the present invention. The treatment apparatus 408 includes an elongated,cylindrical member 90 having a heating element that has a plurality of electrodes designated 92 and 94 located on the outer surface of the member. The electrodes are electrically connected to a source of RF energy viaconnector 98. Preferably each electrode is configured as a band as shown that has a width of about 0.2 mm to about 3 mm, and preferably each electrode band is separate from the next by a distance of about 0.5 mm to 10 mm. The heating element may include one or more electrode bands. The treatment apparatus 408 has adistal end 100 that is rounded to reduce the amount of resistance encountered when the apparatus is advanced into theairway 25. - The apparatus 408 has an outer diameter that is approximately equal to (or can be expandable to equal) the desired final inner diameter of the lumen of an air passage to be treated. Typically, the outer diameter ranges from about 1.3 mm to about 7 mm. When the heating element comprises a plurality of electrode bands, the distance between each band is preferably less than about three times the outer diameter of the apparatus. The effect will be that the patency bands formed on the wall of the lumen by the
electrodes airway 25 to prevent the lumen from collapsing. - The treatment apparatus 408 applies a sufficient amount of energy to the walls of
collapsible air passages 25 to destroy airway smooth muscle tone and damage cells of the airway tissue to induce fibrosis and create a more rigid wall that can support a non-collapsed lumen. In this embodiment, energy emanates from theelectrode bands air passage 25 will develop patency bands corresponding to locations along the walls. The contours of the patency bands should substantially match those of the electrode bands. As is apparent, the number and width of each electrode band are not critical. In the case where there is only one electrode band, it may be necessary to move the apparatus and heat more than one area of the lumen wall in order to damage sufficient amounts of the airway wall to induce enough fibrosis to increase the strength of the airway wall such that it is no longer collapsed, i.e., the lumen remains substantially open during normal breathing. - When the treatment apparatus 408 is positioned at the treatment site, an RF generator is activated to provide suitable RF energy, preferably at a selected frequency in the range of 10 MHZ to 1000 MHZ. The emitted energy is converted within the tissue into heat in the range of about 40° C. to about 95° C.
- RF energy is no longer applied after there has been damage to the tissue to induce a healing response. Preferably, the RF energy is applied for a length of time in the range of about 1 seconds to about 120 seconds. Suitable RF power sources are commercially available and well known to those skilled in the art. In one embodiment the RF generator employed has a single channel, delivering approximately 1 to 25 watts of RF energy and possessing continuous flow capability. The rate of transformation can be controlled by varying the energy delivered to the heating element.
- Besides using RF energy for energizing the heating element, it is to be understood that other forms of energy such as alternating current, microwaves, ultrasound, and light (either coherent (e.g., laser) or incoherent (e.g., light emitting diode or tungsten filament) can be used), and that the thermal energy generated from a resistive coil, a hot fluid element (e.g., circulating liquids, gases, combinations of liquids and gases, etc.), a curie point element, or similar elements can be used as well. The hot fluid element may comprise, for example, an elongated member similar to the one illustrated in
FIG. 8 that includes a conduit system whereby heated fluid is transported through the center of the member and then channeled outward toward the inner surface of the member. In one embodiment the heated fluid is diverted to contact the inner surface of the elongated member so that energy radiates from selected areas on the outer surface of the member corresponding toareas FIG. 8 . Regardless of the source, energy delivered to the lumen wall of the obstructed airway passage should be such that all of the airway tissue is not completely ablated. - The heating element, as shown in
FIG. 8 , operates as a unipolar, internal electrode in the patient's body. An outer electrode (not shown) having a much larger surface area than that of the electrode bands is placed on the outer surface of the patient's body. For example, an external metal mesh or solid plate is placed on the skin with conductive gel. Both electrodes are connected to an RF generator which produces an electric field at a high frequency within the patient's body. Because the collective surface area of the electrode bands is much smaller than that of the outer electrode, the density of the high frequency electric field is much higher around the electrode bands. The electric field reaches its highest density between the two electrodes in the region near the heating element. The increased density of the field around the electrode bands produces localized heating of the tissue of the lumen wall. - A heating element comprising a bipolar electrode can also be used. Referring to
FIG. 8 , in a bipolararrangement electrode band 92 would be a first conductive element andelectrode band 94 would be a second conductive element. - The electrode bands emit RF energy with the first conductive element acting as the active electrode and the second conductive element acting as the return electrode, or vice versa. One electrode would be connected to the positive electrode of the generator and the other would be connected to the negative electrode. An
insulator 96 is located between the conductive elements.FIG. 9 illustrates anothertreatment apparatus 40C for use with another embodiment of the present invention. Thetreatment apparatus 40C includes a heating element having multiple, i.e., double, bipolar electrode bands.Bands 91 are connected to the positive electrode of the RF generator andbands 93 are connected to the negative electrode. The material between the conductive elements are electrically insulated. - While the heating elements have been shown as electrode bands, other configurations can be used such as, for example, spiral, ring and grid patterns. These elements will create corresponding patterns on the lumen wall.
-
FIG. 10A illustrates another embodiment of the treatment apparatus 40D for use with another embodiment of the present invention. The treatment apparatus 40D includes an elongated, cylindrical member having a heating element that compriseselectrodes Segment 108 of the member situated between the electrodes is made of electrically insulating material. - The segment of elongated member in and around
electrode 104 is fabricated of material that is expandable and substantially impervious to air or other suitable gases for causing the elongated member to balloon. In this fashion, this section of the elongated member is radially expandable and deformable in response to compressed gas or any other suitable force or material that is applied into the interior region of the elongated member. Moreover, the elongated member will substantially return to its original, non-expanded form when the internal force is deactivated or the material is withdrawn.FIG. 10B illustrates the elongated member in the expanded position. The degree of expansion or distance that the member expands will depend on, among other things, the pressure applied and the elasticity of the member wall. In this embodiment, material betweenposition 102 on the elongated member to the base ofelectrode 106 is fabricated from expandable material such as latex or polyethylene. The material selected preferably does not melt at the temperature ranges used in the treatment. Radial expansion causeselectrode 104 to come into thermal or electrical contact with tissue of theair passage 25 to be treated.Electrode 104 is preferably a spring coil. Thetreatment apparatus 400 may comprise more than one such coil electrode, which may be positioned along the length of the elongated member so that a plurality of locations along a bronchial tube can be treated simultaneously. -
FIGS. 11A , 11B, 12A and 12B illustrate a further embodiment of thetreatment apparatus 40E for use with an embodiment of the present invention. Thetreatment apparatus 40E includes an elongated,cylindrical member 110 having one ormore electrodes 112 situated on the outer surface of the elongated member. Preferably, a plurality of these electrodes form a number of rows of electrodes that are positioned along the length of the elongated member. As shown in cross sectional viewFIG. 12A , the segment of surface of the elongated member at and around the electrodes is arranged inpleats 114. By being folded in this manner, the surface can expand radially when an outward force is applied from the interior of the cylindrical member as shown inFIGS. 12A and 12B . In this embodiment, the electrodes comprise non-ferrous (e.g., aluminum) strips and anelectromagnet 114 which is positioned in the interior of the elongated member. When the electromagnetic is energized with alternating current the magnetic field will cause the non-ferrous electrodes to repel from the electromagnet. In addition, the temperature of the electrode will rise due to Joule heating. The treatment apparatus may comprise a plurality of rows of the electrodes. -
FIG. 13A illustrates another embodiment of atreatment apparatus 40F for use with another embodiment of the present invention. Thetreatment apparatus 40F includes aballoon 128 placed at the distal end of acatheter shaft 122. The catheter shaft is connected tosyringe 124 located at the proximal end and is connected to anRF generator 126 in between the syringe and balloon. As shown inFIG. 13B which is an enlarged, cut away view of the device, theballoon 128, which is illustrated in the non-inflated state, is constructed of anelastomeric material 144. A preferred elastomeric material is silicone. Extending from lumen 146 of the shaft and into the interior of the balloon areelectrodes rod 145. In this embodiment, each electrode is configured as a loop or ring around the rod. Catheter shafts suitable for use in the present invention are substantially any of the catheter shafts in current clinical use for surgical procedures. Balloons suitable for the present invention may be of similar material and design as those currently being used in percutaneous transluminal angioplasty. For a review of the state of the art, see U.S. Pat. Nos. 4,807,620; 5,057,106; 5,190,517; 5,281,218; 5,314,466; 5,370,677; 5,370,678; 5,405,346; 5,431,649; 5,437,664; 5,447,529; and 5,454,809, the disclosures of which are all incorporated herein by reference. The inventive heat treatment apparatus will be described using balloons that are fabricated from an elastomeric material such as, for instance, silicone, natural latex, and polyethylene. The material selected preferably does not melt at the temperature ranges used in the treatment and is preferably impervious to the fluid used to inflate the balloon. With balloons that are made of elastomeric materials, the degree of expansion is proportional to the amount of force introduced into the interior of the balloon. Moreover, the balloon preferably will substantially return to its original, non-expanded form when the internal force is deactivated. When the balloon is fully expanded, its diameter will preferably be about 1 mm to 30 mm depending on the site to be treated. The balloon is typically attached to the catheter tip and the balloon material is folded or collapsed so that when it is fully inflated the balloon diameter has a fixed dimension. It is understood however that other balloon structures can be employed. For example, balloons made of non-elastic materials such as, for example, polyester (e.g., MYLAR) and polyethylene, can also be used. As is apparent, the balloon serves as a vessel or reservoir for medium that is heated. In the case where the electrodes are bipolar electrodes, the fluid (e.g., saline) between the poles acts as a resistive heating medium or resistive element. In addition, the balloon upon being inflated serves as structural support for the bronchial tubes. - Referring to
FIGS. 13A and 13B ,electrodes cables 136 and 138, through the wall of theballoon 128, and through thecatheter shaft 122 to a radio frequency (RF)generator 126 withcontrols 130. Thecatheter shaft 122 is also connected to thesyringe 124 or other similar device for forcing a noncompressible fluid, such as saline, fromsource 134 throughvalve 132 to inflate the balloon with the fluid as the operating surgeon deems appropriate. - The frequency range of RF radiation useful in the present invention is typically about 10 KHZ to about 100 MHZ and preferably in the range of about 10 KHZ to about 800 KHZ. However, frequencies outside this range may be used at the discretion of the operating surgeon. Alternatively, microwave radiation typically in the frequency range of about 1,000 MHZ to about 2,000 MHZ, preferably in the range of about 1,100 MHZ to about 1,500 MHZ, may be used in place of RF radiation. However, as above, frequencies outside this range may be used at the discretion of the operating surgeon. The
RF generator 126 may be replaced with a microwave generator, and thecables 136 and 138 replaced with a waveguide. Other modifications familiar to those skilled in the art may also be required. In addition, alternating current can be employed. - In use, when the operating surgeon has placed the treatment apparatus with the collapsed balloon within the lumen of a bronchial tube to be treated, the balloon is inflated through the
catheter shaft 122 with fluid from thesyringe 124 located conveniently for the surgeon. In the case where the lumen of the bronchial tube has collapsed or is partially collapsed, the balloon is preferably inflated until the lumen has expanded to its normal diameter with the balloon in substantial contact with the inner surface of the lumen. Alternatively, in the case where the lumen has not collapsed, the balloon is preferably inflated until it is in substantial contact with the inner surface of the lumen. Indeed, inflation of the balloon is not necessary in treating a non-collapsed bronchial lumen which has a diameter that is about equal to, or less than that of the outer surface of the uninflated balloon. As is apparent, even if the balloon does not have to be inflated, the balloon interior has fluid, e.g., electrically conductive saline, present which becomes heated by the application of RF energy. - Preferably, the exact amount of inflation is determined by the operating surgeon who monitors the balloon expansion by means of endoscopy, or other suitable imaging methods of the art. Generally, the heat required is induced in the tissue of the bronchial tube wall by the RF or microwave radiation emitting from the balloon tip.
-
FIGS. 14A , 14B, 15A, 15B, 16A, 16B, 17A, and 17B illustrate other embodiments of the electrode configurations which can be employed with thetreatment apparatus 40F shown inFIG. 13A . In these figures, the balloons are shown in the inflatedstate containing fluid 151. The arrows depict the path of the electric field between the two electrodes or probes that serve as RF poles in the manners described above. - In
FIG. 14A , which is a cross-sectional view ofballoon 150,electrodes nonconductive rod 156.FIG. 14B is a side view of the balloon with the electrodes inside the interior of the balloon which is sealed except forconduit 158 through which fluid 151 (e.g., saline) is introduced and removed. - In
FIG. 15A , which is a cross-sectional view of theballoon 160,electrodes FIG. 15B is a side view of the balloon with the electrodes inside the interior of the balloon which is sealed except forconduit 168 through whichfluid 151 is introduced and removed. - In
FIG. 16A , which is cross-sectional view of theballoon 170,electrodes partition 176 separating the two halves of the disk.Fluid 151 is introduced and removed from the balloon through conduit 178 in support member 175. The electrodes remain stationary in the solid regions of support member 175 as shown in side viewFIG. 16B . -
FIGS. 17A and 17B illustrate another embodiment in which theballoon 180 is fabricated of an electrically conductive material and therefore also serves as an electrode. In this fashion, one of the electrodes is an integral part of the balloon itself. Thesecond electrode 182 is attached tonon-conducting rod 186.FIG. 17B is a perspective view of the balloon withelectrode 182 in the interior of the balloon which is sealed except forconduit 188 through whichfluid 151 is introduced and removed. Suitable electrically conductive materials for fabricating the balloon in this case include, for example, a polyester film (e.g. MYLAR) that is coated with gold, silver, or platinum. -
FIG. 18 illustrates another embodiment of thetreatment apparatus 40G for use with one embodiment of the present invention. With thetreatment apparatus 40G, the heat generated to heat the fluid in the balloon is supplied by a circulating, hot fluid. Referring toFIG. 18 , a balloon 190 (substantially the same asballoon 128 of the embodiment shown inFIG. 13A ) is attached to acatheter 192 containing a smaller, coaxial catheter 194 (coaxial catheter 194 is substantially the same ascatheter 192, differing only in size.) Aheated fluid 198, which may be a liquid, such as water or physiologically compatibly saline solution, is pumped by a metering, circulatingpump 202, through aheating unit 200, then through theouter catheter 192 to the balloon. The fluid heats the surface of the balloon and exits through the innercoaxial catheter 194 to return to the pump. A positive pressure is maintained within the system to keep the balloon at the proper inflation. This embodiment is employed in substantially the same manner as the other embodiments described above regarding its use to heat the airway tissue to induce fibrosis and strengthen the airway and destroy smooth muscle tone. The choice of the temperature of the circulating liquid is at the discretion of the operating surgeon, but will usually be in the range of about 60° C. to about 95° C. - The
treatment apparatus 40H shown inFIG. 19 represents another embodiment of the treatment apparatus for performing another embodiment of the present invention, wherein the heat generated to heat the fluid in the balloon is supplied by a hot fluid that is injected into the balloon. The catheter 208 includeselectrodes lumen 206 of the catheter. The electrodes are connected toAC generator 218 although an RF generator can also be used. The channel orlumen 206 also serves as a reservoir for liquid which is introduced fromsource 222 throughsyringe 204. Once the fluid is heated to the desired temperature, it can be injected into the interior of the balloon. As is apparent, the fluid serves both to inflate the balloon as well as to supply the heat treatment of the bronchial tube. A positive pressure is maintained within the system to keep the balloon at the proper inflation. Instead of using resistive heating, the fluid can be heated with heat exchanger 208. - Preferably, the RF energy is applied for a length of time in the range of about 1 second to about 600 seconds and preferably about 5 to about 120 seconds. Suitable RF power sources are commercially available and well known to those skilled in the art. In one embodiment the RF generator employed has a single channel that is capable of delivering approximately 1 to 100 watts and preferably 1 to 25 watts of RF energy and possesses continuous flow capability. Regardless of the source of energy used during treatment, the lumen or the bronchial tube is maintained at a temperature of at least about 60° C. and typically between 70° C. to 95° C. and preferably between 70° C. to 85° C.
- The treatment apparatus of the present invention may include more than one balloon and attendant bipolar electrodes which are positioned along the length of the elongated member so that a plurality of locations along a bronchial tube can be treated simultaneously.
FIG. 13C illustrates an alternative embodiment of the treatment apparatus ofFIG. 13A described above, which includes twoballoons balloon -
FIGS. 20A and 20B show a further embodiment of thetreatment apparatus 401 for use with another embodiment of the present invention. Thetreatment apparatus 401 includes aballoon 300, similar to the balloons described earlier, that is positioned at or near the distal end ofelongated rod 310 which is positioned within the lumen oraperture 351 ofcatheter sheath 350. It is understood that the term “rod” also encompasses tubes which have hollow channels. As shown, the balloon withinner surface 301 is in the inflated state having been inflated with an appropriate fluid such as air or saline that is injected fromconduit 330 and into the interior of the balloon throughaperture 331 in the rod. The apparatus includeselectrodes airway 25 when the balloon is inflated. The electrodes employed in the present invention can have different configurations. For example, the electrodes can be conventional coil wires with round cross sections, or they can have a non-round configuration, such as, for example, a thin, foil or band with a rectangular cross section. For the device shown inFIG. 20B ,electrodes FIG. 20B ,electrode 302 is a band having ends 303 and 313 with a portion of the band adjacent to end 303 overlapping a portion of the band adjacent to end 313. Similarly,electrode 304 is a band having overlapping ends 305 and 315. - The balloon of the
treatment apparatus 401 is preferably constructed of nonelastic material that is initially folded and/or collapsed. In this non-inflated state, the diameter of the balloon is small enough that the balloon can be positioned inside an aperture or working channel of a bronchoscope. In use, the bronchoscope first is positioned at the treatment site before the balloon is exposed and then inflated. Heat treatment is then commenced to damage airway tissue to induce fibrosis and/or destroy smooth muscle tone. -
FIGS. 20A and 20B show thatelectrodes cables generator 329 withcontrols 338, such as described earlier.Rod 310 is also connected tosyringe 350 which is employed to inject a fluid fromsource 346 throughvalve 348 into the balloon. -
FIG. 21 illustrates another embodiment of thetreatment apparatus 40J for use with another method of the present invention which includes a pair of electrode coils 410 and 420 that are positioned in tandem. The number of electrode coils is not critical. The apparatus also includes anelongated rod 430 which has adistal end 431 that is connected to a tip orknob 440 and has a proximal end which is at least partially slidably positioned insideaperture 451 of catheter sheath 450 that includesend coupler 435. Coil 410 has two ends, thefirst end 411 being attached toknob 440 and thesecond end 412 is attached to rotatable or floatingcoupler 470. Similarly,coil 420 has two ends, thefirst end 421 is attached torotatable coupler 470 and thesecond end 422 is attached to endcoupler 435. - As shown in
FIG. 21 , the coils are in the relaxed state which is meant that no torque is being applied to either coil. In this state, each coil has a “barrel” configuration so that the diameter of the outer contour formed by each coil is largest at its center and smallest at its two ends. A number of preferred methods can be employed to change the diameters of the contour. One method is to compress or expand the coils along the axis. For example, by pushingrod 430 outward so thatknob 440 extends away from catheter sheath 450, the coil diameters will decrease. Another method of changing the diameter is to apply torque to the coils. Torque can be applied by rotating the rod in a clockwise or counterclockwise direction while keepingend coupler 435 stationary, e.g., attached to the inner surface of catheter sheath. Torque can also be applied by keepingrod 430 stationary whilerotating end coupler 435. Alternatively, torque can be applied by rotating the rod in one direction whilerotation end coupler 435 in the opposite direction. During the rotation process,rotatable coupler 470 will also rotate to thereby transfer torque from one coil to the other. - In practice, applying torque to adjust the radial diameters of the coils is preferred over compressing or pulling the coils lengthwise since applying torque creates less of a gradient in the diameter of each coil. According, preferably, the treatment apparatus is constructed so that
end coupler 435 remains stationary. Torque is preferably applied by manually rotatingrod 430. When more than one coil is employed, a rotatable coupler is required to connect adjacent coils. Multiple coil configurations are preferred over one with a single coil that has the same length (in the relaxed state) as the sum of the lengths of the smaller coils since the diameters of the smaller coils will tend to be more uniform and in contact with the wall of the bronchial tube being treated. Each coil in the embodiment shown inFIG. 21 is connected to an appropriate source of energy. For example, coils 410 and 420 can be connected bylines 415 and 425 to aradio frequency generator 430 as described above. In operation, theheat treatment apparatus 40J is positioned at the treatment site before the diameters of the coils are adjusted by applying torque. Energy is then applied to the coils. -
FIGS. 22 and 23 show embodiments of theheat treatment apparatus FIG. 21 . The apparatus ofFIG. 22 includes a pair of electrode coils 510 and 520 that are positioned in tandem. The apparatus also includes anelongated rod 530 which has adistal end 531 that is connected to a tip orknob 540 and has a proximal end which is at least partially slidably positioned inside aperture 551 ofcatheter sheath 550 that includesend coupler 535.Coil 510 has two ends, thefirst end 511 being attached toknob 540 and thesecond end 512 is attached torotatable coupler 570. Similarly,coil 520 has two ends, thefirst end 521 is attached torotatable coupler 570 and thesecond end 522 is attached to endcoupler 535. As is apparent, each electrode has a cone-shaped contour and comprises a coil that is wound about and along the axis of therod 530 and which in the relaxed state has a large diameter at one end and a small diameter at the other end. - The
treatment apparatus 40L ofFIG. 23 includes a pair of electrode coils 610 and 620 that are positioned in tandem. The apparatus also includes anelongated rod 630 which has adistal end 631 that is connected to a tip orknob 640 and has a proximal end which is at least partially slidably positioned insideaperture 651 ofcatheter sheath 650 that includesend coupler 635.Coil 610 has two ends, thefirst end 611 being attached toknob 640 and thesecond end 612 is attached torotatable coupler 670. Similarly,coil 620 has two ends, thefirst end 621 is attached torotatable coupler 670 and thesecond end 622 is attached to endcoupler 635. As is apparent, each electrode has a single loop configuration that comprises a coil that is wound once about therod 630. In this configuration, the two electrodes when in the relaxed state preferably form loops having the same diameter. - The
devices FIGS. 22 and 23 operate in essentially the same manner as thedevice 40J ofFIG. 21 . Specifically, the same methods can be employed to adjust the radial diameter of the coils by compressing or pulling the coils or by applying torque to the coils. In addition, each coil is connected to an appropriate source of energy. For example, coils 610 and 620 can be connected bylines radio frequency generator 330 as shown inFIG. 20A . - The electrodes may be constructed of a suitable current conducting metal or alloys such as, for example, copper, steel, and platinum. The electrodes can also be constructed of a shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature. Such metals are well known in the art as described, for example, in U.S. Pat. Nos. 4,621,882 and 4,772,112 which are incorporated herein. For the present invention, the shape memory metal used should have the characteristic of assuming a deflection away (i.e., expands) from the elongated rod when activated, i.e., heated in excess of the normal body temperature and preferably between 60° C. and 95° C. A preferred shape memory alloy is available as NITINOL from Raychem Corp., Menlo Park, Calif. For the heat treatment apparatuses that employ coils as shown in
FIGS. 20-23 , preferably the electrodes are constructed of NITINOL in a predetermined shape and in the alloy's super elastic phase which can withstand very large deflections without plastic deformation. - Alternatively, the heat treatment apparatuses employing a unipolar electrode can also be employed. For instance, in the case of the embodiment shown in
FIGS. 20A and 20B , the heating device can have one or moreinner electrodes 302 and/or 304 on the balloon surface and an outer orexternal electrode 388 that has a much larger surface area than that of the internal electrode(s) and that is placed on the outer surface of the patient's body. For example, the external electrode can be an external metal mesh or solid plate that is placed on the skin with conductive gel. Both the internal and external electrodes are connected to an RF generator which produces an electric field at a high frequency within the balloon. Because the collective surface area of the internal electrode(s) is much smaller than that of the outer electrode, the density of the high frequency electric field is much higher around the internal electrode(s). The electric field reaches its highest density in the region near the internal electrode(s). The increased density of the field around the internal electrode(s) produces localized heating of the tissue to destroy smooth muscle tone and damage tissue to cause fibrosis, which stiffens theairway 25 so as to increase gas exchange performed by the lung. - As is apparent, the heat treatment apparatus can have more than one electrode that is positioned at or near the distal end of the elongated rod. For example,
FIG. 24 depicts schematically thedistal end 700 of atreatment apparatus 40M which compriseselectrodes electrodes electrodes electrodes - When the
treatment apparatus 40M includes multiple electrodes, not all the electrodes need to be activated at the same time, that is, different combinations of electrodes can be employed sequentially. For example, in the case of the above described bipolar embodiment with three electrodes,electrodes electrode 703 can also be activated so that a second section of the bronchial tube wall is heat treated simultaneously. Alternatively,electrode 701 is disconnected to the RF generator beforeelectrode 703 is activated so that the second section is treated subsequent to treatment of the first section. - In addition, when a
treatment apparatus 40M includes multiple electrodes, the device can operate in the monopolar, bipolar mode, or both modes at the same time. For instance,electrodes electrode 703 is designed to operate in the monopolar mode. As a further variation, the electrodes can be constructed of different materials and/or constructed to have different configurations. For example,electrode 701 can be made of a shape memory alloy and/or it can be a coil while each of theother electrodes - The treatment apparatus can comprise more than one balloon that is attached to the elongated rod. For example,
FIG. 25 depicts schematically the distal end of atreatment apparatus 40N for use with embodiments of the present invention, which comprisesballoons Electrodes balloon 810 andelectrodes exterior surface balloon 820. Thetreatment apparatus 40N includes anelongated rod 860 which is positioned with the lumen ofcatheter sheath 850. Thetreatment apparatus 40N is preferably constructed in the same manner as the device shown inFIG. 208 except for the additional balloon. Operation of thedevice 40N is also similar although the surgeon has the choice of activating both sets of electrode simultaneously or one set at a time. -
FIG. 26 illustrates another embodiment of atreatment apparatus 40P for use with the methods of the present invention. Thetreatment apparatus 40P is introduced through a catheter, bronchoscope, or othertubular introducer member 1012. The heat treatment apparatus includes ashaft 1014 and one ormore electrodes 1016. Electrically connected to theelectrodes 1016 is an RF generator 1018 or other energy source. The RF generator is controlled by acontroller 1020. Although the invention will be described as employing an RF generator, other energy sources, such as alternating current and microwave may also be used. - In accordance with the embodiment of
FIG. 26 , the electrodes include a firstconical electrode 1016A connected to aninner shaft 1022 and a second conical electrode 1016B connected to anouter shaft 1024. Theconical electrodes 1016A, 1016B are positioned with their axes aligned and may be fixed or movable with respect to each other. Each of theconical electrodes 1016A, 1016B, includes at least two overlappingsections 1026. Thesections 1026 are flexible and overlap one another to allow theelectrodes 1016A, 1016B to be compressed within the lumen of thecatheter 1012 for insertion into the bronchial tube of a patient. Once thecatheter 1012 is positioned with a distal end at a desired treatment location within the bronchial tubes, theshaft 1014 is used to push theelectrodes 1016A, 1016B out of the distal end of the catheter. Once deployed from thecatheter 1012, theelectrodes 1016A, 1016B expand radially outwardly until the distal ends of the electrodes contact the walls of the bronchial tube. - The
electrodes 1016A, 10168 are electrically connected to the RF generator 1018 byelectrical cables treatment apparatus 40P employs twoelectrodes 1016A, 10168 the two electrodes are preferably oppositely charged with one of the electrodes connected to a negative output of the RF generator and the other electrode connected to a positive output of the RF generator. Alternatively, both theelectrodes 1016A, 1016B or asingle electrode 1016 may be connected to the same output of the RF generator and anexternal electrode 1034 may be used. Theexternal electrode 1034 is connected to an output of the RF generator 1018 having an opposite polarity of the output connected to theinternal electrode 1016. -
FIG. 27 illustrates an alternative embodiment of a heat treatment apparatus 1040 having asingle electrode 1016 positioned on ashaft 1014. Theelectrode 1016 is shown as it is deployed from the distal end of acatheter 1012 for heat treatment of the lumen of bronchial tubes. - The
electrodes 1016 of the embodiment ofFIGS. 26 and 27 are formed of a suitable conductive material such as metal, plastic with a metal coating, or the like. The two ormore sections 1026 of each of the cone shaped electrodes is fixed to theshaft 1014 and biased outwardly so that the sections expand or unfold to an enlarged diameter upon release from the distal end of thecatheter 1012. Theelectrodes 1016 preferably have an enlarged diameter which is equal to or slightly greater than an interior diameter of the bronchial tube to be treated. As shown most clearly inFIG. 27 , the sides of thesections 1026 overlap one another even in the expanded state. - In operation of the embodiments of
FIGS. 26 and 27 , the distal end of thecatheter 1012 is first positioned at the treatment site by known catheter tracking methods. Thecatheter 1012 is then retracted over the heat treatment apparatus to expose and expand theelectrodes 1016. Eachelectrode 1016 of theenergy emitting apparatus 40P expands radially outward upon retraction of thecatheter 1012 until the electrodes come into contact with the wall of the bronchial tube. In the embodiment ofFIG. 27 , the distance between the twoenergy emitting electrodes 1016A, 1016B may be fixed or may be changeable by sliding theinner shaft 1022 within theouter shaft 1024. When treatment is completed theheat treatment apparatus 40P is retracted back inside thecatheter 1012 by sliding the catheter over the electrodes. As theheat treatment apparatus 40P is retracted the sides of thesections 1026 of theelectrode 1016 slide over each other upon coming into contact with a distal edge of thecatheter 1012. -
FIGS. 28 and 29 illustrate an alternative embodiment of atreatment apparatus 400 for use with the methods of the present invention. Thetreatment apparatus 400 may be delivered to a treatment site in a collapsed configuration illustrated inFIG. 28 . Thetreatment apparatus 400 includes two leaf spring or wire shapedelectrodes electrodes insulating end cap 1056 of ahollow shaft 1058. Theelectrodes electric cables central shaft 1064 which is slid able within thehollow shaft 1058. Thecentral shaft 1064 has ashaft tip 1048 which is connected to a distal end of each of theelectrodes - Each of the
electrodes sleeve 1066 except for an exposedcontact section 1068. Thetreatment apparatus 400 is delivered to the lumen of a bronchial tube to be treated either alone or through a catheter, bronchoscope, or other channel. Theelectrodes central shaft 1064 proximally with respect to thehollow shaft 1058 of thetreatment apparatus 400. Upon expansion, the exposedcontact sections 1068 of theelectrodes FIG. 29 . Theelectrodes FIG. 29 . Alternatively, theelectrodes electrodes electrodes external electrode 1034 may be used. Upon completion of the treatment process the electrodes 1054 are retracted back into the catheter for removal or moving to a subsequent treatment site. -
FIGS. 30 and 30A illustrate another embodiment of thetreatment apparatus 40R for use with embodiments of the present invention. Thetreatment apparatus 40R includes fourelectrodes FIGS. 30 and 30A operates in the same manner as the embodiments ofFIGS. 28 and 29 with a slidablecentral shaft 1064 employed to move the electrodes from a compressed configuration to the expanded configuration illustrated inFIGS. 30 and 30A . Eachelectrode 1054A-1054D is connected at a proximal end to the insulatingend cap 1056 of thehollow shaft 1058 and at a distal end to thecentral shaft 1064. Relative motion of thehollow shaft 1058 with respect to thecentral shaft 1064 moves the electrodes 1054 from the collapsed to the expanded position. -
FIGS. 31 and 32 illustrate a further embodiment of aheat treatment apparatus 40S employing one or more wire or leaf spring shapedloop electrodes 1094. As in the previous embodiments, theloop electrode 1094 expands from a contracted positioned within acatheter 1092 as illustrated inFIG. 31 to an expanded position illustrated inFIG. 32 . In the expanded position, the loop shapedelectrode 1094 comes into contact with the walls of the airway or bronchial tube B. Although the embodiment ofFIGS. 31 and 32 has been illustrated with a single loop shapedelectrode 1094, it should be understood that multiple loop shaped electrodes may also be use. The loop shapedelectrode 1092 is connected to theshaft 1096 of theheat treatment apparatus 40S by anend cap 1098 and is electrically connected to the energy source by theelectric cables 1100. -
FIGS. 33-36 illustrate an alternative embodiment of atreatment apparatus 40T for use with the embodiments of the present invention. Thetreatment apparatus 40T includes a flexible plate shapedelectrode 1114. The flexible plate shapedelectrode 1114 is substantially flower shaped in plan having a plurality ofpetals 1116 with curved distal ends extending from acentral section 1120. Thepetals 1116 flex along ahinge line 1118 to the compressed insertion configuration illustrated inFIG. 33 in which thepetals 1116 extend substantially perpendicularly from thecentral section 1120 of the flexible plate shapedelectrode 1114. - As illustrated in
FIGS. 35 and 36 , when thetreatment apparatus 40T is moved distally with respect to thecatheter 1112 to deploy theelectrode 1114 thepetals 1116 move outwardly until the petal tips come into contact with the walls of the bronchial tube B. The flexible plate shapedelectrode 1114 is preferably formed of a conductive material and fixed to the end of ashaft 1122.Electric cables 1124 connect the plate shapedelectrode 1114 to the energy source. - The electrodes in each of the forgoing embodiments may be fabricated of any material which when compressed will return to an expanded configuration upon release of the compression forces. For example, one method of controlling the expansion of the electrodes is the use of shape memory alloy electrodes. With a shape memory alloy, the constraint of the electrodes within a catheter may not be necessary. The shape memory alloy electrodes may be formed to expand to an expanded energy delivery configuration upon heating to body temperature within the body. The expansion of the electrodes is limited by the size of the bronchial tube in which the electrode is positioned.
- As described above, the heat treatment apparatus may be employed in a bipolar mode in which two different expandable electrodes are connected to two different outputs of the RF generator 1018 having opposite polarities. For example, the
electrodes 1016A, 1016B may be connected by theelectrical cables FIG. 36 , theinner shaft 1022 andouter shaft 1024 are formed of an insulating material. Further, in the embodiments ofFIGS. 28-30 theend cap 1056 and central shaft distal tip are formed of insulating materials. - In the case where the apparatus includes only one
electrode 1016 as shown inFIG. 27 , the electrode will be connected to the positive or negative terminal of the RF generator 1018 and the opposite terminal of the RF generator will be connected to the external electrode 1032. - The frequency range of RF radiation useful in the present invention is typically about 10 KHz to about 100 MHZ, preferably in the range of about 200 KHz to about 800 KHz. However, frequencies outside this range may be used at the discretion of the operating surgeon. Typically, the amount of power employed will be from about 0.01 to 100 watts and preferably in the range of about 1 to 25 watts for about 1 to 60 seconds. Alternatively, alternating current or microwave radiation typically in the frequency range of about 1,000 MHZ to about 2,000 MHZ and preferably from about 1,100 MHZ to about 1,500 MHZ may be used in place of RF radiation. In the latter case, the RF generator 1018 is replaced with a microwave generator, and the
electric cables - When the heat treatment apparatus with the bipolar electrodes is positioned inside the lumen of a bronchial tube, activation of the RF generator 1018 causes tissue in the lumen wall to increase in temperature. The heating may be caused by resistance heating of the electrodes themselves and/or power losses through the tissue of the bronchial wall. The particular heat pattern in the tissue will depend on the path of the electric field created by the positioning and configuration of the electrodes.
- In the monopolar mode, the
external electrode 1034, shown inFIG. 26 , having a much larger surface area than the inner electrodes is placed on the outer surface of the patient's body. For example, theexternal electrode 1034 can be an external metal mesh or a solid plate that is placed on the skin with conductive gel. Both the internal and external electrodes are connected to the RF generator 1018 which produces an electric field at a high frequency. Because the collective surface area of the internal electrodes is much smaller than that of theouter electrode 1034, the density of the high frequency electric field is much higher around the internal electrodes. The electric field reaches its highest density in the region near the internal electrodes. The increased density of the field around the internal electrodes produces localized heating of the tissue around the bronchial tube without causing significant heating of the body tissue between the bronchial tube and the external electrode. - In use, after the operating surgeon has placed the heat treatment apparatus within the lumen of a bronchial tube to be treated, if necessary, the catheter is retracted to expose the electrodes. In the case where the lumen of the bronchial tube has collapsed or is partially collapsed, the size of the energy emitting device is designed so that expansion of the electrodes causes the lumen to expand to its normal or noncollapsed diameter due to contact of the electrodes with the inner surface of the lumen. Alternatively, in the case where the lumen has not collapsed, the device is designed so that upon expansion the electrodes are in substantial contact with the inner surface of the lumen. Indeed, only minimum expansion may be necessary in treating a noncollapsed bronchial lumen.
- The degree of expansion of the electrodes of the heat treatment apparatus can be monitored by means of endoscopy, fluoroscopy, or by other suitable imaging methods of the art. Generally, the heat required is induced in the tissue of the bronchial tube wall by the RF or microwave radiation emitting from the electrodes. The RF or microwave energy is applied while observing the tissue for changes via simultaneous endoscopy, or other suitable imaging methods of the art.
- The electrodes employed in the heat treatment apparatus are constructed of a suitable current conducting metal or alloys such as, for example, copper, steel, platinum, and the like or of a plastic material with a conductive metal insert. The electrodes can also be constructed of a shape memory alloy which is capable of assuming a predetermined, i.e., programmed, shape upon reaching a predetermined, i.e., activation, temperature. Such metals are well known in the art as described, for example, in U.S. Pat. Nos. 4,621,882 and 4,772,112 which are incorporated herein by reference. For the present invention, the shape memory metal used should have the characteristic of assuming a deflection away (i.e., expands) from the elongated rod when activated, i.e., heated in excess of the normal body temperature and preferably between 60° C. and 95° C. A preferred shape memory alloy is available as NITINOL from Raychem Corp., Menlo Park, Calif. In one embodiment, the electrodes are constructed of NITINOL in a predetermined shape and in the alloy's super elastic phase which can withstand very large deflections without plastic deformation.
- Substantial tissue transformation may be achieved very rapidly, depending upon the specific treatment conditions. Because the transformation can proceed at a rather rapid rate, the RF energy should be applied at low power levels. Preferably, the RF energy is applied for a length of time in the range of about 0.1 second to about 600 seconds, and preferably about 1 to about 60 seconds. Suitable RF power sources are commercially available and well known to those skilled in the art. In one embodiment the RF generator 18 employed has a single channel, delivering approximately 1 to 100 watts, preferably 1 to 25 watts and possessing continuous flow capability. The rate of tissue damage to induce fibrosis can be controlled by varying the energy delivered to the heat treatment apparatus. Regardless of the source of energy used during treatment, the lumen or the bronchial tube is maintained at a temperature of at least about 45° C., preferably between 60° C. and 95° C.
- When the heat treatment apparatus includes multiple energy emitting devices, not all the electrodes need to be activated at the same time. That is, different combinations of electrodes can be employed sequentially. For example, in the case of the embodiment shown in
FIG. 26 , with twoelectrodes 1016A, 1016B, the electrodes can be activated simultaneously or sequentially. - In addition, when a heat treatment apparatus includes multiple energy emitting devices, the apparatus can operate in the monopolar, bipolar mode, or both modes at the same time. For instance, one of the electrodes can be designed to operate in the bipolar mode while another electrode operates in the monopolar mode.
- When treating a person with obstructed air passages, a preliminary diagnosis is made to identify the air passages or bronchial tube that can be treated. In treating a particular site, excessive fluid is first removed from the obstructed air passage by conventional means such as with a suction catheter. Thereafter, the heat treatment apparatus is maneuvered to the treatment site. Depending on the diameter of the lumen of the bronchial tube, the device can be positioned directly at the treatment site or it can be positioned into place with a bronchoscope. The
elongated shafts outer catheter 1012 are preferably made of a flexible material so that the catheter can be maneuvered through a bronchoscope. A bronchoscope is a modified catheter which includes an illuminating and visualization instrument for monitoring the treatment site and a channel for passing instruments (e.g., the treatment apparatus) into the bronchial tubes. - In operation, the bronchoscope is advanced from the person's nasal or oral cavity, through the trachea, main stem bronchus, and into an obstructed air passage. The heat treatment apparatus is advanced forward through the bronchoscope to expose the tip of the heat treatment apparatus before the heat treatment apparatus is energized. Depending on the size of the treatment apparatus, the treatment apparatus can be moved to another position for further heat treatment of the air passage. This process can be repeated as many times as necessary to form a series of patency bands supporting an air passage. This procedure is applied to a sufficient number of air passages until the physician determines that he is finished. As is apparent, the procedure can be completed in one treatment or multiple treatments. After completion of the treatment, energy is discontinued and the heat treatment apparatus is removed from the patient.
- Temperature monitoring and impedance monitoring can be utilized in a system which provides feedback to the user in the form of sounds, lights, other displays or a mechanism which shuts down the application of energy from the heating element to the treatment site when sufficient tissue transformation is detected and to avoid burning of the treatment site. The amount of energy applied can be decreased or eliminated manually or automatically under certain conditions. For example, the temperature of the wall of the air passage, or of the heating element can be monitored and the energy being applied adjusted accordingly. The surgeon can, if desired, override the feedback control system. A microprocessor can be included and incorporated into the feedback control system to switch the power on and off, as well as to modulate the power. The microprocessor can serve as a controller to monitor the temperature and modulate the power.
- The invention is also directed to the demonstration or instruction of the inventive surgical techniques including, but not limited to, written instructions, actual instructions involving patients, audio-visual presentations, animal demonstrations, and the like.
- As described above, the
apparatus 40 of the present invention may damage cells of the airway to cause fibrosis to stiffen theairway 25 in other manners besides those described above. For example,FIG. 37 illustrates anothertreatment apparatus 40U that delivers light to the walls of theairway 25. Thelight delivery device 40U includes an outer catheter orsheath 2016 surrounding alight transmitting fiber 2018. Alight directing member 2020 is positioned at a distal end of the light delivery device 2010 for directing the light to the conduit walls. - The
light delivery device 40U is used to irradiate the smooth muscle surrounding the airways to induce fibrosis and/or destroy smooth muscle tone of the airway. - As shown in
FIG. 38 , thelight delivery device 40U is an elongated device such as a catheter containing a fiber optic. Thelight delivery device 40U is connected by a conventional optical connection to alight source 2022. The treatment of an airway with thelight delivery device 40U involves placing a visualization system such as an endoscope or bronchoscope into the airways. Thelight delivery device 40U is then inserted through or next to the bronchoscope or endoscope while visualizing the airways. Thelight delivery device 40U which has been positioned with a distal end within an airway to be treated is energized so that radiant energy is emitted in a generally radially direction from a distal end of the light delivery device. The distal end of thelight delivery device 40U is moved through the airway in a uniform painting like motion to expose the entire length of an airway to be treated to the light. Thelight delivery device 40U may be passed along the airway one or more times to achieve adequate treatment. The painting like motion used to exposed the entire length of an airway to the light may be performed by moving the entire light delivery device from the proximal end either manually or by motor. - The light used may be coherent or incoherent light in the range of infrared, visible, or ultraviolet. The
light source 2022 may be any known source, such as a UV laser source. Preferably the light is ultraviolet light having a wavelength of about 240-350 nm or visible light in the red visible range. The intensity of the light may vary depending on the application. The light intensity should be bright enough to damage the cells of the tissue to induce fibrosis and/or to destroy the smooth muscle tone or the airway. The light intensity may vary depending on the wavelength used, the application, the thickness of the smooth muscle, and other factors. -
FIGS. 39-42 illustrate different exemplary embodiments of the distal tip of the light delivery device for irradiating the airway walls. InFIG. 39 , alight delivery device 40V includes asheath 2016 having a plurality ofwindows 2024 which allow the light which has been redirected by thelight directing member 2020 to pass substantially radially out of the sheath. Thelight directing member 2020 is fitted into the distal end of thesheath 2016. Thelight directing member 2020 is a parabolic diffusing mirror having areflective surface 2026 which is substantially parabolic in cross section. The light passes from the light source along thelight transmitting fiber 2018 and is reflected by thereflective surface 2026 of thelight directing member 2020 through thewindows 2024. Thewindows 2024 are preferably a plurality of light transmitting sections spaced around the distal end of the sheath. Thewindows 2024 may be open bores extending through thesheath 2016. Alternatively, thewindows 2024 may be formed of a transparent material which allows the light to pass out of thesheath 2016. -
FIG. 40 illustrates an alternative embodiment of alight delivery device 40W in which thelight directing member 2020 has a conical shapedreflective surface 2032. This conical shaped reflective surface may be formed at any desired angle which directs the light transmitted by thelight transmitting fiber 2018 radially out of thesheath 2016. The use of a conicalreflective surface 2032 creates a light delivery pattern in which the light rays are directed in a generally coherent radial pattern which is at a generally fixed angle with respect to a longitudinal axis of the light delivery device. In contrast, the light delivery device ofFIG. 39 with the parabolicreflective surface 2026 directs light in a diverging radial pattern which will illuminate a larger area of the airway walls. -
FIG. 41 illustrates a further alternative embodiment of alight delivery device 40X in which thelight directing member 2020 is a substantially conical member including concavereflective surfaces 2036. These concavereflective surfaces 2036 direct the light which passes in a generally parallel arrangement through thelight transmitting fiber 2018 out of thesheath 2016 in a converging or crossing pattern. In addition, in the embodiment ofFIG. 41 , the windows have been replaced by atransparent tip 2038 of thesheath 2016. - The
light directing members 2020 having a reflective surface as illustrated inFIGS. 39-41 may be formed in any of the known manners, such as by coating a molded member with a reflective coating, such as aluminum. - As an alternative to the reflective light directing members of
FIGS. 39-41 ,treatment apparatus 40Y includes a diffusinglens 2042, such as a Teflon lens, that may be positioned at the end of thelight transmitting fiber 2018 as illustrated schematically inFIG. 42 . The diffusinglens 2042 may direct the light from thelight transmitting fiber 2018 in a generally conical pattern as shown inFIG. 42 . Alternatively, the diffusinglens 2042 may direct the light in a more radially oriented pattern with the light rays being prevented from exiting the lens in a direction substantially parallel with the longitudinal axis of thelight transmitting fiber 2018 by a reflective or blocking member. In the embodiment ofFIG. 42 , thesheath 2016 surrounding thelight transmitting fiber 2018 and the diffusinglens 2042 may be eliminated entirely and the lens may be affixed directly to the end of the fiber. - According to one alternative embodiment, the
light delivery devices -
FIGS. 43-56 illustrate further embodiments of treatment apparatus that may be used with the methods of the present invention. The treatment apparatus ofFIGS. 43-53 include tissue contacting electrodes configured to be placed within the airway. These apparatus can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated electrodes, similar to the previously described treatment apparatus. For monopolar energy delivery, one or more electrodes of the treatment apparatus are connected to a single pole of the energy source 3032 and an optional external electrode 3044 is connected to an opposite pole of the energy source. For bipolar energy delivery, multiple electrodes are connected to opposite poles of the energy source 3032 and the external electrode 3044 is omitted. The number and arrangement of the electrodes may vary depending on the pattern of energy delivery desired. The treatment apparatus ofFIGS. 54 and 55 are used to deliver radiant or heat energy to the airway. The treatment apparatus ofFIG. 54 can also deliver indirect radio frequency or microwave energy to the tissue. Finally, the treatment apparatus ofFIG. 56 is used to remove heat energy from the tissue. - The treatment apparatus 40Z of
FIG. 43A includes acatheter 3036 for delivering ashaft 3040 having a plurality ofelectrodes 3038 to a treatment site. Theelectrodes 3038 are formed from a plurality of wires which are soldered or otherwise connected together at twoconnection areas 3042. Theelectrodes 3038 between theconnection areas 3042 are formed into a basket shape so that arch shaped portions of the wires will contact the walls of an airway. The wires may be coated with an insulating material except at the tissue contact points. Alternatively, the wires of the basket may be exposed while theconnection areas 3042 andshaft 3040 are insulated. Preferably, theelectrodes 3038 are formed of a resilient material which will allow the distal end of the treatment apparatus to be retracted into thecatheter 3036 for delivery of the catheter to the treatment site and will allow the electrodes to return to their original basket shape upon deployment. The treatment apparatus 40Z is preferably configured such that theelectrodes 3038 have sufficient resilience to come into contact with the airway walls for treatment. -
FIG. 43B illustrates a treatment apparatus 40AA in which the distal end of the device is provided with a ball shapedmember 3050 for easily inserting the device to a treatment site without causing trauma to surrounding tissue.FIG. 43C illustrates a treatment apparatus40 AB having electrodes 3038 connected to the distal end of thecatheter 3036 and forming a basket shape. The basket shape may be expanded radially during use to insure contact between theelectrodes 3038 and the airway walls by pulling on acenter pull wire 3052 which is connected to adistal end 3050 of the device and extends through a lumen of thecatheter 3036. The treatment apparatus 40A may be delivered to a treatment site through a delivery catheter orsheath 3054 and may be drawn along the airway to treat the airway in a pattern of longitudinal or helical stripes. -
FIG. 44 illustrates a treatment apparatus 40AC in which acatheter shaft 3046 is provided with a plurality ofelectrodes 3048 positioned oninflatable balloons 3050. Theballoons 3050 are inflated through thecatheter shaft 3046 to cause theelectrodes 3048 come into contact with theairway walls 3100. Theelectrodes 3048 are preferably connected to the energy source 3032 by conductive wires (not shown) which extend from the electrodes through or along theballoons 3050 and through thecatheter shaft 3046 to the energy source. The electrodes may be used in a bipolar mode without an external electrode. Alternatively, thetreatment apparatus 40C may be operated in a monopolar mode with an external electrode 3044. Theelectrodes 3048 may be continuous circular electrodes or may be spaced around theballoons 3050. - An alternative apparatus device 40AD of
FIG. 45 includes acatheter 3056 having one ormore grooves 3060 in an exterior surface. Positioned within thegrooves 3060 areelectrodes 3058 for delivery of energy to the airway walls. Although thegrooves 3060 have been illustrated in a longitudinal pattern, the grooves may be easily configured in any desired pattern. Preferably, thetreatment apparatus 400 ofFIG. 45 includes a biasing member (not shown) for biasing thecatheter 3056 against the airway wall such that theelectrodes 3058 contact the tissue. The biasing member may be a spring element, an off axis pull wire, an inflatable balloon element, or other biasing member. Alternatively, the biasing function may be performed by providing a preformed curve in thecatheter 3056 which causes the catheter to curve into contact with the airway wall when extended from a delivery catheter. -
FIG. 46 illustrates a treatment apparatus 40AE having one ormore electrodes 3068 connected to a distal end of acatheter 3066. Theelectrodes 3068 are supported between the distal end of thecatheter 3066 and adevice tip 3070. A connectingshaft 3072 supports thetip 3070. Also connected between the distal end of thecatheter 3066 and thetip 3070 is a spring element 307 4 for biasing theelectrodes 3068 against a wall of the airway. The spring element 307 4 may have one end which slides in a track or groove in thecatheter 3066 such that the spring can flex to a variety of different positions depending on an internal diameter of the airway to be treated. -
FIG. 47 illustrates an alternative treatment apparatus 40AF in which the one ormore electrodes 3078 are positioned on a body 80 secured to an end of acatheter 3076. In theFIG. 47 embodiment, thebody 3080 is illustrated as egg shaped, however, other body shapes may also be used. Theelectrodes 3078 extend throughholes 3082 in thebody 3080 and along the body surface. A biasing member such as thespring element 3084 is preferably provided on thebody 3080 for biasing the body with the electrodes against the airway walls.Leads 3085 are connected to the electrodes and extend through thecatheter 3076 to the energy source 3032. -
FIGS. 48 and 49 illustrate a further treatment apparatus 40AG having one or more loop shapedelectrodes 3088 connected to acatheter shaft 3086. In the unexpanded position shown inFIG. 48 , the loop of theelectrode 3088 lies along the sides of acentral core 3090. A distal end of theloop electrode 3088 is secured to thecore 3090 and to anoptional tip member 3092. Thecore 3090 is slidable in a lumen of thecatheter 3086. Once the treatment apparatus 40AG has been positioned with the distal end in the airway to be treated, the electrode is expanded by pulling thecore 3090 proximally with respect to thecatheter 3086, as shown inFIG. 49 . Alternatively, theelectrode 3088 or thecore 3090 may be spring biased to return to the configuration ofFIG. 49 when a constraining force is removed. This constraining force may be applied by a delivery catheter or bronchoscope through which the treatment apparatus 40AG is inserted or by a releasable catch. - The treatment apparatus 40AH of
FIG. 50 includes aplurality electrodes 3098 positioned onleaf springs 3096 which are outwardly biased. Theleaf springs 3096 are connected to a shaft 3102 which is positioned within a delivery catheter 3094. Theleaf springs 3096 andelectrodes 3098 are delivered through the delivery catheter 3094 to a treatment site within the airways. When theleaf springs 3096 exit the distal end of the delivery catheter 3094, the leaf springs bend outward until theelectrodes 3098 come into contact with the airway walls for application of energy to the airway walls. -
FIGS. 51 and 52 illustrate embodiments of treatment apparatus 40AI, 40AJ in whichelectrodes 3106 in the form of wires are positioned in one ormore lumens 3108 of acatheter 3104.Openings 3110 are formed in the side walls of thecatheters 3104 to expose theelectrodes 3106. As shown inFIG. 51 , the treatment apparatus 40AI hasmultiple lumens 3108 with electrodes provided in each of the lumens. The side wall of the treatment apparatus 40AI is cut away to expose one or more of theelectrodes 3106 through aside wall opening 3110. InFIG. 51 , theopening 3110 exposes two electrodes positioned in adjacent lumens. The treatment apparatus 40AI may be provided with a biasing member as discussed above to bring theelectrodes 3106 of the treatment apparatus into contact with the airway wall. - The treatment apparatus 40AJ of
FIG. 52 includes acatheter 3104 which has been formed into a loop shape to allow theelectrode 3106 to be exposed on opposite sides of the device which contact opposite sides of the airway. The resilience of the loop shape causes the electrodes to come into contact with the airway walls. - The treatment apparatus 40AK of
FIG. 53 is in the form of a balloon catheter. The treatment apparatus 40AK includeselectrodes 3118 positioned on an exterior surface of an inflatable balloon 3116. Theelectrodes 3118 are electrically connected to the energy source 3032 by theleads 3120 extending through the balloon and through the lumen-of the balloon catheter 3114. The balloon 3116 is filled with a fluid such as saline or air to bring the electrodes into contact with theairway wall 3100. -
FIG. 54 illustrates an alternative embodiment of a balloon catheter treatment apparatus 40AM in which a fluid within theballoon 3126 is heated byinternal electrodes 3128. Theelectrodes 3128 are illustrated in the shape of coils surrounding the shaft of the catheter 3124, however other electrode shapes may also be used. Theelectrodes 3128 may be used as resistance heaters by application of an electric current to the electrodes. Alternatively, radio frequency or microwave energy may be applied to theelectrodes 3128 to heat a fluid within theballoon 3126. The heat then passes from an exterior of theballoon 3126 to the airway wall. The radio frequency or microwave energy may also be applied indirectly to the airway wall through the fluid and the balloon. In addition, hot fluid may be transmitted to theballoon 3126 from an external heating device for conductive heating of the airway tissue. -
FIG. 55 illustrates a treatment apparatus 40AN for delivering heated fluid to the airway walls to heat the airway tissue. The treatment apparatus 40A includes aheating element 3132 provided within afluid delivery catheter 3134. The fluid passes over theheating element 3132 and out ofopenings 3136 in the end of thecatheter 3134. Theopenings 3136 are arranged to direct the fluid at theairway walls 3100. Theheating element 3132 may be a coiled resistance heating element or any other heating element. Theheating element 3132 may be positioned anywhere along the body of thecatheter 3134 or may be an external heating device separate from the catheter. - The
heating element 3132 may also be replaced with a friction producing heating element which heats fluid passing through thefluid delivery catheter 3134. According to one embodiment of a friction producing heating element, a friction element rotates and contacts a stationary element for purpose of heating the fluid. -
FIG. 56 illustrates an alternative embodiment of a treatment apparatus 40AP including acryoprobe tip 3150 for transferring or removing energy in the form of heat from anairway wall 3100. Thecryoprobe tip 3150 is delivered to the treatment site by acryoprobe shaft 3152. Transfer of energy from the tissue structures of the airway wall can be used in the same manner as the delivery of energy with any of the devices discussed above. The particular configuration of the cryoprobe treatment apparatus 40AP may vary as is known in the art. -
FIGS. 57 and 58 illustrate another embodiment of a treatment apparatus 40AQ that may be used to treat a lung according to the present invention. The treatment apparatus 40AQ, like the previously described treatment apparatus, damages tissue of theairway 25 so as to induce fibrosis and add thickness to the airway wall. The treatment apparatus 40AQ also destroys the airway smooth muscle tone to increase gas exchange. With the treatment apparatus 40AQ, a bristledbrush 4000 having a plurality ofbristles 4002 is introduced into theairway 25 so as to puncture the airway wall with thebristles 4002. Thebristles 4002 may be needles, pins, or other similarly shaped members. Thebristles 4002 are located at the distal end of anelongated member 4004. Thebristles 4002 extend radially outward from the outer surface of the distal end of theelongated member 4004, and are preferably flexible. Thebrush 4000 has at least one bristle 4002 that may be manipulated to damage the tissue of theairway 25. - As shown in
FIG. 57 , thebrush 4000 is inserted through a tube-like member orcannula 4006 which has been inserted into theairway 25. Because the outer diameter of the brush 4000 (as measured about the most distal ends or tips of the bristles 4002) is greater than the interior diameter of thecannula 4006, thebristles 4002 bend against the interior surface of thecannula 4006 when thebrush 4000 is located within the interior of thecannula 4006. -
FIG. 58 illustrates thebrush 4000 after it has been pushed through the mostdistal opening 4005 of thecannula 4006. Hence, as shown inFIG. 58 , thebrush 4000 is located at least partially outside of thecannula 4006. As also shown byFIG. 58 , when thebrush 4000 exits theoutlet 4005 of thecannula 4006, thebristles 4002 will return radially outward to their original straight configuration, rather than the bent configuration shown inFIG. 57 where the bristles interfere with the interior surface of thecannula 4006. Hence, thebristles 4002 extend radially outward toward the wall of theairway 25 when the distal end of the brush is forced through the opening of the cannula. As shown inFIG. 58 , thebristles 4002 have penetrated the wall of theairway 25 to thus cause trauma to the tissue. Once thebrush 4000 of the treatment apparatus 40A extends from theoutlet 4005 of thecannula 4006, thebrush 4000 may be moved along the length of the duct as illustrated by thearrow 4007 inFIG. 58 so as to cause further trauma and damage to theairway 25. Additionally, as also illustrated by thearrow 4009 inFIG. 58 , thebrush 4000 may be rotated while in theairway 25 so as to cause damage to theairway 25. Thebrush 4000 may be moved along the select lengths of theairway 25 to damage predetermined portions of the airway, as desired. After the desire˜ damage has been completed, thebrush 4000 may be retracted back through theopening 4005 of thecannula 4000 such that undesired damage is not caused to other portions of theairway 25 when thebrush 4000 is removed from the airway and eventually the lung. - The
bristles 4002 are preferably the flexible pins illustrated inFIG. 58 , and are preferably made of a metallic material such as stainless steel. The bristles preferably have a caliber that permits them to be easily bent and resiliently return to their original position after being bent. However, thebristles 4002 may take other forms. For example, thebristles 4002 may be rigid and substantially not elastic such that they are not easily bendable. That is, the bristles may be needle-like members. In this case, the length of each needle-like member must be sufficiently small so that thebrush 4000 may travel through thecannula 4006, because the needle-like members will not bend in thecannula 4006 when contacting the interior surface of thecannula 4006. Thebrush 4000 has needle-like members which may be manipulated in theairway 25 so as to cause trauma to the airway wall. - The
bristles 4002 preferably each have a sharp point or tip that will puncture the airway wall to cause damage and thus induce fibrosis and/or destroy smooth muscle tone. However, the tips of the bristles may be blunt such that the bristles will tear or rip the airway, rather than simply puncturing the airway wall. In this case, the tearing action will damage cells of tissue to induce a fibrotic response. Alternatively, thebristles 4002 may be razor-like members having a sharp longitudinal edge that slices theairway 25 to cause damage. -
FIGS. 59 and 60 illustrate another embodiment of a treatment apparatus 40AR for use with the method of the present invention. The treatment apparatus 40AR causes damage to theairway 25 by preferably cutting through the airway wall. The treatment apparatus 40AR includes acutting device 4100 having a plurality ofelongated blades FIG. 60A , theelongated blades inner rod 4104. However, additional blades may be included. For example, the blades may be circumferentially spaced at eight locations along the exterior surface of theinner rod 4104. - The inner rod or
tube 4104 is located at least partially inside the interior of an outer tube orcannula 4106. As shown by thearrow 4107 inFIG. 60 , theinner tube 4104 is movable within the interior of theouter tube 4106 along the lengthwise direction of theouter tube 4106. As shown inFIGS. 59 and 60 , each of theelongated blades 4102 is pivotally connected to theinner tube 4104 by apivot connection 4112 located at the most distal end of theinner tube 4104 so as to be rotatable about thepivot connection 4112. Each of theelongated blades 4102 located toward the distal end of theinner rod 4104 is also pivotally connected by anotherpivot connection 4110 to anotherelongated blade 4103. Hence, thepivot connection 4110 defines a point about which each of theblades elongated blade 4103 is pivotally connected to theouter tube 4106 by a furtherpivot blade connection 4108 so as to be rotatable about thepivot connection 4108. Hence, theblades arrow 4109 inFIG. 60 when relative motion occurs between theinner tube 4104 and theouter tube 4106, preferably when theinner tube 4104 and/or theouter tube 4106 are moved in the direction of thearrow 4107. For example, when theinner tube 4104 and theouter tube 4106 are moved from the positions illustrated inFIG. 59 to the positions illustrated inFIG. 60 , each of theelongated blades pivot connections elongated blades airway 25 and cut through tissue of the airway to induce fibrosis. The more the most distal end of theinner tube 4104 having thepivot connection 4112 and the most distal end of theouter tube 4106 having thepivot connection 4108 are moved toward each other, the more theblades pivot connections elongated blades airway 25 so as to cause trauma. Preferably, theelongated blades tissue 27 such that scar tissue develops to thicken the wall of the airway and thus strengthen the airway. As shown inFIG. 60 , theelongated blades - The
elongated blades FIGS. 59 and 60 so as to cause multiple cuts to the airway tissue, as desired. Additionally, theelongated blades FIG. 60 so as to further slice the airway tissue. Likewise, thecutting apparatus 4100 may be rotated in theairway 25 as shown by thearrow 4105 inFIG. 60 so as to cut and/or tear the tissue of theairway 25. - The
elongated blades elongated blades elongated blades elongated blades -
FIGS. 61-62 illustrate a further embodiment of a treatment apparatus 40AS for use with the method of the present invention. The treatment apparatus 40AS includes aslicing device 4200 that slices through the airway tissue to destroy smooth muscle tone and/or damage lung tissue and induce fibrosis to strengthen the airway wall. Theslicing device 4200 includes a plurality ofelongated slicing members 4202 that each include arazor edge 4208 located at the most distal end of the slicing members. The slicingmembers 4202 are preferably elongated metallic members that protrude from the anoutlet 4201 of aninner tube 4204. The slicingmembers 4202 are movable in theinner tube 4202 along the lengthwise direction of theinner tube 4204 as shown by thearrows 4207 illustrated inFIG. 62 . Theinner tube 4204, similar to the previously described embodiments, is located within an outer tube orcannula 4206. The slicingmembers 4202 may be forced out of anopening 4203 of theouter tube 4206 at the most distal end of the outer tube such that they project outwardly from the end of theouter tube 4206.FIG. 61 illustrates theslicing members 4202 located completely inside of theouter tube 4206, whileFIG. 62 illustrates theslicing members 4202 after they have been moved out of theopening 4203 of theouter tube 4206. The slicingmembers 4202 may be manually forced through theopening 4203 or automatically caused to move through theopening 4203 by a controller (not illustrated). - As illustrated in
FIGS. 61 and 62 , when theslicing members 4202 are moved out of theopening 4203, they bend or curve away from the longitudinal axis of theouter tube 4206 such that the members slice through the airway tissue of theairway 25. Hence, the slicingmembers 4202 are preferably biased to bend away from the longitudinal axis of theouter tube 4206. That is, each of the slicing members acts like a spring and moves toward the airway wall after exiting theoutlet 4203. - The slicing
members 4202 may be attached to theinner tube 4204 such that theslicing members 4202 move with theinner tube 4204 when the inner tube is moved relative to theouter tube 4206. Additionally, the slicing members 402 may not be attached to theinner tube 4204 such that they are movable relative to theinner tube 4204, as well as theouter tube 4206. As shown by thearrow 4209 inFIG. 61 , the slicingmembers 4202 can be rotated relative to theairway 25 during the treatment process so as to slice, cut, or tear through the airway wall to cause further trauma. - Although the embodiment shown in
FIGS. 61-62 includes only fourslicing members 4202, other numbers of slicing members are contemplated. For example, the treatment apparatus 4AS can slice the airway tissue with 8, 16, 32, 56, or other numbers of slicingmembers 4202 that are movable relative theairway 25 so as to cause damage to the airway tissue of the lung. - The slicing
members 4202 can be moved to repetitively slice through the tissue of theairway 25 so as to define a plurality ofsliced areas 4210. In general, the greater the number ofsliced areas 4210 made with the treatment apparatus 40AS, the greater the damage of smooth muscle tone and the greater the fibrotic response, which will thicken the airway wall and strengthen the airway wall to thus increase gas exchange. - The slicing
members 4202 are preferably thin and elongated members having arazor edge 4208. However, the slicingmembers 4202 can be other configurations. For example, each of theslicing members 4202 may include a pin point rather than a razor edge. Additionally, each of theslicing members 4202 may include serrations or a razor edge along the elongated edges or sides of theslicing members 4202, which may extend the entire length of the slicing member or only along predetermined portions of the length. -
FIGS. 63-65 illustrate further embodiments of treatment apparatus 40AT for use with the present invention. As shown inFIG. 63 , the treatment apparatus 40AT includes aballoon 4312 having a plurality ofpins 4308 attached to the outer surface of the balloon. Theballoon 4312 is similar to the previously described balloons and may be fabricated from like materials. Theballoon 4312 is partially located within aninner tube 4304, as well as acontainment sheath 4309. Theballoon 4312 extends from the outlet end of theinner tube 4304. As shown inFIG. 64 , theinner tube 4304 is connected to afluid supply 4314, which can supply a pressurized gas or fluid to the interior of thetube 4304 and hence the interior of theballoon 4312 to cause the balloon to expand as shown inFIG. 64 . - The
sheath 4309 that surrounds or encases theballoon 4312 includes a plurality ofopenings 4302 that extend through the cylindrical wall of thesheath 4309. Hence, theopenings 4302 communicate the exterior of thesheath 4309 with the interior of the sheath. Theballoon 4312 is attached to thesheath 4309 at the mostdistal end 4310 of the sheath. Theopenings 4302 in thesheath 4309 are located at locations on the exterior surface of thesheath 4309 such that when theballoon 4312 is expanded thepins 4308 will travel through theopenings 4302 and protrude from the exterior surface of thesheath 4309. That is, theopenings 4302 are spaced along the length and the circumference of thesheath 4309 the same distance that thepins 4308 are spaced along the length and circumference of theballoon 4312. Hence, when theballoon 4312 is expanded upon application of pressure by thefluid supply 4314, the pins will move radially toward the airway and extend through theopenings 4302. When theballoon 4312 has been fully expanded as shown inFIG. 64 , thepins 4308 will protrude through theopenings 4302 and will puncture the tissue of theairway 25 so as to destroy smooth muscle tone and/or induce fibrosis and strengthen the airway. - The
sheath 4309 is preferably formed of a rigid material, such as hard plastic, so that the location of theopenings 4302 relative to the location of thepins 4308 on theballoon 4312 remains relatively constant during the treatment process. Thesheath 4309 is preferably attached to theouter tube 4306 such that thesheath 4309 will move when theouter tube 4306 is moved: Hence, after the balloon has been expanded to causepins 4308 to extend through theopenings 4302 and puncture the airway tissue, thesheath 4309, theouter tube 4306, the balloon, and thepins 4308 may be moved in the longitudinal direction of theairway 25 so as to further tear or slice through the airway tissue. Likewise, as shown by thearrow 4307 shown inFIG. 64 , thesheath 4309 may be rotated so as to rotate thepins 4308 to cause further damage to the tissue of the airway. - As shown in
FIGS. 63 and 64 , thepins 4308 are located on diametrically opposite sides of theballoon 4312, as are theopenings 4302 of thesheath 4309. However, theballoon 4312 may include further rows and columns ofpins 4308 and the sheath may include further rows and columns ofopenings 4302, as illustrated by the embodiment of the treatment apparatus 40AT illustrated inFIG. 65 . As shown inFIG. 65 , theballoon 4312 includes eight rows ofpins 4308 equally spaced along the length and circumference of theballoon 4312. Hence, thesheath 4309 also includes correspondingly locatedopenings 4302 that thepins 4308 may protrude through when theballoon 4312 is expanded. Other numbers ofpins 4308 andopenings 4302 are also contemplated. - The balloons of the embodiments illustrated in
FIGS. 63-65 can be repeatedly expanded and contracted so as to cause multiple punctures to the airway tissue to destroy the airway smooth muscle tone and induce fibrosis and hence stiffen the wall of the airway. Additionally, thepins 4308 can be other configurations. For example, a plurality of razors, knives, or blunt members can be attached to the balloon such that the airway tissue is sliced, cut, or torn when the balloon is expanded. -
FIG. 66 illustrates another embodiment of a treatment apparatus 40AU that may be used according to the present invention. The treatment apparatus 40AU includes aballoon 4412, which is illustrated in its expanded state inFIG. 66 . Theballoon 4412 includes a plurality ofopenings 4402 that communicate the exterior of the balloon with the interior of the balloon. Theopenings 4402 are a plurality of small holes that extend through the wall of theballoon 4412. Theballoon 4412 is attached to the end of a tube orcannula 4406. The interior of theballoon 4412 may be filled with a liquid or gas from thefluid supply 4408. Hence, thefluid supply 4408 is in communication with the interior of theballoon 4412 through thetube 4406. The balloon may be expanded as shown inFIG. 66 by pressurizing the interior of theballoon 4412 with a liquid or gas from thesupply 4408. The liquid or gas supplied from thesupply 4408 will exit theballoon 4412 through theopenings 4402 located in the balloon. The expandedballoon 4412 contacts with the airway wall. Hence, when the fluid exits theballoon 4412 through theopenings 4402, it will contact the tissue of theairway 25. The fluid that exits theballoon 4412 may be a heated liquid or gas, similar to the above-described embodiments that destroy cells of the airway tissue by the application of heat. The fluid is preferably a biocompatible liquid, such as liquid saline or air. Additionally, the fluid delivered by thesupply 4408 may be cold liquid or gas that destroys the airway tissue by removing heat from the airway tissue when it passes through theopenings 4402 of theballoon 4412. In a preferred embodiment of the treatment apparatus 40AU, the liquid or gas supplied by thesupply 4408 is cooled to a temperature that destroys airway smooth muscle tone and/or damage airway tissue to induce a fibrotic response to strengthen theairway 25. The liquid or gas delivered by the treatment apparatus 40AU can also destroy tissue cells by chemically reacting with the tissue. For example, the treatment apparatus 40AU can deliver an acid to the airway tissue to cause trauma to the tissue. - Although the expanded
balloon 4412 illustrated inFIG. 66 contacts the wall of theairway 25, theballoon 4412 can be smaller than theairway 25 such that it does not contact the airway wall when expanded. -
FIGS. 67 and 68 illustrate another embodiment of a treatment apparatus 40A that can be used to perform the present method of the invention. The treatment apparatus 40AV, like the apparatus 40AU illustrated inFIG. 66 , includes aballoon 4512. Theballoon 4512 is illustrated in its collapsed condition inFIG. 67 , and is illustrated in its expanded condition inFIG. 68 . As shown inFIGS. 67 and 68 , theballoon 4512 includes a plurality oftubes 4504 attached to the exterior surface of theballoon 4512. The interior of theballoon 4512 is not in communication with the interior of thetubes 4504. The plurality oftubes 4504 are preferably circumferentially spaced about the exterior cylindrical surface of theballoon 4512. Each of thetubes 4504 extends along the longitudinal length of theballoon 4512 and through the interior of a tube orcannula 4508. Like the embodiment illustrated inFIG. 66 , theballoon 4512 may be inflated by afluid supply 4514 which supplies a gas or liquid to the interior of theballoon 4512 to cause it to expand to the position illustrated inFIG. 68 . However, unlike the embodiment illustrated inFIG. 66 , the expansion of theballoon 4512 does not cause a liquid or gas to be delivered to the wall of theairway 25. Rather, aseparate fluid supply 4510 delivers a liquid or gas to the interior of each of thetubes 4504. - The liquid or gas delivered by the
fluid supply 4510 travels through the interior of theelongated tubes 4504 and out of a plurality ofopenings 4502 spaced along the length of each of thetubes 4504. Theopenings 4502 are equidistantly spaced along the length of thetube 4504. Hence, after the balloon is expanded by pressure from thesupply 4514, thesupply 4510 may supply a liquid or gas to the interior of thetubes 4504 and out of theopenings 4502 such that the liquid or gas from thesupply 4510 contacts the airway tissue. As with the embodiment described above in reference toFIG. 66 , the liquid or gas supplied from thesupply 4510 will damage the airway tissue. The fluid or gas delivered through theholes 4502damages tissue 27 to induce fibrosis and thicken the wall of theairway 25 so as to strengthen the airway wall and increase the gas exchange efficiency of the lung. The fluid or gas can also destroy the smooth muscle tone to increase gas exchange. -
FIG. 69 illustrates an additional embodiment of a treatment apparatus 40AW for use with the methods of the present invention. The treatment apparatus 40AW includes a tube orcannula 4604 having a plurality ofholes 4602 located at a most distal end of thetube 4604. The plurality ofholes 4602 form a plurality of columns and rows about the circumference of thetube 4604, as illustrated inFIG. 69 . Theholes 4602 deliver a fluid, such as that described above in reference toFIGS. 66-68 to the tissue of theairway 25 to damage cells and induce fibrosis. As shown inFIG. 69 , agas supply 4610 and/or aliquid supply 4612 may deliver a fluid to the interior of thetube 4604, through theholes 4602, and to the tissue of theairway 25. In this manner, a gas and/or a fluid will destroy smooth muscle tone and/or damage tissue to induce fibrosis and increase the gas exchange efficiency of the lung. -
FIG. 70 illustrates a further embodiment of a treatment apparatus 40AX for use with the methods according to the present invention. The treatment apparatus 40AX, like the embodiments illustrated inFIGS. 66-69 , delivers a liquid or a gas to theairway 25 so as to damage of the airway tissue. In the embodiment illustrated inFIG. 70 , aninner tube 4702 is located within anouter tube 4704. Theinner tube 4702 may be connected to a gas supply or aliquid supply 4710. Likewise, theouter tube 4704 may be connected to a gas supply orliquid supply 4712. The fluid delivered to the interior of theinner tube 4702 from thesupply 4710 exits theoutlet 4708 at the distal end of theinner tube 4702. The fluid delivered from thesupply 4712 exits theoutlet 4706 at the most distal end of theouter tube 4704. Because there are twoseparate tubes separate supplies airway 25. For example, two liquids or gases may be combined at theoutlets -
FIGS. 71 and 72 illustrate a bronchoscope, such as described earlier, that may be used with each of the above-describedtreatment apparatus 40. Thebronchoscope 5000 has atreatment apparatus 40 slidably positioned within a lumen of the bronchoscope. The bronchoscope also includes an image-transmittingfiber 5008 and illuminatingfiber 5020. Any conventional bronchoscope with an appropriately sized and directed working lumen may be employed. The image transmitting fiber collects light from the distal end of the treating apparatus and directs the light to a viewing apparatus (not shown) for displaying an image of the air passage. The bronchoscope may have a panning system which enables the tip to be moved in different directions. In treating a particular site, excessive fluid is first removed from the obstructed air passage by conventional means such as with suction. Thereafter, the bronchoscope as illustrated inFIGS. 71 and 72 is advanced from the person's nasal or oral cavity, and through the trachea, main stem bronchus, and into an air passage. Thetreatment apparatus 40 is advanced forward from the bronchoscope such that the treatment apparatus may be used to destroy airway smooth muscle tone and/or cause damage to airway tissue to induce fibrosis and strengthen an airway of the lung. This procedure is applied to a sufficient number of obstructed air passages until the physician determines that the treatment is finished. As is apparent, the procedure can be completed in one treatment or multiple treatments. The bronchoscope and thetreatment apparatus 40 are then removed from the patient. - The principles, preferred embodiments and modes of operation of the present invention have been described in the foregoing specification. However, the invention which is intended to be protected is not to be construed as limited to the particular embodiments disclosed. Further, the embodiments described herein are to be regarded as illustrative rather than restrictive. Variations and changes may be made by others, and equivalents employed, without departing from the spirit of the present invention. Accordingly, it is expressly intended that all such variations, changes and equivalents which fall within the spirit and scope of the present invention as defined in the claims be embraced thereby.
Claims (21)
1-32. (canceled)
33. A method for treating a lung, the method comprising:
moving a balloon through an airway of the lung while the balloon is in a deflated configuration;
inflating the balloon to cause one or more radio frequency electrodes disposed adjacent an outer surface of the balloon to contact tissue defining the airway; and
delivering radio frequency energy from the one or more radio frequency electrodes to damage nerve tissue.
34. The method of claim 33 , wherein inflating the balloon includes delivering a fluid to the balloon via a lumen.
35. The method of claim 34 , further including delivering energy to the one or more radio frequency electrodes via an energizing member extending through the lumen.
36. The method of claim 35 , wherein the energizing member extends from the lumen through the outer surface of the balloon to the one or more radio frequency electrodes.
37. The method of claim 34 , wherein the fluid is saline.
38. The method of claim 33 , wherein the balloon includes a plurality of radio frequency electrodes that are longitudinally spaced from one another.
39. The method of claim 33 , wherein the radio frequency energy is in the range of 10 MHz and 1000 MHz.
40. The method of claim 33 , wherein the tissue defining the airway or the nerve tissue is heated by the radio frequency electrodes to a temperature in the range of 40° C. to 95° C.
41. The method of claim 33 , wherein the one or more radio frequency electrode is formed as a coil.
42. The method of claim 33 , wherein the radio frequency energy is delivered in a monopolar manner.
43. The method of claim 33 , wherein the radio frequency energy is delivered in a bipolar manner.
44. The method of claim 33 , wherein damaging nerve tissue increases a diameter of the airway.
45. The method of claim 33 , wherein the nerve tissue is disposed within or radially outward of the tissue defining the airway.
46. The method of claim 33 , wherein the one or more radio frequency electrodes are disposed on the outer surface of the balloon.
47. A method for treating a lung, the method comprising:
moving a balloon through an airway of the lung while the balloon is in a deflated configuration;
inflating the balloon to cause one or more radio frequency electrodes disposed adjacent an outer surface of the balloon to contact tissue defining the airway, wherein inflating the balloon includes delivering a fluid to the balloon via a lumen; and
delivering radio frequency energy from the one or more radio frequency electrodes to the tissue defining the airway, wherein the radio frequency energy is transferred from an energy source to the one or more radio frequency electrodes via an energizing member extending through the lumen.
48. The method of claim 47 , wherein the energizing member extends through the outer surface of the balloon.
49. The method of claim 47 , wherein the fluid is saline.
50. The method of claim 47 , wherein the balloon includes a plurality of radio frequency electrodes that are longitudinally spaced from one another.
51. The method of claim 47 , wherein the tissue defining the airway is heated by the one or more radio frequency electrodes to a temperature in the range of 40° C. to 95° C.
52. The method of claim 47 , wherein delivering radio frequency energy increases a diameter of the airway.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/540,870 US20150141984A1 (en) | 1997-04-07 | 2014-11-13 | Methods for treating a lung |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/833,550 US6273907B1 (en) | 1997-04-07 | 1997-04-07 | Bronchial stenter |
US09/003,750 US5972026A (en) | 1997-04-07 | 1998-01-07 | Bronchial stenter having diametrically adjustable electrodes |
US9532398A | 1998-06-10 | 1998-06-10 | |
US09/260,401 US6283988B1 (en) | 1997-04-07 | 1999-03-01 | Bronchial stenter having expandable electrodes |
US09/296,040 US6411852B1 (en) | 1997-04-07 | 1999-04-21 | Modification of airways by application of energy |
US09/349,715 US6488673B1 (en) | 1997-04-07 | 1999-07-08 | Method of increasing gas exchange of a lung |
US09/436,455 US7425212B1 (en) | 1998-06-10 | 1999-11-08 | Devices for modification of airways by transfer of energy |
US09/535,856 US6634363B1 (en) | 1997-04-07 | 2000-03-27 | Methods of treating lungs having reversible obstructive pulmonary disease |
US09/999,851 US7027869B2 (en) | 1998-01-07 | 2001-10-25 | Method for treating an asthma attack |
US10/232,909 US7556624B2 (en) | 1997-04-07 | 2002-08-30 | Method of increasing gas exchange of a lung |
US11/117,905 US7740017B2 (en) | 1997-04-07 | 2005-04-29 | Method for treating an asthma attack |
US12/328,582 US8267094B2 (en) | 1997-04-07 | 2008-12-04 | Modification of airways by application of ultrasound energy |
US13/590,129 US8944071B2 (en) | 1997-04-07 | 2012-08-20 | Method for treating an asthma attack |
US14/540,870 US20150141984A1 (en) | 1997-04-07 | 2014-11-13 | Methods for treating a lung |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/590,129 Continuation US8944071B2 (en) | 1997-04-07 | 2012-08-20 | Method for treating an asthma attack |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150141984A1 true US20150141984A1 (en) | 2015-05-21 |
Family
ID=39523630
Family Applications (13)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/999,851 Expired - Lifetime US7027869B2 (en) | 1997-04-07 | 2001-10-25 | Method for treating an asthma attack |
US11/117,905 Expired - Fee Related US7740017B2 (en) | 1997-04-07 | 2005-04-29 | Method for treating an asthma attack |
US12/325,985 Expired - Fee Related US7938123B2 (en) | 1997-04-07 | 2008-12-01 | Modification of airways by application of cryo energy |
US12/328,596 Expired - Fee Related US7770584B2 (en) | 1997-04-07 | 2008-12-04 | Modification of airways by application of microwave energy |
US12/328,582 Expired - Fee Related US8267094B2 (en) | 1997-04-07 | 2008-12-04 | Modification of airways by application of ultrasound energy |
US12/727,156 Expired - Fee Related US8161978B2 (en) | 1997-04-07 | 2010-03-18 | Methods for treating asthma by damaging nerve tissue |
US12/964,678 Expired - Fee Related US8640711B2 (en) | 1997-04-07 | 2010-12-09 | Method for treating an asthma attack |
US13/590,129 Expired - Fee Related US8944071B2 (en) | 1997-04-07 | 2012-08-20 | Method for treating an asthma attack |
US13/891,959 Expired - Fee Related US9027564B2 (en) | 1997-04-07 | 2013-05-10 | Method for treating a lung |
US14/146,193 Expired - Lifetime US9956023B2 (en) | 1997-04-07 | 2014-01-02 | System for treating a lung |
US14/540,870 Abandoned US20150141984A1 (en) | 1997-04-07 | 2014-11-13 | Methods for treating a lung |
US14/579,646 Expired - Lifetime US11033317B2 (en) | 1997-04-07 | 2014-12-22 | Methods for treating a lung |
US14/694,397 Expired - Fee Related US10058370B2 (en) | 1997-04-07 | 2015-04-23 | Method for treating a lung |
Family Applications Before (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/999,851 Expired - Lifetime US7027869B2 (en) | 1997-04-07 | 2001-10-25 | Method for treating an asthma attack |
US11/117,905 Expired - Fee Related US7740017B2 (en) | 1997-04-07 | 2005-04-29 | Method for treating an asthma attack |
US12/325,985 Expired - Fee Related US7938123B2 (en) | 1997-04-07 | 2008-12-01 | Modification of airways by application of cryo energy |
US12/328,596 Expired - Fee Related US7770584B2 (en) | 1997-04-07 | 2008-12-04 | Modification of airways by application of microwave energy |
US12/328,582 Expired - Fee Related US8267094B2 (en) | 1997-04-07 | 2008-12-04 | Modification of airways by application of ultrasound energy |
US12/727,156 Expired - Fee Related US8161978B2 (en) | 1997-04-07 | 2010-03-18 | Methods for treating asthma by damaging nerve tissue |
US12/964,678 Expired - Fee Related US8640711B2 (en) | 1997-04-07 | 2010-12-09 | Method for treating an asthma attack |
US13/590,129 Expired - Fee Related US8944071B2 (en) | 1997-04-07 | 2012-08-20 | Method for treating an asthma attack |
US13/891,959 Expired - Fee Related US9027564B2 (en) | 1997-04-07 | 2013-05-10 | Method for treating a lung |
US14/146,193 Expired - Lifetime US9956023B2 (en) | 1997-04-07 | 2014-01-02 | System for treating a lung |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/579,646 Expired - Lifetime US11033317B2 (en) | 1997-04-07 | 2014-12-22 | Methods for treating a lung |
US14/694,397 Expired - Fee Related US10058370B2 (en) | 1997-04-07 | 2015-04-23 | Method for treating a lung |
Country Status (1)
Country | Link |
---|---|
US (13) | US7027869B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120136343A1 (en) * | 2009-06-01 | 2012-05-31 | Channel Medsystems, Inc. | Methods and apparatus for treatment of a body cavity or lumen |
US9757196B2 (en) | 2011-09-28 | 2017-09-12 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US10702337B2 (en) | 2016-06-27 | 2020-07-07 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US10959879B2 (en) | 2011-02-01 | 2021-03-30 | Channel Medsystems, Inc. | Methods and apparatus for cryogenic treatment of a body cavity or lumen |
US11707629B2 (en) | 2009-05-28 | 2023-07-25 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US11723710B2 (en) | 2016-11-17 | 2023-08-15 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11931096B2 (en) | 2010-10-13 | 2024-03-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US11957405B2 (en) | 2013-06-13 | 2024-04-16 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
Families Citing this family (271)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US6488673B1 (en) * | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
GB9721506D0 (en) * | 1997-10-10 | 1997-12-10 | Virulite Limited | Treatment of diseases |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US6709431B2 (en) * | 2001-12-18 | 2004-03-23 | Scimed Life Systems, Inc. | Cryo-temperature monitoring |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US20060206150A1 (en) | 2002-04-08 | 2006-09-14 | Ardian, Inc. | Methods and apparatus for treating acute myocardial infarction |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US20110207758A1 (en) | 2003-04-08 | 2011-08-25 | Medtronic Vascular, Inc. | Methods for Therapeutic Renal Denervation |
US7620451B2 (en) * | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8347891B2 (en) * | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
US8021359B2 (en) * | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
EP1596746B1 (en) * | 2003-02-20 | 2016-10-19 | ReCor Medical, Inc. | Ultrasonic ablation devices |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
WO2005122870A2 (en) | 2004-06-14 | 2005-12-29 | Pneumrx, Inc. | Lung access device |
EP3542736A1 (en) * | 2004-06-16 | 2019-09-25 | PneumRx, Inc. | Intra-bronchial lung volume reduction system |
GB0414113D0 (en) * | 2004-06-24 | 2004-07-28 | Virulite Distrib Ltd | Cosmetic uses of electromagnetic radiation |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
WO2006014567A2 (en) | 2004-07-08 | 2006-02-09 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
US7906124B2 (en) * | 2004-09-18 | 2011-03-15 | Asthmatx, Inc. | Inactivation of smooth muscle tissue |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
US20070093802A1 (en) | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
KR20070108141A (en) | 2004-11-16 | 2007-11-08 | 로버트 엘 베리 | Device and method for lung treatment |
WO2006058195A2 (en) | 2004-11-23 | 2006-06-01 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
EP3804647A1 (en) * | 2005-04-21 | 2021-04-14 | Boston Scientific Scimed Inc. | Control methods and devices for energy delivery |
US7644714B2 (en) | 2005-05-27 | 2010-01-12 | Apnex Medical, Inc. | Devices and methods for treating sleep disorders |
GB0512038D0 (en) * | 2005-06-14 | 2005-07-20 | Dougal Gordon | Therapeutic and cosmetic uses of electromagnetic radiation |
EP1906923B1 (en) | 2005-07-22 | 2018-01-24 | The Foundry, LLC | Systems and methods for delivery of a therapeutic agent |
US20070021803A1 (en) | 2005-07-22 | 2007-01-25 | The Foundry Inc. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US20070093805A1 (en) * | 2005-10-17 | 2007-04-26 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue, including via asymmetric electrodes |
US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US8812112B2 (en) | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
WO2007058780A2 (en) * | 2005-11-10 | 2007-05-24 | Electrocore, Inc. | Electrical stimulation treatment of bronchial constriction |
US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
US20070179495A1 (en) * | 2006-01-27 | 2007-08-02 | Mitchell Mathew E | Combination electrosurgery |
US7711430B2 (en) | 2006-02-10 | 2010-05-04 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
AU2006338184B2 (en) | 2006-02-10 | 2011-11-24 | ElectroCore, LLC. | Electrical stimulation treatment of hypotension |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US8721734B2 (en) | 2009-05-18 | 2014-05-13 | Pneumrx, Inc. | Cross-sectional modification during deployment of an elongate lung volume reduction device |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US20100241188A1 (en) * | 2009-03-20 | 2010-09-23 | Electrocore, Inc. | Percutaneous Electrical Treatment Of Tissue |
US10499937B2 (en) | 2006-05-19 | 2019-12-10 | Recor Medical, Inc. | Ablation device with optimized input power profile and method of using the same |
EP2037840B2 (en) | 2006-06-28 | 2019-02-20 | Medtronic Ardian Luxembourg S.à.r.l. | Systems for thermally-induced renal neuromodulation |
EP2116274B1 (en) | 2006-10-13 | 2012-07-11 | Apnex Medical, Inc. | Obstructive sleep apnea treatment device |
US8855771B2 (en) | 2011-01-28 | 2014-10-07 | Cyberonics, Inc. | Screening devices and methods for obstructive sleep apnea therapy |
US9186511B2 (en) | 2006-10-13 | 2015-11-17 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9913982B2 (en) | 2011-01-28 | 2018-03-13 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9205262B2 (en) | 2011-05-12 | 2015-12-08 | Cyberonics, Inc. | Devices and methods for sleep apnea treatment |
US9744354B2 (en) | 2008-12-31 | 2017-08-29 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US7931647B2 (en) * | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
US7993323B2 (en) | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US20100217347A1 (en) * | 2006-12-16 | 2010-08-26 | Greatbatch, Inc. | Neurostimulation for the treatment of pulmonary disorders |
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
US8983609B2 (en) | 2007-05-30 | 2015-03-17 | The Cleveland Clinic Foundation | Apparatus and method for treating pulmonary conditions |
US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
AU2008279121B2 (en) | 2007-07-24 | 2013-09-19 | Boston Scientific Scimed, Inc. | System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices |
US20090043301A1 (en) * | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
US8235986B2 (en) * | 2007-10-05 | 2012-08-07 | Coaptus Medical Corporation | Systems and methods for transeptal cardiac procedures, including tissue penetrating members and associated methods |
US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
EP2280741A4 (en) | 2008-04-29 | 2012-06-13 | Virginia Tech Intell Prop | Irreversible electroporation to create tissue scaffolds |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
CA2723806C (en) | 2008-05-09 | 2022-05-31 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
GB0812753D0 (en) * | 2008-07-14 | 2008-08-20 | Dougal Gordon R P | Electromagnetic radiation and its therapeutic effect |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
US9173669B2 (en) | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US8386010B2 (en) * | 2008-10-23 | 2013-02-26 | Covidien Lp | Surgical tissue monitoring system |
US8444635B2 (en) * | 2008-11-19 | 2013-05-21 | Samuel Victor Lichtenstein | Methods for selectively heating tissue |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US8808345B2 (en) | 2008-12-31 | 2014-08-19 | Medtronic Ardian Luxembourg S.A.R.L. | Handle assemblies for intravascular treatment devices and associated systems and methods |
WO2010080886A1 (en) | 2009-01-09 | 2010-07-15 | Recor Medical, Inc. | Methods and apparatus for treatment of mitral valve in insufficiency |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8632534B2 (en) * | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
EP2493408B1 (en) | 2009-10-27 | 2015-06-24 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
CN102686180B (en) * | 2009-11-04 | 2015-09-30 | 艾姆西森有限公司 | Intracavity remodeling device and method |
US20110112400A1 (en) * | 2009-11-06 | 2011-05-12 | Ardian, Inc. | High intensity focused ultrasound catheter apparatuses, systems, and methods for renal neuromodulation |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
AU2010319477A1 (en) | 2009-11-11 | 2012-05-24 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9028483B2 (en) | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
CN102883659A (en) * | 2010-01-19 | 2013-01-16 | 美敦力阿迪安卢森堡有限公司 | Methods and apparatus for renal neuromodulation via stereotactic radiotherapy |
DE102010006035A1 (en) * | 2010-01-27 | 2011-07-28 | Paterok, Peter, Dr., 41061 | Applicator for use in photodynamic therapy |
US20110208175A1 (en) * | 2010-02-24 | 2011-08-25 | Medtronic Vascular, Inc. | Methods for Treating Sleep Apnea Via Renal Denervation |
US8556891B2 (en) | 2010-03-03 | 2013-10-15 | Medtronic Ablation Frontiers Llc | Variable-output radiofrequency ablation power supply |
US8870863B2 (en) | 2010-04-26 | 2014-10-28 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
CN107349009B (en) | 2010-08-05 | 2020-06-26 | 美敦力Af卢森堡有限责任公司 | Cryoablation apparatus, systems, and methods for renal neuromodulation |
US9084610B2 (en) | 2010-10-21 | 2015-07-21 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
TW201221174A (en) | 2010-10-25 | 2012-06-01 | Medtronic Ardian Luxembourg | Microwave catheter apparatuses, systems, and methods for renal neuromodulation |
EP3449856B1 (en) | 2010-10-25 | 2023-06-28 | Medtronic Ardian Luxembourg S.à.r.l. | Device for evaluation and feedback of neuromodulation treatment |
US8998894B2 (en) | 2010-10-25 | 2015-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
US9060754B2 (en) | 2010-10-26 | 2015-06-23 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9023040B2 (en) | 2010-10-26 | 2015-05-05 | Medtronic Advanced Energy Llc | Electrosurgical cutting devices |
US9066713B2 (en) | 2010-10-26 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9421062B2 (en) | 2010-11-05 | 2016-08-23 | Ethicon Endo-Surgery, Llc | Surgical instrument shaft with resiliently biased coupling to handpiece |
US9375255B2 (en) | 2010-11-05 | 2016-06-28 | Ethicon Endo-Surgery, Llc | Surgical instrument handpiece with resiliently biased coupling to modular shaft and end effector |
US9017851B2 (en) | 2010-11-05 | 2015-04-28 | Ethicon Endo-Surgery, Inc. | Sterile housing for non-sterile medical device component |
US10959769B2 (en) | 2010-11-05 | 2021-03-30 | Ethicon Llc | Surgical instrument with slip ring assembly to power ultrasonic transducer |
US9247986B2 (en) | 2010-11-05 | 2016-02-02 | Ethicon Endo-Surgery, Llc | Surgical instrument with ultrasonic transducer having integral switches |
US20120116381A1 (en) | 2010-11-05 | 2012-05-10 | Houser Kevin L | Surgical instrument with charging station and wireless communication |
US10085792B2 (en) | 2010-11-05 | 2018-10-02 | Ethicon Llc | Surgical instrument with motorized attachment feature |
US10660695B2 (en) | 2010-11-05 | 2020-05-26 | Ethicon Llc | Sterile medical instrument charging device |
US9089338B2 (en) | 2010-11-05 | 2015-07-28 | Ethicon Endo-Surgery, Inc. | Medical device packaging with window for insertion of reusable component |
US9381058B2 (en) | 2010-11-05 | 2016-07-05 | Ethicon Endo-Surgery, Llc | Recharge system for medical devices |
US9649150B2 (en) | 2010-11-05 | 2017-05-16 | Ethicon Endo-Surgery, Llc | Selective activation of electronic components in medical device |
US9782215B2 (en) | 2010-11-05 | 2017-10-10 | Ethicon Endo-Surgery, Llc | Surgical instrument with ultrasonic transducer having integral switches |
US9510895B2 (en) | 2010-11-05 | 2016-12-06 | Ethicon Endo-Surgery, Llc | Surgical instrument with modular shaft and end effector |
US9597143B2 (en) | 2010-11-05 | 2017-03-21 | Ethicon Endo-Surgery, Llc | Sterile medical instrument charging device |
US9526921B2 (en) * | 2010-11-05 | 2016-12-27 | Ethicon Endo-Surgery, Llc | User feedback through end effector of surgical instrument |
US9072523B2 (en) | 2010-11-05 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Medical device with feature for sterile acceptance of non-sterile reusable component |
US9000720B2 (en) | 2010-11-05 | 2015-04-07 | Ethicon Endo-Surgery, Inc. | Medical device packaging with charging interface |
US20120116265A1 (en) | 2010-11-05 | 2012-05-10 | Houser Kevin L | Surgical instrument with charging devices |
US10881448B2 (en) | 2010-11-05 | 2021-01-05 | Ethicon Llc | Cam driven coupling between ultrasonic transducer and waveguide in surgical instrument |
US9011471B2 (en) | 2010-11-05 | 2015-04-21 | Ethicon Endo-Surgery, Inc. | Surgical instrument with pivoting coupling to modular shaft and end effector |
US9017849B2 (en) | 2010-11-05 | 2015-04-28 | Ethicon Endo-Surgery, Inc. | Power source management for medical device |
US9161803B2 (en) | 2010-11-05 | 2015-10-20 | Ethicon Endo-Surgery, Inc. | Motor driven electrosurgical device with mechanical and electrical feedback |
US9782214B2 (en) | 2010-11-05 | 2017-10-10 | Ethicon Llc | Surgical instrument with sensor and powered control |
US9039720B2 (en) | 2010-11-05 | 2015-05-26 | Ethicon Endo-Surgery, Inc. | Surgical instrument with ratcheting rotatable shaft |
AU2011328921B2 (en) | 2010-11-17 | 2015-07-09 | Medtronic Af Luxembourg S.A.R.L. | Therapeutic renal neuromodulation for treating dyspnea and associated systems and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9254169B2 (en) | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9427281B2 (en) | 2011-03-11 | 2016-08-30 | Medtronic Advanced Energy Llc | Bronchoscope-compatible catheter provided with electrosurgical device |
WO2012125785A1 (en) | 2011-03-17 | 2012-09-20 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
WO2012148969A2 (en) | 2011-04-25 | 2012-11-01 | Brian Kelly | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US9314370B2 (en) * | 2011-09-28 | 2016-04-19 | Zoll Circulation, Inc. | Self-centering patient temperature control catheter |
US10201386B2 (en) | 2011-10-05 | 2019-02-12 | Nuvaira, Inc. | Apparatus for injuring nerve tissue |
US9327123B2 (en) | 2011-11-07 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular nerve monitoring devices and associated systems and methods |
US9192766B2 (en) | 2011-12-02 | 2015-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and devices for treatment of polycystic kidney disease |
US10342592B2 (en) | 2012-03-07 | 2019-07-09 | Medtronic Ardian Luxembourg S.A.R.L. | Selective modulation of renal nerves |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
WO2013134492A1 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg Sarl | Neuromodulation and associated systems and methods for the treatment of sexual dysfunction |
WO2013134472A1 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and systems for treatment of hyperaldosteronism |
WO2013134541A2 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg Sarl | Gastrointestinal neuromodulation and associated systems and methods |
AU2013230893B2 (en) | 2012-03-08 | 2015-12-03 | Medtronic Af Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the management of pain |
CA2865242A1 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Biomarker sampling in the context of neuromodulation devices and associated systems and methods |
US10258791B2 (en) | 2012-04-27 | 2019-04-16 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods |
US9848950B2 (en) | 2012-04-27 | 2017-12-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for localized disease treatment by ablation |
US9241752B2 (en) | 2012-04-27 | 2016-01-26 | Medtronic Ardian Luxembourg S.A.R.L. | Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods |
US20150088113A1 (en) | 2012-04-27 | 2015-03-26 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices for renal neuromodulation and associated systems and methods |
WO2013162721A1 (en) | 2012-04-27 | 2013-10-31 | Medtronic Ardian Luxembourg Sarl | Methods and devices for localized inhibition of inflammation by ablation |
EP2846724B1 (en) | 2012-05-11 | 2016-11-09 | Medtronic Ardian Luxembourg S.à.r.l. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems |
US9427255B2 (en) | 2012-05-14 | 2016-08-30 | Ethicon Endo-Surgery, Inc. | Apparatus for introducing a steerable camera assembly into a patient |
JP5756568B2 (en) | 2012-05-31 | 2015-07-29 | カラー セブン カンパニー、リミテッド | Human body smooth muscle relaxation device |
EP2854682B1 (en) | 2012-06-04 | 2021-06-23 | Boston Scientific Scimed, Inc. | Systems for treating tissue of a passageway within a body |
US8951296B2 (en) | 2012-06-29 | 2015-02-10 | Medtronic Ardian Luxembourg S.A.R.L. | Devices and methods for photodynamically modulating neural function in a human |
US9078662B2 (en) | 2012-07-03 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Endoscopic cap electrode and method for using the same |
WO2014015065A1 (en) * | 2012-07-17 | 2014-01-23 | Boston Scientific Scimed, Inc. | Renal nerve modulation catheter design |
EP2877113B1 (en) | 2012-07-24 | 2018-07-25 | Boston Scientific Scimed, Inc. | Electrodes for tissue treatment |
US9545290B2 (en) | 2012-07-30 | 2017-01-17 | Ethicon Endo-Surgery, Inc. | Needle probe guide |
US9572623B2 (en) | 2012-08-02 | 2017-02-21 | Ethicon Endo-Surgery, Inc. | Reusable electrode and disposable sheath |
US10314649B2 (en) * | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US9833207B2 (en) | 2012-08-08 | 2017-12-05 | William Harrison Zurn | Analysis and clearing module, system and method |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
AU2013312785B2 (en) | 2012-09-05 | 2018-03-01 | ElectroCore, LLC | Non-invasive vagal nerve stimulation to treat disorders |
US8612022B1 (en) | 2012-09-13 | 2013-12-17 | Invatec S.P.A. | Neuromodulation catheters and associated systems and methods |
US20140088586A1 (en) * | 2012-09-26 | 2014-03-27 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US20140110296A1 (en) | 2012-10-19 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods |
US9399115B2 (en) | 2012-10-22 | 2016-07-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9044575B2 (en) | 2012-10-22 | 2015-06-02 | Medtronic Adrian Luxembourg S.a.r.l. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9272132B2 (en) | 2012-11-02 | 2016-03-01 | Boston Scientific Scimed, Inc. | Medical device for treating airways and related methods of use |
WO2014071372A1 (en) | 2012-11-05 | 2014-05-08 | Boston Scientific Scimed, Inc. | Devices for delivering energy to body lumens |
US9095321B2 (en) | 2012-11-21 | 2015-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices having integral multi-helical balloons and methods of making the same |
US9017317B2 (en) | 2012-12-06 | 2015-04-28 | Medtronic Ardian Luxembourg S.A.R.L. | Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9888956B2 (en) | 2013-01-22 | 2018-02-13 | Angiodynamics, Inc. | Integrated pump and generator device and method of use |
CN104994783B (en) | 2013-02-08 | 2018-11-13 | 柯惠有限合伙公司 | System and method for nervus pulmonalis resection |
US9962533B2 (en) | 2013-02-14 | 2018-05-08 | William Harrison Zurn | Module for treatment of medical conditions; system for making module and methods of making module |
US10098527B2 (en) | 2013-02-27 | 2018-10-16 | Ethidcon Endo-Surgery, Inc. | System for performing a minimally invasive surgical procedure |
US20140276051A1 (en) * | 2013-03-13 | 2014-09-18 | Gyrus ACM, Inc. (d.b.a Olympus Surgical Technologies America) | Device for Minimally Invasive Delivery of Treatment Substance |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US20140276771A1 (en) * | 2013-03-15 | 2014-09-18 | Volcano Corporation | Systems and methods for controlled tissue ablation |
AU2014233354B2 (en) | 2013-03-15 | 2017-01-12 | Medtronic Af Luxembourg S.A.R.L. | Controlled neuromodulation systems and methods of use |
US9066726B2 (en) | 2013-03-15 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode apposition judgment using pressure elements |
WO2014189794A1 (en) | 2013-05-18 | 2014-11-27 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US9814618B2 (en) | 2013-06-06 | 2017-11-14 | Boston Scientific Scimed, Inc. | Devices for delivering energy and related methods of use |
EP3708104A1 (en) | 2013-08-09 | 2020-09-16 | Boston Scientific Scimed, Inc. | Expandable catheter and related methods of manufacture and use |
JP2015037505A (en) * | 2013-08-19 | 2015-02-26 | テルモ株式会社 | Method for reducing lung capacity |
US9326816B2 (en) | 2013-08-30 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation systems having nerve monitoring assemblies and associated devices, systems, and methods |
US9339332B2 (en) | 2013-08-30 | 2016-05-17 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with nerve monitoring features for transmitting digital neural signals and associated systems and methods |
US20150073515A1 (en) | 2013-09-09 | 2015-03-12 | Medtronic Ardian Luxembourg S.a.r.I. | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
US9138578B2 (en) | 2013-09-10 | 2015-09-22 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular catheters with tuned control members and associated systems and methods |
US9782211B2 (en) | 2013-10-01 | 2017-10-10 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
WO2015113034A1 (en) | 2014-01-27 | 2015-07-30 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
EP3104768B1 (en) | 2014-02-11 | 2023-07-26 | Cyberonics, Inc. | Systems for detecting and treating obstructive sleep apnea |
US10492842B2 (en) | 2014-03-07 | 2019-12-03 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring and controlling internally administered cryotherapy |
US10463424B2 (en) | 2014-03-11 | 2019-11-05 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with independent radial-expansion members and associated devices, systems, and methods |
US9579149B2 (en) | 2014-03-13 | 2017-02-28 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
US9974597B2 (en) | 2014-03-19 | 2018-05-22 | Boston Scientific Scimed, Inc. | Systems and methods for assessing and treating tissue |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
WO2015153500A1 (en) * | 2014-03-31 | 2015-10-08 | Spiration, Inc. | Simulated valve device for airway |
CN106232043B (en) | 2014-04-24 | 2019-07-23 | 美敦力阿迪安卢森堡有限公司 | Nerve modulation conduit and relevant system and method with braiding axle |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
JP6594901B2 (en) | 2014-05-12 | 2019-10-23 | バージニア テック インテレクチュアル プロパティース インコーポレイテッド | Selective modulation of intracellular effects of cells using pulsed electric fields |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
US11154712B2 (en) | 2014-08-28 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for assessing efficacy of renal neuromodulation and associated systems and devices |
EP3791817B1 (en) | 2014-10-01 | 2024-05-22 | Medtronic Ardian Luxembourg S.à.r.l. | Systems for evaluating neuromodulation therapy via hemodynamic responses |
US10136938B2 (en) | 2014-10-29 | 2018-11-27 | Ethicon Llc | Electrosurgical instrument with sensor |
WO2016075536A2 (en) | 2014-11-14 | 2016-05-19 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for modulation of nerves in communication with the pulmonary system and associated systems and methods |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
WO2016100325A1 (en) | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10667736B2 (en) | 2014-12-17 | 2020-06-02 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing sympathetic nervous system tone for neuromodulation therapy |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
KR101644072B1 (en) * | 2016-01-21 | 2016-08-01 | 부경대학교 산학협력단 | Apparatus for translumenal circumferential energy delivery |
US10980737B1 (en) | 2016-03-08 | 2021-04-20 | Samuel Victor Lichtenstein | System for treating unwanted tissue using heat and heat activated drugs |
US10736692B2 (en) | 2016-04-28 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the treatment of cancer |
CN105997235A (en) * | 2016-05-06 | 2016-10-12 | 上海安臻医疗科技有限公司 | A bronchial thermoplasty system |
US10905329B2 (en) | 2016-06-09 | 2021-02-02 | Biosense Webster (Israel) Ltd. | Multi-function conducting elements for a catheter |
US10231784B2 (en) | 2016-10-28 | 2019-03-19 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics |
JP6671077B2 (en) * | 2016-11-10 | 2020-03-25 | 日本ライフライン株式会社 | Electrode catheter for lung cancer treatment |
US10646713B2 (en) | 2017-02-22 | 2020-05-12 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for treating patients via renal neuromodulation to reduce a risk of developing cognitive impairment |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
US11344356B2 (en) | 2018-02-28 | 2022-05-31 | Medtronic Cryocath Lp | Apparatus and method for targeted bronchial denervation by cryo-ablation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
JP2020018606A (en) * | 2018-08-01 | 2020-02-06 | テルモ株式会社 | Medical device |
US11944388B2 (en) | 2018-09-28 | 2024-04-02 | Covidien Lp | Systems and methods for magnetic interference correction |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
US11007001B1 (en) * | 2020-04-07 | 2021-05-18 | Sonivie Ltd. | Devices and methods for reducing parasympathetic nerve activity in patients with a respiratory syndrome |
CN111772773B (en) * | 2020-06-23 | 2021-11-30 | 广州启骏生物科技有限公司 | Ablation catheter for pulmonary artery stimulation |
US11666370B2 (en) | 2020-07-27 | 2023-06-06 | Medtronic, Inc. | Apparatus and method for targeted temporary bronchial nerve modulation by cryo-ablation for prevention and treatment of acute respiratory distress syndromes |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5957919A (en) * | 1997-07-02 | 1999-09-28 | Laufer; Michael D. | Bleb reducer |
US6083255A (en) * | 1997-04-07 | 2000-07-04 | Broncus Technologies, Inc. | Bronchial stenter |
US6493589B1 (en) * | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
US6634363B1 (en) * | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US8088127B2 (en) * | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8632534B2 (en) * | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
US8944071B2 (en) * | 1997-04-07 | 2015-02-03 | Asthmatx, Inc. | Method for treating an asthma attack |
Family Cites Families (505)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US612724A (en) | 1898-10-18 | Bert j | ||
US1155169A (en) | 1914-11-28 | 1915-09-28 | John Starkweather | Surgical instrument. |
US1207479A (en) | 1915-03-05 | 1916-12-05 | Holger Bisgaard | Self-retaining gatheter. |
US1216183A (en) | 1916-09-18 | 1917-02-13 | Charles M Swingle | Electrotherapeutic rejuvenator. |
US2072348A (en) | 1934-03-05 | 1937-03-02 | Hercules Powder Co Ltd | Chlorinated trialkyl amines and method of producing |
US2072346A (en) | 1934-10-04 | 1937-03-02 | Ward R Smith | Drainage tube |
US3320957A (en) | 1964-05-21 | 1967-05-23 | Sokolik Edward | Surgical instrument |
US3568659A (en) | 1968-09-24 | 1971-03-09 | James N Karnegis | Disposable percutaneous intracardiac pump and method of pumping blood |
US3667476A (en) | 1970-04-27 | 1972-06-06 | Bio Data Corp | Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature |
US3692029A (en) | 1971-05-03 | 1972-09-19 | Edwin Lloyd Adair | Retention catheter and suprapubic shunt |
US3995617A (en) | 1972-05-31 | 1976-12-07 | Watkins David H | Heart assist method and catheter |
SU545358A1 (en) | 1974-07-11 | 1977-02-05 | Предприятие П/Я В-2481 | Circulatory Support Device |
US4095602A (en) | 1976-09-27 | 1978-06-20 | Leveen Harry H | Multi-portal radiofrequency generator |
US4129129A (en) | 1977-03-18 | 1978-12-12 | Sarns, Inc. | Venous return catheter and a method of using the same |
US4116589A (en) | 1977-04-15 | 1978-09-26 | Avco Corporation | Extracorporeal pulsatile blood pump comprised of side by side bladders |
US4154246A (en) | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4557272A (en) | 1980-03-31 | 1985-12-10 | Microwave Associates, Inc. | Microwave endoscope detection and treatment system |
US4565200A (en) | 1980-09-24 | 1986-01-21 | Cosman Eric R | Universal lesion and recording electrode system |
US4502490A (en) | 1980-10-28 | 1985-03-05 | Antec Systems Limited | Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions |
JPS57168656A (en) | 1981-04-10 | 1982-10-18 | Medos Kenkyusho Kk | Endoscope laser coagulator |
US4706688A (en) | 1981-05-18 | 1987-11-17 | Don Michael T Anthony | Non-invasive cardiac device |
US4612934A (en) | 1981-06-30 | 1986-09-23 | Borkan William N | Non-invasive multiprogrammable tissue stimulator |
US4584998A (en) | 1981-09-11 | 1986-04-29 | Mallinckrodt, Inc. | Multi-purpose tracheal tube |
JPS5883966A (en) | 1981-11-13 | 1983-05-19 | テルモ株式会社 | Blood circuit for membrane type artificial lung |
DE3247793C2 (en) | 1981-12-31 | 1986-01-09 | Harald 7200 Tuttlingen Maslanka | High frequency surgical loop electrode |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4512762A (en) | 1982-11-23 | 1985-04-23 | The Beth Israel Hospital Association | Method of treatment of atherosclerosis and a balloon catheter for same |
US4773899A (en) | 1982-11-23 | 1988-09-27 | The Beth Israel Hospital Association | Method of treatment of artherosclerosis and balloon catheter the same |
US4567882A (en) | 1982-12-06 | 1986-02-04 | Vanderbilt University | Method for locating the illuminated tip of an endotracheal tube |
US4784135A (en) | 1982-12-09 | 1988-11-15 | International Business Machines Corporation | Far ultraviolet surgical and dental procedures |
JPS59167707A (en) | 1983-03-14 | 1984-09-21 | Toshiba Corp | Sample value controller |
JPS59167707U (en) | 1983-04-26 | 1984-11-09 | 石川島芝浦機械株式会社 | Tractor swing drawbar device |
US4646737A (en) | 1983-06-13 | 1987-03-03 | Laserscope, Inc. | Localized heat applying medical device |
US4625712A (en) | 1983-09-28 | 1986-12-02 | Nimbus, Inc. | High-capacity intravascular blood pump utilizing percutaneous access |
US4704121A (en) | 1983-09-28 | 1987-11-03 | Nimbus, Inc. | Anti-thrombogenic blood pump |
US4522212A (en) | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
FR2561929B1 (en) | 1984-03-27 | 1989-02-03 | Atesys | IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION |
US4621882A (en) | 1984-05-14 | 1986-11-11 | Beta Phase, Inc. | Thermally responsive electrical connector |
JPS6148350A (en) | 1984-08-15 | 1986-03-10 | オリンパス光学工業株式会社 | Medical laser apparatus |
US4799479A (en) | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US4772112A (en) | 1984-11-30 | 1988-09-20 | Cvi/Beta Ventures, Inc. | Eyeglass frame including shape-memory elements |
US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
EP0189329A3 (en) | 1985-01-25 | 1987-06-03 | Robert E. Fischell | A tunneling catheter system for transluminal arterial angioplasty |
GB2171309B (en) | 1985-02-26 | 1988-11-02 | North China Res I Electro Opti | Microwave therapeutic apparatus |
US4739759A (en) | 1985-02-26 | 1988-04-26 | Concept, Inc. | Microprocessor controlled electrosurgical generator |
US4862886A (en) | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
US4976709A (en) | 1988-12-15 | 1990-12-11 | Sand Bruce J | Method for collagen treatment |
US4643186A (en) | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US4683890A (en) | 1985-12-23 | 1987-08-04 | Brunswick Manufacturing Co., Inc. | Method and apparatus for controlled breathing employing internal and external electrodes |
US4827935A (en) | 1986-04-24 | 1989-05-09 | Purdue Research Foundation | Demand electroventilator |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4790305A (en) | 1986-06-23 | 1988-12-13 | The Johns Hopkins University | Medication delivery system |
US4754752A (en) | 1986-07-28 | 1988-07-05 | Robert Ginsburg | Vascular catheter |
US5215103A (en) | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US5027829A (en) | 1986-12-15 | 1991-07-02 | Larsen Lawrence E | Apparatus for diathermy treatment and control |
GB8704104D0 (en) | 1987-02-21 | 1987-03-25 | Manitoba University Of | Respiratory system load apparatus |
IT1203503B (en) | 1987-02-25 | 1989-02-15 | Cardiosistemi Spa | VENOUS DRAINAGE CANNULA |
GB8705451D0 (en) | 1987-03-09 | 1987-04-15 | Driver Southall | Combinational weighing systems |
US4802492A (en) | 1987-03-11 | 1989-02-07 | National Jewish Center For Immunology And Respiratory Medicine | Method for determining respiratory function |
US4779614A (en) | 1987-04-09 | 1988-10-25 | Nimbus Medical, Inc. | Magnetically suspended rotor axial flow blood pump |
MC1921A1 (en) | 1987-04-10 | 1989-04-06 | Sankei Yakuhin Kk | ACYL DERIVATIVES |
US5849026A (en) * | 1987-05-20 | 1998-12-15 | Zhou; Lin | Physiotherapy method |
JPS6446056U (en) | 1987-09-17 | 1989-03-22 | ||
US4846152A (en) | 1987-11-24 | 1989-07-11 | Nimbus Medical, Inc. | Single-stage axial flow blood pump |
US4817586A (en) | 1987-11-24 | 1989-04-04 | Nimbus Medical, Inc. | Percutaneous bloom pump with mixed-flow output |
US4895557A (en) | 1987-12-07 | 1990-01-23 | Nimbus Medical, Inc. | Drive mechanism for powering intravascular blood pumps |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US4907589A (en) | 1988-04-29 | 1990-03-13 | Cosman Eric R | Automatic over-temperature control apparatus for a therapeutic heating device |
US4906229A (en) | 1988-05-03 | 1990-03-06 | Nimbus Medical, Inc. | High-frequency transvalvular axisymmetric blood pump |
US5010892A (en) | 1988-05-04 | 1991-04-30 | Triangle Research And Development Corp. | Body lumen measuring instrument |
WO1989011311A1 (en) | 1988-05-18 | 1989-11-30 | Kasevich Associates, Inc. | Microwave balloon angioplasty |
DE3821544C2 (en) | 1988-06-25 | 1994-04-28 | H Prof Dr Med Just | Dilatation catheter |
US4967765A (en) | 1988-07-28 | 1990-11-06 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US4908012A (en) | 1988-08-08 | 1990-03-13 | Nimbus Medical, Inc. | Chronic ventricular assist system |
US4920978A (en) | 1988-08-31 | 1990-05-01 | Triangle Research And Development Corporation | Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia |
JP2686982B2 (en) | 1988-09-02 | 1997-12-08 | 日産自動車株式会社 | Method for forming clear coating film |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US5191883A (en) | 1988-10-28 | 1993-03-09 | Prutech Research And Development Partnership Ii | Device for heating tissue in a patient's body |
US4945912A (en) | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US4969865A (en) | 1989-01-09 | 1990-11-13 | American Biomed, Inc. | Helifoil pump |
US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US4944722A (en) | 1989-02-23 | 1990-07-31 | Nimbus Medical, Inc. | Percutaneous axial flow blood pump |
US5433730A (en) | 1989-05-03 | 1995-07-18 | Intermedics, Inc. | Conductive pouch electrode for defibrillation |
US5152286A (en) * | 1989-05-08 | 1992-10-06 | Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" | Method of microwave resonance therapy and device therefor |
US5114423A (en) | 1989-05-15 | 1992-05-19 | Advanced Cardiovascular Systems, Inc. | Dilatation catheter assembly with heated balloon |
US5074860A (en) | 1989-06-09 | 1991-12-24 | Heraeus Lasersonics, Inc. | Apparatus for directing 10.6 micron laser radiation to a tissue site |
DE3920862A1 (en) | 1989-06-26 | 1991-01-03 | Teves Gmbh Alfred | AUXILIARY STEERING FOR MOTOR VEHICLES |
US4985014A (en) | 1989-07-11 | 1991-01-15 | Orejola Wilmo C | Ventricular venting loop |
US5084044A (en) | 1989-07-14 | 1992-01-28 | Ciron Corporation | Apparatus for endometrial ablation and method of using same |
US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
JP2935519B2 (en) * | 1989-08-28 | 1999-08-16 | シーキンス,ケイ・マイケル | Lung cancer hyperthermia treatment via convection with ultrasound and / or perfluorocarbon liquid |
US5562608A (en) * | 1989-08-28 | 1996-10-08 | Biopulmonics, Inc. | Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation |
US5057105A (en) | 1989-08-28 | 1991-10-15 | The University Of Kansas Med Center | Hot tip catheter assembly |
WO1991003207A1 (en) | 1989-09-08 | 1991-03-21 | Boston Scientific Corporation | Physiologic low stress angioplasty |
US5167223A (en) | 1989-09-08 | 1992-12-01 | Tibor Koros | Heart valve retractor and sternum spreader surgical instrument |
US5100388A (en) | 1989-09-15 | 1992-03-31 | Interventional Thermodynamics, Inc. | Method and device for thermal ablation of hollow body organs |
US5117828A (en) | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
US5036848A (en) | 1989-10-16 | 1991-08-06 | Brunswick Biomedical Technologies, Inc. | Method and apparatus for controlling breathing employing internal and external electrodes |
US4991603A (en) | 1989-10-30 | 1991-02-12 | Siemens-Pacesetter, Inc. | Transvenously placed defibrillation leads via an inferior vena cava access site and method of use |
US5203832A (en) | 1989-11-17 | 1993-04-20 | Long Manufacturing Ltd. | Circumferential flow heat exchanger |
US5009636A (en) | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5254088A (en) | 1990-02-02 | 1993-10-19 | Ep Technologies, Inc. | Catheter steering mechanism |
ES2071207T3 (en) | 1990-02-08 | 1995-06-16 | Howmedica | INFLATABLE DILATOR. |
FR2659240B1 (en) | 1990-03-06 | 1997-07-04 | Daniel Galley | EPIDURAL ELECTRODE SYSTEM CALLED TO BE INTRODUCED INTO THE EPIDURAL SPACE. |
US5549559A (en) | 1990-03-22 | 1996-08-27 | Argomed Ltd. | Thermal treatment apparatus |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5096916A (en) | 1990-05-07 | 1992-03-17 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
US5078716A (en) | 1990-05-11 | 1992-01-07 | Doll Larry F | Electrosurgical apparatus for resecting abnormal protruding growth |
US5265604A (en) | 1990-05-14 | 1993-11-30 | Vince Dennis J | Demand - diaphragmatic pacing (skeletal muscle pressure modified) |
US5056519A (en) | 1990-05-14 | 1991-10-15 | Vince Dennis J | Unilateral diaphragmatic pacer |
US5360443A (en) | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
SE500550C2 (en) | 1990-06-18 | 1994-07-11 | Siemens Elema Ab | Methods and apparatus for reducing gas re-breathing from the harmful space |
US5103804A (en) | 1990-07-03 | 1992-04-14 | Boston Scientific Corporation | Expandable tip hemostatic probes and the like |
US5188602A (en) | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5135517A (en) | 1990-07-19 | 1992-08-04 | Catheter Research, Inc. | Expandable tube-positioning apparatus |
US5100423A (en) | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
AU664157B2 (en) | 1990-09-14 | 1995-11-09 | American Medical Systems, Inc. | Combined hyperthermia and dilation catheter |
US5170803A (en) | 1990-09-28 | 1992-12-15 | Brunswick Biomedical Technologies, Inc. | Esophageal displacement electrode |
US5053033A (en) | 1990-10-10 | 1991-10-01 | Boston Advanced Technologies, Inc. | Inhibition of restenosis by ultraviolet radiation |
US5030645A (en) | 1990-10-15 | 1991-07-09 | Merck & Co., Inc. | Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof |
US5105826A (en) | 1990-10-26 | 1992-04-21 | Medtronic, Inc. | Implantable defibrillation electrode and method of manufacture |
US5174288A (en) | 1990-11-30 | 1992-12-29 | Medtronic, Inc. | Method and apparatus for cardiac defibrillation |
US5165420A (en) | 1990-12-21 | 1992-11-24 | Ballard Medical Products | Bronchoalveolar lavage catheter |
US5324255A (en) | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
US5409453A (en) | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5415166A (en) | 1991-02-15 | 1995-05-16 | Cardiac Pathways Corporation | Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method |
US5345936A (en) | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
RU2091054C1 (en) * | 1991-03-25 | 1997-09-27 | Владивостокский государственный медицинский университет | Method for treating asthmatic bronchitis in children affected with constitutional diathesis |
US5116864A (en) | 1991-04-09 | 1992-05-26 | Indiana University Foundation | Method for preventing restenosis following reconfiguration of body vessels |
JPH06507097A (en) | 1991-04-10 | 1994-08-11 | ビーティージー・インターナショナル・インコーポレーテッド | Defibrillator, temporary pacer catheter, and its implantation method |
US5213576A (en) | 1991-06-11 | 1993-05-25 | Cordis Corporation | Therapeutic porous balloon catheter |
US5255678A (en) | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
JPH0522345A (en) | 1991-07-12 | 1993-01-29 | Hitachi Ltd | Optimum management decision system for maximum transfer unit |
US5520682A (en) * | 1991-09-06 | 1996-05-28 | Cryomedical Sciences, Inc. | Cryosurgical instrument with vent means and method using same |
JPH05121329A (en) | 1991-10-30 | 1993-05-18 | Toshiba Corp | Method and apparatus for manufacturing compound thin film |
US6159194A (en) | 1992-01-07 | 2000-12-12 | Arthrocare Corporation | System and method for electrosurgical tissue contraction |
US5366443A (en) | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
US6053172A (en) | 1995-06-07 | 2000-04-25 | Arthrocare Corporation | Systems and methods for electrosurgical sinus surgery |
US5231996A (en) | 1992-01-28 | 1993-08-03 | Medtronic, Inc. | Removable endocardial lead |
RU2053814C1 (en) * | 1992-02-11 | 1996-02-10 | Новиков Валерий Николаевич | Method for treatment of local endobronchitis |
US5555883A (en) | 1992-02-24 | 1996-09-17 | Avitall; Boaz | Loop electrode array mapping and ablation catheter for cardiac chambers |
US5540681A (en) | 1992-04-10 | 1996-07-30 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of tissue |
US5269758A (en) | 1992-04-29 | 1993-12-14 | Taheri Syde A | Intravascular catheter and method for treatment of hypothermia |
US5443470A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
US5255679A (en) | 1992-06-02 | 1993-10-26 | Cardiac Pathways Corporation | Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method |
US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
US5782239A (en) | 1992-06-30 | 1998-07-21 | Cordis Webster, Inc. | Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire |
US5772590A (en) | 1992-06-30 | 1998-06-30 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire |
US5411025A (en) | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
AU4686993A (en) | 1992-07-30 | 1994-03-03 | Temple University - Of The Commonwealth System Of Higher Education | Direct manual cardiac compression device and method of use thereof |
US5630794A (en) | 1992-08-12 | 1997-05-20 | Vidamed, Inc. | Catheter tip and method of manufacturing |
GB9219102D0 (en) | 1992-09-09 | 1992-10-21 | Fairfax Andrew J | Flowmeters |
US5293869A (en) | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
US5309910A (en) | 1992-09-25 | 1994-05-10 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US6086581A (en) | 1992-09-29 | 2000-07-11 | Ep Technologies, Inc. | Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart |
US5471982A (en) | 1992-09-29 | 1995-12-05 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
AU5295493A (en) | 1992-10-01 | 1994-04-26 | Cardiac Pacemakers, Inc. | Stent-type defibrillation electrode structures |
US5431696A (en) | 1992-10-13 | 1995-07-11 | Atlee, Iii; John L. | Esophageal probe for transeophageal cardiac stimulation |
US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
US5393207A (en) | 1993-01-21 | 1995-02-28 | Nimbus, Inc. | Blood pump with disposable rotor assembly |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5893847A (en) | 1993-03-16 | 1999-04-13 | Ep Technologies, Inc. | Multiple electrode support structures with slotted hub and hoop spline elements |
US5823189A (en) | 1993-03-16 | 1998-10-20 | Ep Technologies, Inc. | Multiple electrode support structures with spline elements and over-molded hub |
CA2158453C (en) | 1993-03-16 | 1999-11-16 | Thomas F. Kordis | Multiple electrode support structures |
US5725525A (en) | 1993-03-16 | 1998-03-10 | Ep Technologies, Inc. | Multiple electrode support structures with integral hub and spline elements |
WO1994021170A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Flexible circuit assemblies employing ribbon cable |
US5417687A (en) | 1993-04-30 | 1995-05-23 | Medical Scientific, Inc. | Bipolar electrosurgical trocar |
US6749604B1 (en) | 1993-05-10 | 2004-06-15 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5860974A (en) | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
US5571088A (en) | 1993-07-01 | 1996-11-05 | Boston Scientific Corporation | Ablation catheters |
EP0706345B1 (en) | 1993-07-01 | 2003-02-19 | Boston Scientific Limited | Imaging, electrical potential sensing, and ablation catheters |
GB9314640D0 (en) | 1993-07-15 | 1993-08-25 | Salim Aws S M | Tunnellimg catheter |
US5422362A (en) | 1993-07-29 | 1995-06-06 | Quadra Logic Technologies, Inc. | Method to inhibit restenosis |
US5507791A (en) | 1993-08-31 | 1996-04-16 | Sit'ko; Sergei P. | Microwave resonance therapy |
US5490521A (en) | 1993-08-31 | 1996-02-13 | Medtronic, Inc. | Ultrasound biopsy needle |
US5396887A (en) | 1993-09-23 | 1995-03-14 | Cardiac Pathways Corporation | Apparatus and method for detecting contact pressure |
US5626618A (en) | 1993-09-24 | 1997-05-06 | The Ohio State University | Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring |
US5607462A (en) | 1993-09-24 | 1997-03-04 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-catheter introducer for use therewith |
US5908446A (en) | 1994-07-07 | 1999-06-01 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-port introducer for use therewith |
US5415656A (en) | 1993-09-28 | 1995-05-16 | American Medical Systems, Inc. | Electrosurgical apparatus |
US5496312A (en) | 1993-10-07 | 1996-03-05 | Valleylab Inc. | Impedance and temperature generator control |
US5437665A (en) | 1993-10-12 | 1995-08-01 | Munro; Malcolm G. | Electrosurgical loop electrode instrument for laparoscopic surgery |
US5400783A (en) | 1993-10-12 | 1995-03-28 | Cardiac Pathways Corporation | Endocardial mapping apparatus with rotatable arm and method |
US5881727A (en) | 1993-10-14 | 1999-03-16 | Ep Technologies, Inc. | Integrated cardiac mapping and ablation probe |
US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
US5991650A (en) | 1993-10-15 | 1999-11-23 | Ep Technologies, Inc. | Surface coatings for catheters, direct contacting diagnostic and therapeutic devices |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
US6641580B1 (en) | 1993-11-08 | 2003-11-04 | Rita Medical Systems, Inc. | Infusion array ablation apparatus |
US6071280A (en) | 1993-11-08 | 2000-06-06 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus |
US5599346A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment system |
US5536267A (en) | 1993-11-08 | 1996-07-16 | Zomed International | Multiple electrode ablation apparatus |
US5487385A (en) | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
US5641326A (en) | 1993-12-13 | 1997-06-24 | Angeion Corporation | Method and apparatus for independent atrial and ventricular defibrillation |
US5423812A (en) * | 1994-01-31 | 1995-06-13 | Ellman; Alan G. | Electrosurgical stripping electrode for palatopharynx tissue |
AUPM411494A0 (en) | 1994-02-25 | 1994-03-24 | Central Sydney Area Health Service | Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum |
US6216043B1 (en) | 1994-03-04 | 2001-04-10 | Ep Technologies, Inc. | Asymmetric multiple electrode support structures |
US5394880A (en) | 1994-03-17 | 1995-03-07 | Atlee, Iii; John L. | Esophageal stethoscope |
US5598848A (en) | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
JPH07289557A (en) | 1994-04-25 | 1995-11-07 | Inter Noba Kk | Heating treatment method of constricted part of blood vessel and local heating type catheter therefor |
CA2189004A1 (en) | 1994-04-29 | 1995-11-09 | Charles D. Lennox | Resecting coagulated tissue |
US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US6152143A (en) | 1994-05-09 | 2000-11-28 | Somnus Medical Technologies, Inc. | Method for treatment of air way obstructions |
US5807308A (en) * | 1996-02-23 | 1998-09-15 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
US5547469A (en) | 1994-05-13 | 1996-08-20 | Boston Scientific Corporation | Apparatus for performing diagnostic and therapeutic modalities in the biliary tree |
US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5836905A (en) | 1994-06-20 | 1998-11-17 | Lemelson; Jerome H. | Apparatus and methods for gene therapy |
US5827277A (en) | 1994-06-24 | 1998-10-27 | Somnus Medical Technologies, Inc. | Minimally invasive apparatus for internal ablation of turbinates |
US6006755A (en) | 1994-06-24 | 1999-12-28 | Edwards; Stuart D. | Method to detect and treat aberrant myoelectric activity |
US6009877A (en) | 1994-06-24 | 2000-01-04 | Edwards; Stuart D. | Method for treating a sphincter |
US6056744A (en) | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5681308A (en) | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US6092528A (en) | 1994-06-24 | 2000-07-25 | Edwards; Stuart D. | Method to treat esophageal sphincters |
US5843077A (en) | 1994-06-24 | 1998-12-01 | Somnus Medical Technologies, Inc. | Minimally invasive apparatus for internal ablation of turbinates with surface cooling |
US5735846A (en) | 1994-06-27 | 1998-04-07 | Ep Technologies, Inc. | Systems and methods for ablating body tissue using predicted maximum tissue temperature |
JP3682066B2 (en) | 1994-06-27 | 2005-08-10 | ボストン サイエンティフィック リミテッド | Nonlinear control system and method for thermal ablation of human tissue |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
DE4427106A1 (en) | 1994-07-30 | 1996-02-01 | Otto Werner Woelky | Process for control of tumours and skin cancer |
US5623940A (en) | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
US5454782A (en) | 1994-08-11 | 1995-10-03 | Perkins; Rodney C. | Translumenal circumferential energy delivery device |
US5522862A (en) | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
US5549655A (en) | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US5836947A (en) | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
ATE250394T1 (en) | 1994-10-07 | 2003-10-15 | Boston Scient Ltd | FLEXIBLE ELECTRODE STRUCTURE |
US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
US6142994A (en) | 1994-10-07 | 2000-11-07 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body |
US5740808A (en) | 1996-10-28 | 1998-04-21 | Ep Technologies, Inc | Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions |
US5722401A (en) | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
US5899882A (en) | 1994-10-27 | 1999-05-04 | Novoste Corporation | Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient |
AU4252596A (en) | 1994-12-13 | 1996-07-03 | Torben Lorentzen | An electrosurgical instrument for tissue ablation, an apparatus, and a method for providing a lesion in damaged and diseased tissue from a mammal |
US5707336A (en) | 1995-01-09 | 1998-01-13 | Cardassist Incorporated | Ventricular assist device |
IT1277790B1 (en) | 1995-02-17 | 1997-11-12 | Tecres Spa | METACARPO-FALANGEA AND INTERPHALANGE PROSTHESES FOR HAND OR FOOT JOINTS |
US5595183A (en) | 1995-02-17 | 1997-01-21 | Ep Technologies, Inc. | Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes |
US5605157A (en) | 1995-02-17 | 1997-02-25 | Ep Technologies, Inc. | Systems and methods for filtering signals derived from biological events |
US5722416A (en) | 1995-02-17 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites |
US5792064A (en) | 1995-02-17 | 1998-08-11 | Panescu; Dorin | Systems and methods for analyzing cardiac biopotential morphologies by cross-correlation |
US5711305A (en) | 1995-02-17 | 1998-01-27 | Ep Technologies, Inc. | Systems and methods for acquiring endocardially or epicardially paced electrocardiograms |
US5630425A (en) | 1995-02-17 | 1997-05-20 | Ep Technologies, Inc. | Systems and methods for adaptive filtering artifacts from composite signals |
CA2213133C (en) | 1995-02-17 | 2003-06-17 | Ep Technologies, Inc. | Systems and methods for making time-sequential measurements of biological events |
US5601088A (en) | 1995-02-17 | 1997-02-11 | Ep Technologies, Inc. | Systems and methods for filtering artifacts from composite signals |
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
JP4408958B2 (en) | 1995-02-28 | 2010-02-03 | ボストン サイエンティフィック コーポレーション | Medical instruments |
US6106524A (en) | 1995-03-03 | 2000-08-22 | Neothermia Corporation | Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue |
US5868740A (en) | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
US5707218A (en) | 1995-04-19 | 1998-01-13 | Nimbus, Inc. | Implantable electric axial-flow blood pump with blood cooled bearing |
US5588812A (en) | 1995-04-19 | 1996-12-31 | Nimbus, Inc. | Implantable electric axial-flow blood pump |
US5620438A (en) | 1995-04-20 | 1997-04-15 | Angiomedics Ii Incorporated | Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis |
US5678535A (en) | 1995-04-21 | 1997-10-21 | Dimarco; Anthony Fortunato | Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient |
US5607419A (en) | 1995-04-24 | 1997-03-04 | Angiomedics Ii Inc. | Method and apparatus for treating vessel wall with UV radiation following angioplasty |
ATE189964T1 (en) | 1995-04-28 | 2000-03-15 | Target Therapeutics Inc | HIGH PERFORMANCE CATHETER WITH BRAIDED ELEMENT |
US5688267A (en) | 1995-05-01 | 1997-11-18 | Ep Technologies, Inc. | Systems and methods for sensing multiple temperature conditions during tissue ablation |
US5681280A (en) | 1995-05-02 | 1997-10-28 | Heart Rhythm Technologies, Inc. | Catheter control system |
US6575969B1 (en) | 1995-05-04 | 2003-06-10 | Sherwood Services Ag | Cool-tip radiofrequency thermosurgery electrode system for tumor ablation |
US5755753A (en) | 1995-05-05 | 1998-05-26 | Thermage, Inc. | Method for controlled contraction of collagen tissue |
US5817073A (en) | 1995-06-02 | 1998-10-06 | Krespi; Yosef P. | Apparatus for administering local anesthetics and therapeutic medications during endoscopic surgery |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
US5741248A (en) | 1995-06-07 | 1998-04-21 | Temple University-Of The Commonwealth System Of Higher Education | Fluorochemical liquid augmented cryosurgery |
US6837888B2 (en) | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
US5697925A (en) | 1995-06-09 | 1997-12-16 | Engineering & Research Associates, Inc. | Apparatus and method for thermal ablation |
US5868737A (en) | 1995-06-09 | 1999-02-09 | Engineering Research & Associates, Inc. | Apparatus and method for determining ablation |
JPH0947518A (en) | 1995-06-26 | 1997-02-18 | Lederle Japan Ltd | Optical fiber laser probe for photodynamic therapy |
US5873852A (en) | 1995-07-10 | 1999-02-23 | Interventional Technologies | Device for injecting fluid into a wall of a blood vessel |
US6008211A (en) | 1995-07-27 | 1999-12-28 | Pdt Pharmaceuticals, Inc. | Photoactivatable compounds comprising benzochlorin and furocoumarin |
WO1997004702A1 (en) | 1995-07-28 | 1997-02-13 | Ep Technologies, Inc. | Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue |
US6023638A (en) | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
US5782827A (en) | 1995-08-15 | 1998-07-21 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with multiple sensor feedback |
US5624439A (en) | 1995-08-18 | 1997-04-29 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
US5660175A (en) | 1995-08-21 | 1997-08-26 | Dayal; Bimal | Endotracheal device |
ZA967182B (en) | 1995-08-24 | 1998-05-25 | Magainin Pharma | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders. |
US6210367B1 (en) | 1995-09-06 | 2001-04-03 | Microwave Medical Systems, Inc. | Intracorporeal microwave warming method and apparatus |
US6496738B2 (en) | 1995-09-06 | 2002-12-17 | Kenneth L. Carr | Dual frequency microwave heating apparatus |
US5848972A (en) | 1995-09-15 | 1998-12-15 | Children's Medical Center Corporation | Method for endocardial activation mapping using a multi-electrode catheter |
EP0768091B1 (en) | 1995-10-16 | 2003-07-30 | Sun Medical Technology Research Corporation | Artificial heart |
US5574059A (en) | 1995-10-27 | 1996-11-12 | Cornell Research Foundation, Inc. | Treating disorders mediated by vascular smooth muscle cell proliferation |
US6198970B1 (en) * | 1995-10-27 | 2001-03-06 | Esd Limited Liability Company | Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation |
US5837001A (en) | 1995-12-08 | 1998-11-17 | C. R. Bard | Radio frequency energy delivery system for multipolar electrode catheters |
US5891136A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Expandable-collapsible mesh electrode structures |
US5846238A (en) | 1996-01-19 | 1998-12-08 | Ep Technologies, Inc. | Expandable-collapsible electrode structures with distal end steering or manipulation |
US5891135A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures |
US5904711A (en) | 1996-02-08 | 1999-05-18 | Heartport, Inc. | Expandable thoracoscopic defibrillation catheter system and method |
US5695471A (en) | 1996-02-20 | 1997-12-09 | Kriton Medical, Inc. | Sealless rotary blood pump with passive magnetic radial bearings and blood immersed axial bearings |
US5727569A (en) | 1996-02-20 | 1998-03-17 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery |
US5730726A (en) | 1996-03-04 | 1998-03-24 | Klingenstein; Ralph James | Apparatus and method for removing fecal impaction |
US6152899A (en) | 1996-03-05 | 2000-11-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
US6033397A (en) | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
US6036687A (en) | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6139527A (en) | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
JP4060887B2 (en) * | 1996-03-05 | 2008-03-12 | ヴィナス メディカル テクノロジーズ インコーポレイテッド | Vascular catheter utilization system for heating tissue |
US5755760A (en) | 1996-03-11 | 1998-05-26 | Medtronic, Inc. | Deflectable catheter |
NL1002598C2 (en) | 1996-03-13 | 1997-09-17 | Bootsman Holding Bv | Method and device for processing substrate. |
JPH09243837A (en) | 1996-03-14 | 1997-09-19 | Hitachi Cable Ltd | Laser waveguide |
US6458121B1 (en) | 1996-03-19 | 2002-10-01 | Diapulse Corporation Of America | Apparatus for athermapeutic medical treatments |
US5699799A (en) | 1996-03-26 | 1997-12-23 | Siemens Corporate Research, Inc. | Automatic determination of the curved axis of a 3-D tube-shaped object in image volume |
US5863291A (en) | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
US5694934A (en) | 1996-04-17 | 1997-12-09 | Beth Israel Hospital | MR studies in which a paramagnetic gas is administered to a living patient |
US5979456A (en) | 1996-04-22 | 1999-11-09 | Magovern; George J. | Apparatus and method for reversibly reshaping a body part |
US6036640A (en) | 1996-04-29 | 2000-03-14 | Medtronic, Inc. | Device and method for repositioning the heart during surgery |
AUPN957296A0 (en) | 1996-04-30 | 1996-05-23 | Cardiac Crc Nominees Pty Limited | A system for simultaneous unipolar multi-electrode ablation |
US5810807A (en) | 1996-05-22 | 1998-09-22 | Ganz; Robert A. | Sphincterotome with deflectable cutting plane and method of using the same |
US5976709A (en) | 1996-05-31 | 1999-11-02 | Hitachi Kinzoku Kabushiki Kaisha | Aluminum alloy member, with insert provided therein, possessing improved damping capacity and process for producing the same |
US5782797A (en) | 1996-06-06 | 1998-07-21 | Scimed Life Systems, Inc. | Therapeutic infusion device |
US6743197B1 (en) | 1996-07-10 | 2004-06-01 | Novasys Medical, Inc. | Treatment of discrete tissues in respiratory, urinary, circulatory, reproductive and digestive systems |
JPH1026709A (en) | 1996-07-11 | 1998-01-27 | Harufumi Kato | Device for laterally irradiating with laser beam |
US5882346A (en) | 1996-07-15 | 1999-03-16 | Cardiac Pathways Corporation | Shapable catheter using exchangeable core and method of use |
US5919172A (en) | 1996-07-17 | 1999-07-06 | Becton, Dickinson And Company | Hypodermic needle having a differential surface finish |
US5755714A (en) | 1996-09-17 | 1998-05-26 | Eclipse Surgical Technologies, Inc. | Shaped catheter for transmyocardial revascularization |
US5855577A (en) | 1996-09-17 | 1999-01-05 | Eclipse Surgical Technologies, Inc. | Bow shaped catheter |
US5906636A (en) | 1996-09-20 | 1999-05-25 | Texas Heart Institute | Heat treatment of inflamed tissue |
US6464697B1 (en) | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
US6016437A (en) | 1996-10-21 | 2000-01-18 | Irvine Biomedical, Inc. | Catheter probe system with inflatable soft shafts |
JP4162716B2 (en) | 1996-10-23 | 2008-10-08 | Tdk株式会社 | Method for manufacturing battery electrode |
US5779669A (en) | 1996-10-28 | 1998-07-14 | C. R. Bard, Inc. | Steerable catheter with fixed curve |
US5752518A (en) | 1996-10-28 | 1998-05-19 | Ep Technologies, Inc. | Systems and methods for visualizing interior regions of the body |
US5848969A (en) | 1996-10-28 | 1998-12-15 | Ep Technologies, Inc. | Systems and methods for visualizing interior tissue regions using expandable imaging structures |
US5904651A (en) | 1996-10-28 | 1999-05-18 | Ep Technologies, Inc. | Systems and methods for visualizing tissue during diagnostic or therapeutic procedures |
US5908445A (en) | 1996-10-28 | 1999-06-01 | Ep Technologies, Inc. | Systems for visualizing interior tissue regions including an actuator to move imaging element |
US5722403A (en) | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US5919147A (en) | 1996-11-01 | 1999-07-06 | Jain; Krishna M. | Method and apparatus for measuring the vascular diameter of a vessel |
US5833651A (en) | 1996-11-08 | 1998-11-10 | Medtronic, Inc. | Therapeutic intraluminal stents |
US6073052A (en) | 1996-11-15 | 2000-06-06 | Zelickson; Brian D. | Device and method for treatment of gastroesophageal reflux disease |
US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
US6056769A (en) | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
US5999855A (en) | 1997-02-28 | 1999-12-07 | Dimarco; Anthony F. | Method and apparatus for electrical activation of the expiratory muscles to restore cough |
US5897554A (en) | 1997-03-01 | 1999-04-27 | Irvine Biomedical, Inc. | Steerable catheter having a loop electrode |
US6063078A (en) | 1997-03-12 | 2000-05-16 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US5954661A (en) | 1997-03-31 | 1999-09-21 | Thomas Jefferson University | Tissue characterization and treatment using pacing |
US6411852B1 (en) | 1997-04-07 | 2002-06-25 | Broncus Technologies, Inc. | Modification of airways by application of energy |
US6283988B1 (en) | 1997-04-07 | 2001-09-04 | Broncus Technologies, Inc. | Bronchial stenter having expandable electrodes |
US5972026A (en) * | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
US6488673B1 (en) | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
US6200333B1 (en) * | 1997-04-07 | 2001-03-13 | Broncus Technologies, Inc. | Bronchial stenter |
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US7425212B1 (en) * | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
US6273907B1 (en) * | 1997-04-07 | 2001-08-14 | Broncus Technologies, Inc. | Bronchial stenter |
US5876340A (en) | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6217576B1 (en) | 1997-05-19 | 2001-04-17 | Irvine Biomedical Inc. | Catheter probe for treating focal atrial fibrillation in pulmonary veins |
US6050992A (en) | 1997-05-19 | 2000-04-18 | Radiotherapeutics Corporation | Apparatus and method for treating tissue with multiple electrodes |
US7255693B1 (en) | 1997-05-23 | 2007-08-14 | Csa Medical, Inc. | Heated catheter used in cryotherapy |
US5876399A (en) | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
WO1998056324A1 (en) | 1997-06-13 | 1998-12-17 | Arthrocare Corporation | Electrosurgical systems and methods for recanalization of occluded body lumens |
US6251109B1 (en) | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6547788B1 (en) | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6139571A (en) | 1997-07-09 | 2000-10-31 | Fuller Research Corporation | Heated fluid surgical instrument |
US6014579A (en) | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US6010500A (en) | 1997-07-21 | 2000-01-04 | Cardiac Pathways Corporation | Telescoping apparatus and method for linear lesion ablation |
US6626903B2 (en) | 1997-07-24 | 2003-09-30 | Rex Medical, L.P. | Surgical biopsy device |
US5891138A (en) | 1997-08-11 | 1999-04-06 | Irvine Biomedical, Inc. | Catheter system having parallel electrodes |
US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US5964782A (en) | 1997-09-18 | 1999-10-12 | Scimed Life Systems, Inc. | Closure device and method |
US5954717A (en) | 1997-09-25 | 1999-09-21 | Radiotherapeutics Corporation | Method and system for heating solid tissue |
US6045549A (en) | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
EP0908713A1 (en) | 1997-10-06 | 1999-04-14 | Claud S. Gordon Company | Temperature instrumented semiconductor wafer |
US6645200B1 (en) | 1997-10-10 | 2003-11-11 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |
US5893835A (en) | 1997-10-10 | 1999-04-13 | Ethicon Endo-Surgery, Inc. | Ultrasonic clamp coagulator apparatus having dual rotational positioning |
US6071281A (en) | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
US6917834B2 (en) | 1997-12-03 | 2005-07-12 | Boston Scientific Scimed, Inc. | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates |
US7921855B2 (en) * | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US6200311B1 (en) | 1998-01-20 | 2001-03-13 | Eclipse Surgical Technologies, Inc. | Minimally invasive TMR device |
US6258087B1 (en) | 1998-02-19 | 2001-07-10 | Curon Medical, Inc. | Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
US6355031B1 (en) | 1998-02-19 | 2002-03-12 | Curon Medical, Inc. | Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter |
US6331166B1 (en) | 1998-03-03 | 2001-12-18 | Senorx, Inc. | Breast biopsy system and method |
US6142993A (en) | 1998-02-27 | 2000-11-07 | Ep Technologies, Inc. | Collapsible spline structure using a balloon as an expanding actuator |
AU3072499A (en) | 1998-03-09 | 1999-09-27 | Cardiofocus, Inc. | Thermal treatment device including expansion element |
EP1063931A2 (en) | 1998-03-19 | 2001-01-03 | Oratec Interventions, Inc. | Catheter for delivery of energy to a surgical site |
US6053909A (en) | 1998-03-27 | 2000-04-25 | Shadduck; John H. | Ionothermal delivery system and technique for medical procedures |
US6338727B1 (en) | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6003517A (en) | 1998-04-30 | 1999-12-21 | Ethicon Endo-Surgery, Inc. | Method for using an electrosurgical device on lung tissue |
US6558378B2 (en) | 1998-05-05 | 2003-05-06 | Cardiac Pacemakers, Inc. | RF ablation system and method having automatic temperature control |
US6045550A (en) | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
US6001054A (en) | 1998-05-19 | 1999-12-14 | Regulla; D. F. | Method and apparatus for differential energy application for local dose enhancement of ionizing radiation |
US6241727B1 (en) | 1998-05-27 | 2001-06-05 | Irvine Biomedical, Inc. | Ablation catheter system having circular lesion capabilities |
US5997534A (en) | 1998-06-08 | 1999-12-07 | Tu; Hosheng | Medical ablation device and methods thereof |
US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
US7198635B2 (en) * | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US20070106348A1 (en) | 1998-06-10 | 2007-05-10 | Asthmatx, Inc. | Method for treating airways in the lung |
US20070123958A1 (en) | 1998-06-10 | 2007-05-31 | Asthmatx, Inc. | Apparatus for treating airways in the lung |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6029091A (en) | 1998-07-09 | 2000-02-22 | Irvine Biomedical, Inc. | Catheter system having lattice electrodes |
US6296639B1 (en) | 1999-02-12 | 2001-10-02 | Novacept | Apparatuses and methods for interstitial tissue removal |
US6212433B1 (en) | 1998-07-28 | 2001-04-03 | Radiotherapeutics Corporation | Method for treating tumors near the surface of an organ |
US6322584B2 (en) | 1998-07-31 | 2001-11-27 | Surx, Inc. | Temperature sensing devices and methods to shrink tissues |
US5992419A (en) | 1998-08-20 | 1999-11-30 | Mmtc, Inc. | Method employing a tissue-heating balloon catheter to produce a "biological stent" in an orifice or vessel of a patient's body |
US5980563A (en) | 1998-08-31 | 1999-11-09 | Tu; Lily Chen | Ablation apparatus and methods for treating atherosclerosis |
US6245065B1 (en) | 1998-09-10 | 2001-06-12 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6183468B1 (en) | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6123702A (en) | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6123703A (en) | 1998-09-19 | 2000-09-26 | Tu; Lily Chen | Ablation catheter and methods for treating tissues |
US6036689A (en) | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
ES2238862T3 (en) | 1998-11-16 | 2005-09-01 | United States Surgical Corporation | APPARATUS FOR THERMAL TREATMENT OF FABRIC. |
US6269813B1 (en) | 1999-01-15 | 2001-08-07 | Respironics, Inc. | Tracheal gas insufflation bypass and phasic delivery system and method |
US6432102B2 (en) * | 1999-03-15 | 2002-08-13 | Cryovascular Systems, Inc. | Cryosurgical fluid supply |
US6582427B1 (en) | 1999-03-05 | 2003-06-24 | Gyrus Medical Limited | Electrosurgery system |
US6409723B1 (en) | 1999-04-02 | 2002-06-25 | Stuart D. Edwards | Treating body tissue by applying energy and substances |
US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US6149647A (en) | 1999-04-19 | 2000-11-21 | Tu; Lily Chen | Apparatus and methods for tissue treatment |
US6939346B2 (en) | 1999-04-21 | 2005-09-06 | Oratec Interventions, Inc. | Method and apparatus for controlling a temperature-controlled probe |
US6270476B1 (en) | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6235024B1 (en) | 1999-06-21 | 2001-05-22 | Hosheng Tu | Catheters system having dual ablation capability |
JP3262164B2 (en) * | 1999-06-29 | 2002-03-04 | 日本電気株式会社 | Semiconductor device and manufacturing method thereof |
US6364878B1 (en) | 1999-07-07 | 2002-04-02 | Cardiac Pacemakers, Inc. | Percutaneous transluminal ablation catheter manipulation tool |
US6200332B1 (en) | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
US6749606B2 (en) | 1999-08-05 | 2004-06-15 | Thomas Keast | Devices for creating collateral channels |
US6264653B1 (en) | 1999-09-24 | 2001-07-24 | C. R. Band, Inc. | System and method for gauging the amount of electrode-tissue contact using pulsed radio frequency energy |
US6338836B1 (en) | 1999-09-28 | 2002-01-15 | Siemens Aktiengesellschaft | Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging |
US20030069570A1 (en) | 1999-10-02 | 2003-04-10 | Witzel Thomas H. | Methods for repairing mitral valve annulus percutaneously |
US20040249401A1 (en) | 1999-10-05 | 2004-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with a non-compliant balloon |
US6287304B1 (en) | 1999-10-15 | 2001-09-11 | Neothermia Corporation | Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6589235B2 (en) | 2000-01-21 | 2003-07-08 | The Regents Of The University Of California | Method and apparatus for cartilage reshaping by radiofrequency heating |
US6723091B2 (en) | 2000-02-22 | 2004-04-20 | Gyrus Medical Limited | Tissue resurfacing |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US6544226B1 (en) | 2000-03-13 | 2003-04-08 | Curon Medical, Inc. | Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US6673068B1 (en) | 2000-04-12 | 2004-01-06 | Afx, Inc. | Electrode arrangement for use in a medical instrument |
US6640120B1 (en) | 2000-10-05 | 2003-10-28 | Scimed Life Systems, Inc. | Probe assembly for mapping and ablating pulmonary vein tissue and method of using same |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
ES2255514T3 (en) | 2000-10-17 | 2006-07-01 | Asthmatx, Inc. | MODIFICATION OF THE RESPIRATORY ROADS THROUGH THE ENERGY APPLICATION. |
US6575623B2 (en) | 2000-11-10 | 2003-06-10 | Cardiostream, Inc. | Guide wire having extendable contact sensors for measuring temperature of vessel walls |
US7785323B2 (en) | 2000-12-04 | 2010-08-31 | Boston Scientific Scimed, Inc. | Loop structure including inflatable therapeutic device |
US6676657B2 (en) | 2000-12-07 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Endoluminal radiofrequency cauterization system |
US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
DE10101143A1 (en) | 2001-01-08 | 2002-07-18 | Ulrich Speck | Sterile tissue access system |
US6699243B2 (en) | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
US6620159B2 (en) | 2001-06-06 | 2003-09-16 | Scimed Life Systems, Inc. | Conductive expandable electrode body and method of manufacturing the same |
US20030018327A1 (en) * | 2001-07-20 | 2003-01-23 | Csaba Truckai | Systems and techniques for lung volume reduction |
US20070162085A1 (en) | 2001-07-23 | 2007-07-12 | Dilorenzo Biomedical, Llc | Method, apparatus, surgical technique, and stimulation parameters for autonomic neuromodulation for the treatment of obesity |
US6802843B2 (en) | 2001-09-13 | 2004-10-12 | Csaba Truckai | Electrosurgical working end with resistive gradient electrodes |
JP3607231B2 (en) | 2001-09-28 | 2005-01-05 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US6635056B2 (en) | 2001-10-09 | 2003-10-21 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using amplitude control |
US6895267B2 (en) | 2001-10-24 | 2005-05-17 | Scimed Life Systems, Inc. | Systems and methods for guiding and locating functional elements on medical devices positioned in a body |
US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
US6692492B2 (en) | 2001-11-28 | 2004-02-17 | Cardiac Pacemaker, Inc. | Dielectric-coated ablation electrode having a non-coated window with thermal sensors |
US6893436B2 (en) | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
US20030187430A1 (en) | 2002-03-15 | 2003-10-02 | Vorisek James C. | System and method for measuring power at tissue during RF ablation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
DE10218894A1 (en) | 2002-04-26 | 2003-11-13 | Storz Endoskop Prod Gmbh | Device for monitoring medical devices |
US6881213B2 (en) | 2002-06-28 | 2005-04-19 | Ethicon, Inc. | Device and method to expand treatment array |
US6866662B2 (en) | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
US6852110B2 (en) | 2002-08-01 | 2005-02-08 | Solarant Medical, Inc. | Needle deployment for temperature sensing from an electrode |
US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
US20040153056A1 (en) | 2002-11-11 | 2004-08-05 | Berchtold Holding Gmbh, A German Corporation | Probe |
US7131445B2 (en) | 2002-12-23 | 2006-11-07 | Gyrus Medical Limited | Electrosurgical method and apparatus |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US7100616B2 (en) * | 2003-04-08 | 2006-09-05 | Spiration, Inc. | Bronchoscopic lung volume reduction method |
US20040226556A1 (en) * | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US20060064137A1 (en) | 2003-05-16 | 2006-03-23 | Stone Robert T | Method and system to control respiration by means of simulated action potential signals |
US20050171396A1 (en) | 2003-10-20 | 2005-08-04 | Cyberheart, Inc. | Method for non-invasive lung treatment |
WO2005039689A2 (en) | 2003-10-24 | 2005-05-06 | Sinus Rhythm Technologies, Inc. | Methods and devices for creating cardiac electrical blocks |
US20050096644A1 (en) | 2003-10-30 | 2005-05-05 | Hall Jeffrey A. | Energy delivery optimization for RF duty cycle for lesion creation |
US20080132886A1 (en) | 2004-04-09 | 2008-06-05 | Palomar Medical Technologies, Inc. | Use of fractional emr technology on incisions and internal tissues |
US7377918B2 (en) | 2004-04-28 | 2008-05-27 | Gyrus Medical Limited | Electrosurgical method and apparatus |
EP1768591B1 (en) * | 2004-06-23 | 2014-07-30 | Trod Medical | Flexible endoscope for endo luminal access radio frequency tumor ablation |
US7906124B2 (en) | 2004-09-18 | 2011-03-15 | Asthmatx, Inc. | Inactivation of smooth muscle tissue |
US7553309B2 (en) | 2004-10-08 | 2009-06-30 | Covidien Ag | Electrosurgical system employing multiple electrodes and method thereof |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US7200445B1 (en) | 2005-10-21 | 2007-04-03 | Asthmatx, Inc. | Energy delivery devices and methods |
US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
US20070093802A1 (en) | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
US20060135953A1 (en) | 2004-12-22 | 2006-06-22 | Wlodzimierz Kania | Tissue ablation system including guidewire with sensing element |
EP3804647A1 (en) | 2005-04-21 | 2021-04-14 | Boston Scientific Scimed Inc. | Control methods and devices for energy delivery |
US20070055175A1 (en) * | 2005-05-25 | 2007-03-08 | Pulmosonix Pty Ltd | Devices and methods for tissue analysis |
EP2759276A1 (en) | 2005-06-20 | 2014-07-30 | Medtronic Ablation Frontiers LLC | Ablation catheter |
US7628789B2 (en) * | 2005-08-17 | 2009-12-08 | Pulmonx Corporation | Selective lung tissue ablation |
WO2007058780A2 (en) | 2005-11-10 | 2007-05-24 | Electrocore, Inc. | Electrical stimulation treatment of bronchial constriction |
US20080004596A1 (en) | 2006-05-25 | 2008-01-03 | Palo Alto Institute | Delivery of agents by microneedle catheter |
EP2037840B2 (en) | 2006-06-28 | 2019-02-20 | Medtronic Ardian Luxembourg S.à.r.l. | Systems for thermally-induced renal neuromodulation |
US7931647B2 (en) | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
US7993323B2 (en) * | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US8983609B2 (en) * | 2007-05-30 | 2015-03-17 | The Cleveland Clinic Foundation | Apparatus and method for treating pulmonary conditions |
US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
AU2008279121B2 (en) | 2007-07-24 | 2013-09-19 | Boston Scientific Scimed, Inc. | System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices |
US20090043301A1 (en) | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
TW200942282A (en) | 2007-12-05 | 2009-10-16 | Reset Medical Inc | Method for cryospray ablation |
US8483831B1 (en) * | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
WO2010045222A1 (en) * | 2008-10-13 | 2010-04-22 | E-Pacing, Inc. | Devices and methods for electrical stimulation of the diaphragm and nerves |
US20100160906A1 (en) | 2008-12-23 | 2010-06-24 | Asthmatx, Inc. | Expandable energy delivery devices having flexible conductive elements and associated systems and methods |
EP2493408B1 (en) | 2009-10-27 | 2015-06-24 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
AU2010319477A1 (en) | 2009-11-11 | 2012-05-24 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
WO2011060201A1 (en) | 2009-11-11 | 2011-05-19 | Innovative Pulmonary Solutions, Inc. | Methods and systems for screening subjects |
US20110301587A1 (en) | 2010-04-06 | 2011-12-08 | Innovative Pulmonary Solutions, Inc. | System and method for pulmonary treatment |
US10201386B2 (en) * | 2011-10-05 | 2019-02-12 | Nuvaira, Inc. | Apparatus for injuring nerve tissue |
US20160058502A1 (en) * | 2014-08-27 | 2016-03-03 | Boston Scientific Scimed, Inc. | Devices for damaging nerves and related methods of use |
-
2001
- 2001-10-25 US US09/999,851 patent/US7027869B2/en not_active Expired - Lifetime
-
2005
- 2005-04-29 US US11/117,905 patent/US7740017B2/en not_active Expired - Fee Related
-
2008
- 2008-12-01 US US12/325,985 patent/US7938123B2/en not_active Expired - Fee Related
- 2008-12-04 US US12/328,596 patent/US7770584B2/en not_active Expired - Fee Related
- 2008-12-04 US US12/328,582 patent/US8267094B2/en not_active Expired - Fee Related
-
2010
- 2010-03-18 US US12/727,156 patent/US8161978B2/en not_active Expired - Fee Related
- 2010-12-09 US US12/964,678 patent/US8640711B2/en not_active Expired - Fee Related
-
2012
- 2012-08-20 US US13/590,129 patent/US8944071B2/en not_active Expired - Fee Related
-
2013
- 2013-05-10 US US13/891,959 patent/US9027564B2/en not_active Expired - Fee Related
-
2014
- 2014-01-02 US US14/146,193 patent/US9956023B2/en not_active Expired - Lifetime
- 2014-11-13 US US14/540,870 patent/US20150141984A1/en not_active Abandoned
- 2014-12-22 US US14/579,646 patent/US11033317B2/en not_active Expired - Lifetime
-
2015
- 2015-04-23 US US14/694,397 patent/US10058370B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083255A (en) * | 1997-04-07 | 2000-07-04 | Broncus Technologies, Inc. | Bronchial stenter |
US6634363B1 (en) * | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US8944071B2 (en) * | 1997-04-07 | 2015-02-03 | Asthmatx, Inc. | Method for treating an asthma attack |
US5957919A (en) * | 1997-07-02 | 1999-09-28 | Laufer; Michael D. | Bleb reducer |
US6493589B1 (en) * | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
US8088127B2 (en) * | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8632534B2 (en) * | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11707629B2 (en) | 2009-05-28 | 2023-07-25 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US10004551B2 (en) | 2009-06-01 | 2018-06-26 | Channel Medsystems, Inc. | Methods and apparatus for treatment of a body cavity or lumen |
US20120136343A1 (en) * | 2009-06-01 | 2012-05-31 | Channel Medsystems, Inc. | Methods and apparatus for treatment of a body cavity or lumen |
US10849673B2 (en) | 2009-06-01 | 2020-12-01 | Channel Medsystems, Inc. | Methods and apparatus for treatment of a body cavity or lumen |
US11957398B2 (en) | 2009-06-01 | 2024-04-16 | Channel Medsystems, Inc. | Methods and apparatus for treatment of a body cavity or lumen |
US9427556B2 (en) * | 2009-06-01 | 2016-08-30 | Channel Medsystems, Inc. | Methods for treatment of a body cavity or lumen |
US11931096B2 (en) | 2010-10-13 | 2024-03-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US11883324B2 (en) | 2011-02-01 | 2024-01-30 | Channel Medsystems, Inc. | Cryogenic treatment systems |
US10959879B2 (en) | 2011-02-01 | 2021-03-30 | Channel Medsystems, Inc. | Methods and apparatus for cryogenic treatment of a body cavity or lumen |
US11833076B2 (en) | 2011-02-01 | 2023-12-05 | Channel Medsystems, Inc. | Methods and apparatus for cryogenic treatment of a body cavity or lumen |
US9757196B2 (en) | 2011-09-28 | 2017-09-12 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US11779395B2 (en) | 2011-09-28 | 2023-10-10 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US11957405B2 (en) | 2013-06-13 | 2024-04-16 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
US10702337B2 (en) | 2016-06-27 | 2020-07-07 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US11369433B2 (en) | 2016-06-27 | 2022-06-28 | Galvanize Therapeutics, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US10939958B2 (en) | 2016-06-27 | 2021-03-09 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US11723710B2 (en) | 2016-11-17 | 2023-08-15 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
Also Published As
Publication number | Publication date |
---|---|
US20130253492A1 (en) | 2013-09-26 |
US8944071B2 (en) | 2015-02-03 |
US20050187579A1 (en) | 2005-08-25 |
US20020091379A1 (en) | 2002-07-11 |
US20150305794A1 (en) | 2015-10-29 |
US9027564B2 (en) | 2015-05-12 |
US20100185190A1 (en) | 2010-07-22 |
US7770584B2 (en) | 2010-08-10 |
US7740017B2 (en) | 2010-06-22 |
US11033317B2 (en) | 2021-06-15 |
US7938123B2 (en) | 2011-05-10 |
US20090143705A1 (en) | 2009-06-04 |
US20120323235A1 (en) | 2012-12-20 |
US20140114378A1 (en) | 2014-04-24 |
US7027869B2 (en) | 2006-04-11 |
US9956023B2 (en) | 2018-05-01 |
US10058370B2 (en) | 2018-08-28 |
US20090143776A1 (en) | 2009-06-04 |
US20050159736A9 (en) | 2005-07-21 |
US8640711B2 (en) | 2014-02-04 |
US20110079230A1 (en) | 2011-04-07 |
US20150173943A1 (en) | 2015-06-25 |
US8161978B2 (en) | 2012-04-24 |
US20090112203A1 (en) | 2009-04-30 |
US8267094B2 (en) | 2012-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11033317B2 (en) | Methods for treating a lung | |
US7556624B2 (en) | Method of increasing gas exchange of a lung | |
JP6928632B2 (en) | Delivery device with coolable energy release assembly | |
US5972026A (en) | Bronchial stenter having diametrically adjustable electrodes | |
US6283988B1 (en) | Bronchial stenter having expandable electrodes | |
US6200333B1 (en) | Bronchial stenter | |
JP6734082B2 (en) | Systems, devices and methods for tissue treatment and stenosis control | |
US6299633B1 (en) | Bronchial stenter | |
US6083255A (en) | Bronchial stenter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ASTHMATX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOOMAS, BRYAN E.;LAUFER, MICHAEL D.;THOMPSON, DAVID P.;SIGNING DATES FROM 20141210 TO 20150129;REEL/FRAME:034872/0448 |
|
AS | Assignment |
Owner name: ASTHMATX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DANEK, CHRISTOPHER J.;KEAST, THOMAS M.;LOOMAS, BRYAN E.;SIGNING DATES FROM 20150518 TO 20151001;REEL/FRAME:036969/0565 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |